id	sid	tid	token	lemma	pos
aiua-6590	1	1	archivio	archivio	PROPN
aiua-6590	1	2	italiano	italiano	X
aiua-6590	1	3	di	di	X
aiua-6590	1	4	urologia	urologia	PROPN
aiua-6590	1	5	e	e	PROPN
aiua-6590	1	6	andrologia	andrologia	NOUN
aiua-6590	1	7	2017	2017	NUM
aiua-6590	1	8	;	;	PUNCT
aiua-6590	1	9	89	89	NUM
aiua-6590	1	10	,	,	PUNCT
aiua-6590	1	11	112	112	NUM
aiua-6590	1	12	original	original	ADJ
aiua-6590	1	13	paper	paper	NOUN
aiua-6590	1	14	daidzein	daidzein	ADJ
aiua-6590	1	15	plus	plus	CCONJ
aiua-6590	1	16	isolase	isolase	NOUN
aiua-6590	1	17	associated	associate	VERB
aiua-6590	1	18	with	with	ADP
aiua-6590	1	19	zinc	zinc	NOUN
aiua-6590	1	20	improves	improve	VERB
aiua-6590	1	21	clinical	clinical	ADJ
aiua-6590	1	22	symptoms	symptom	NOUN
aiua-6590	1	23	and	and	CCONJ
aiua-6590	1	24	quality	quality	NOUN
aiua-6590	1	25	of	of	ADP
aiua-6590	1	26	life	life	NOUN
aiua-6590	1	27	in	in	ADP
aiua-6590	1	28	patients	patient	NOUN
aiua-6590	1	29	with	with	ADP
aiua-6590	1	30	luts	luts	PROPN
aiua-6590	1	31	due	due	ADP
aiua-6590	1	32	to	to	ADP
aiua-6590	1	33	benign	benign	ADJ
aiua-6590	1	34	prostatic	prostatic	ADJ
aiua-6590	1	35	hyperplasia	hyperplasia	NOUN
aiua-6590	1	36	:	:	PUNCT
aiua-6590	1	37	results	result	VERB
aiua-6590	1	38	from	from	ADP
aiua-6590	1	39	a	a	DET
aiua-6590	1	40	phase	phase	NOUN
aiua-6590	1	41	i	i	PRON
aiua-6590	1	42	-	-	PUNCT
aiua-6590	1	43	ii	ii	PROPN
aiua-6590	1	44	study	study	NOUN
aiua-6590	1	45	daniele	daniele	PROPN
aiua-6590	1	46	tiscione	tiscione	PROPN
aiua-6590	1	47	1	1	NUM
aiua-6590	1	48	,	,	PUNCT
aiua-6590	1	49	luca	luca	PROPN
aiua-6590	1	50	gallelli	gallelli	PROPN
aiua-6590	1	51	2	2	NUM
aiua-6590	1	52	,	,	PUNCT
aiua-6590	1	53	irene	irene	PROPN
aiua-6590	1	54	tamanini	tamanini	PROPN
aiua-6590	1	55	1	1	NUM
aiua-6590	1	56	,	,	PUNCT
aiua-6590	1	57	lorenzo	lorenzo	PROPN
aiua-6590	1	58	giuseppe	giuseppe	PROPN
aiua-6590	1	59	luciani	luciani	PROPN
aiua-6590	1	60	1	1	NUM
aiua-6590	1	61	,	,	PUNCT
aiua-6590	1	62	paolo	paolo	PROPN
aiua-6590	1	63	verze	verze	PROPN
aiua-6590	1	64	3	3	NUM
aiua-6590	1	65	,	,	PUNCT
aiua-6590	1	66	alessandro	alessandro	PROPN
aiua-6590	1	67	palmieri	palmieri	PROPN
aiua-6590	1	68	3	3	NUM
aiua-6590	1	69	,	,	PUNCT
aiua-6590	1	70	vincenzo	vincenzo	PROPN
aiua-6590	1	71	mirone	mirone	NOUN
aiua-6590	1	72	3	3	NUM
aiua-6590	1	73	,	,	PUNCT
aiua-6590	1	74	riccardo	riccardo	NOUN
aiua-6590	1	75	bartoletti	bartoletti	PROPN
aiua-6590	1	76	4	4	NUM
aiua-6590	1	77	,	,	PUNCT
aiua-6590	1	78	gianni	gianni	PROPN
aiua-6590	1	79	malossini	malossini	PROPN
aiua-6590	1	80	1	1	NUM
aiua-6590	1	81	,	,	PUNCT
aiua-6590	1	82	tommaso	tommaso	PROPN
aiua-6590	1	83	cai	cai	PROPN
aiua-6590	1	84	1	1	NUM
aiua-6590	1	85	1	1	NUM
aiua-6590	1	86	department	department	NOUN
aiua-6590	1	87	of	of	ADP
aiua-6590	1	88	urology	urology	NOUN
aiua-6590	1	89	,	,	PUNCT
aiua-6590	1	90	santa	santa	PROPN
aiua-6590	1	91	chiara	chiara	PROPN
aiua-6590	1	92	regional	regional	ADJ
aiua-6590	1	93	hospital	hospital	NOUN
aiua-6590	1	94	,	,	PUNCT
aiua-6590	1	95	trento	trento	PROPN
aiua-6590	1	96	,	,	PUNCT
aiua-6590	1	97	italy	italy	PROPN
aiua-6590	1	98	;	;	PUNCT
aiua-6590	1	99	2	2	NUM
aiua-6590	1	100	department	department	NOUN
aiua-6590	1	101	of	of	ADP
aiua-6590	1	102	health	health	NOUN
aiua-6590	1	103	science	science	NOUN
aiua-6590	1	104	,	,	PUNCT
aiua-6590	1	105	school	school	NOUN
aiua-6590	1	106	of	of	ADP
aiua-6590	1	107	medicine	medicine	NOUN
aiua-6590	1	108	,	,	PUNCT
aiua-6590	1	109	university	university	NOUN
aiua-6590	1	110	of	of	ADP
aiua-6590	1	111	catanzaro	catanzaro	PROPN
aiua-6590	1	112	,	,	PUNCT
aiua-6590	1	113	catanzaro	catanzaro	PROPN
aiua-6590	1	114	,	,	PUNCT
aiua-6590	1	115	italy	italy	PROPN
aiua-6590	1	116	;	;	PUNCT
aiua-6590	1	117	3	3	NUM
aiua-6590	1	118	department	department	NOUN
aiua-6590	1	119	of	of	ADP
aiua-6590	1	120	urology	urology	NOUN
aiua-6590	1	121	,	,	PUNCT
aiua-6590	1	122	university	university	PROPN
aiua-6590	1	123	of	of	ADP
aiua-6590	1	124	naples	naples	PROPN
aiua-6590	1	125	,	,	PUNCT
aiua-6590	1	126	federico	federico	PROPN
aiua-6590	1	127	ii	ii	PROPN
aiua-6590	1	128	,	,	PUNCT
aiua-6590	1	129	naples	naples	PROPN
aiua-6590	1	130	,	,	PUNCT
aiua-6590	1	131	italy	italy	PROPN
aiua-6590	1	132	;	;	PUNCT
aiua-6590	1	133	4	4	NUM
aiua-6590	1	134	department	department	NOUN
aiua-6590	1	135	of	of	ADP
aiua-6590	1	136	urology	urology	NOUN
aiua-6590	1	137	,	,	PUNCT
aiua-6590	1	138	university	university	NOUN
aiua-6590	1	139	of	of	ADP
aiua-6590	1	140	pisa	pisa	PROPN
aiua-6590	1	141	,	,	PUNCT
aiua-6590	1	142	pisa	pisa	PROPN
aiua-6590	1	143	,	,	PUNCT
aiua-6590	1	144	italy	italy	PROPN
aiua-6590	1	145	.	.	PUNCT
aiua-6590	2	1	objective	objective	NOUN
aiua-6590	2	2	:	:	PUNCT
aiua-6590	2	3	in	in	ADP
aiua-6590	2	4	the	the	DET
aiua-6590	2	5	last	last	ADJ
aiua-6590	2	6	years	year	NOUN
aiua-6590	2	7	there	there	PRON
aiua-6590	2	8	is	be	VERB
aiua-6590	2	9	a	a	DET
aiua-6590	2	10	growing	grow	VERB
aiua-6590	2	11	interest	interest	NOUN
aiua-6590	2	12	in	in	ADP
aiua-6590	2	13	nutraceutical	nutraceutical	ADJ
aiua-6590	2	14	substances	substance	NOUN
aiua-6590	2	15	that	that	PRON
aiua-6590	2	16	seems	seem	VERB
aiua-6590	2	17	able	able	ADJ
aiua-6590	2	18	to	to	PART
aiua-6590	2	19	improve	improve	VERB
aiua-6590	2	20	clinical	clinical	ADJ
aiua-6590	2	21	symptoms	symptom	NOUN
aiua-6590	2	22	in	in	ADP
aiua-6590	2	23	patients	patient	NOUN
aiua-6590	2	24	with	with	ADP
aiua-6590	2	25	lower	low	ADJ
aiua-6590	2	26	urinary	urinary	ADJ
aiua-6590	2	27	tract	tract	NOUN
aiua-6590	2	28	symptoms	symptom	NOUN
aiua-6590	2	29	(	(	PUNCT
aiua-6590	2	30	luts	luts	PROPN
aiua-6590	2	31	)	)	PUNCT
aiua-6590	2	32	due	due	ADP
aiua-6590	2	33	to	to	ADP
aiua-6590	2	34	benign	benign	ADJ
aiua-6590	2	35	prostatic	prostatic	ADJ
aiua-6590	2	36	hyperplasia	hyperplasia	NOUN
aiua-6590	2	37	(	(	PUNCT
aiua-6590	2	38	bph	bph	NOUN
aiua-6590	2	39	)	)	PUNCT
aiua-6590	2	40	.	.	PUNCT
aiua-6590	3	1	in	in	ADP
aiua-6590	3	2	this	this	DET
aiua-6590	3	3	paper	paper	NOUN
aiua-6590	3	4	,	,	PUNCT
aiua-6590	3	5	we	we	PRON
aiua-6590	3	6	evaluated	evaluate	VERB
aiua-6590	3	7	both	both	DET
aiua-6590	3	8	efficacy	efficacy	NOUN
aiua-6590	3	9	and	and	CCONJ
aiua-6590	3	10	safety	safety	NOUN
aiua-6590	3	11	of	of	ADP
aiua-6590	3	12	a	a	DET
aiua-6590	3	13	combination	combination	NOUN
aiua-6590	3	14	of	of	ADP
aiua-6590	3	15	daidzein	daidzein	NOUN
aiua-6590	3	16	with	with	ADP
aiua-6590	3	17	isolase	isolase	NOUN
aiua-6590	3	18	and	and	CCONJ
aiua-6590	3	19	zinc	zinc	NOUN
aiua-6590	3	20	in	in	ADP
aiua-6590	3	21	patients	patient	NOUN
aiua-6590	3	22	with	with	ADP
aiua-6590	3	23	luts	luts	PROPN
aiua-6590	3	24	due	due	ADP
aiua-6590	3	25	to	to	ADP
aiua-6590	3	26	bph	bph	NOUN
aiua-6590	3	27	.	.	PUNCT
aiua-6590	4	1	materials	material	NOUN
aiua-6590	4	2	and	and	CCONJ
aiua-6590	4	3	methods	method	NOUN
aiua-6590	4	4	:	:	PUNCT
aiua-6590	4	5	in	in	ADP
aiua-6590	4	6	a	a	DET
aiua-6590	4	7	phase	phase	NOUN
aiua-6590	4	8	i	i	PRON
aiua-6590	4	9	-	-	PUNCT
aiua-6590	4	10	ii	ii	PROPN
aiua-6590	4	11	study	study	NOUN
aiua-6590	4	12	clinical	clinical	ADJ
aiua-6590	4	13	trial	trial	NOUN
aiua-6590	4	14	we	we	PRON
aiua-6590	4	15	enrolled	enrol	VERB
aiua-6590	4	16	patients	patient	NOUN
aiua-6590	4	17	with	with	ADP
aiua-6590	4	18	clinical	clinical	ADJ
aiua-6590	4	19	and	and	CCONJ
aiua-6590	4	20	instrumental	instrumental	ADJ
aiua-6590	4	21	diagnosis	diagnosis	NOUN
aiua-6590	4	22	of	of	ADP
aiua-6590	4	23	luts	luts	PROPN
aiua-6590	4	24	associated	associate	VERB
aiua-6590	4	25	to	to	ADP
aiua-6590	4	26	bph	bph	NOUN
aiua-6590	4	27	that	that	PRON
aiua-6590	4	28	received	receive	VERB
aiua-6590	4	29	a	a	DET
aiua-6590	4	30	six	six	NUM
aiua-6590	4	31	-	-	PUNCT
aiua-6590	4	32	month	month	NOUN
aiua-6590	4	33	treatment	treatment	NOUN
aiua-6590	4	34	with	with	ADP
aiua-6590	4	35	a	a	DET
aiua-6590	4	36	combination	combination	NOUN
aiua-6590	4	37	of	of	ADP
aiua-6590	4	38	daidzein	daidzein	NOUN
aiua-6590	4	39	with	with	ADP
aiua-6590	4	40	isolase	isolase	NOUN
aiua-6590	4	41	and	and	CCONJ
aiua-6590	4	42	zinc	zinc	NOUN
aiua-6590	4	43	(	(	PUNCT
aiua-6590	4	44	1	1	NUM
aiua-6590	4	45	tablet	tablet	NOUN
aiua-6590	4	46	/	/	SYM
aiua-6590	4	47	day	day	NOUN
aiua-6590	4	48	)	)	PUNCT
aiua-6590	4	49	.	.	PUNCT
aiua-6590	5	1	clinical	clinical	ADJ
aiua-6590	5	2	,	,	PUNCT
aiua-6590	5	3	laboratory	laboratory	NOUN
aiua-6590	5	4	and	and	CCONJ
aiua-6590	5	5	instrumental	instrumental	ADJ
aiua-6590	5	6	analyses	analysis	NOUN
aiua-6590	5	7	were	be	AUX
aiua-6590	5	8	carried	carry	VERB
aiua-6590	5	9	out	out	ADP
aiua-6590	5	10	at	at	ADP
aiua-6590	5	11	the	the	DET
aiua-6590	5	12	time	time	NOUN
aiua-6590	5	13	of	of	ADP
aiua-6590	5	14	admission	admission	NOUN
aiua-6590	5	15	(	(	PUNCT
aiua-6590	5	16	t0	t0	NOUN
aiua-6590	5	17	)	)	PUNCT
aiua-6590	5	18	and	and	CCONJ
aiua-6590	5	19	6	6	NUM
aiua-6590	5	20	months	month	NOUN
aiua-6590	5	21	after	after	ADP
aiua-6590	5	22	the	the	DET
aiua-6590	5	23	ending	ending	NOUN
aiua-6590	5	24	of	of	ADP
aiua-6590	5	25	the	the	DET
aiua-6590	5	26	treatment	treatment	NOUN
aiua-6590	5	27	(	(	PUNCT
aiua-6590	5	28	t1	t1	NOUN
aiua-6590	5	29	)	)	PUNCT
aiua-6590	5	30	.	.	PUNCT
aiua-6590	6	1	the	the	DET
aiua-6590	6	2	italian	italian	ADJ
aiua-6590	6	3	version	version	NOUN
aiua-6590	6	4	of	of	ADP
aiua-6590	6	5	international	international	ADJ
aiua-6590	6	6	prostatic	prostatic	ADJ
aiua-6590	6	7	symptom	symptom	NOUN
aiua-6590	6	8	score	score	NOUN
aiua-6590	6	9	(	(	PUNCT
aiua-6590	6	10	ipss	ipss	PROPN
aiua-6590	6	11	)	)	PUNCT
aiua-6590	6	12	,	,	PUNCT
aiua-6590	6	13	international	international	ADJ
aiua-6590	6	14	index	index	NOUN
aiua-6590	6	15	of	of	ADP
aiua-6590	6	16	erectile	erectile	NOUN
aiua-6590	6	17	function	function	NOUN
aiua-6590	6	18	(	(	PUNCT
aiua-6590	6	19	iief-5	iief-5	NUM
aiua-6590	6	20	)	)	PUNCT
aiua-6590	6	21	and	and	CCONJ
aiua-6590	6	22	quality	quality	NOUN
aiua-6590	6	23	of	of	ADP
aiua-6590	6	24	well	well	ADV
aiua-6590	6	25	-	-	PUNCT
aiua-6590	6	26	being	be	AUX
aiua-6590	6	27	(	(	PUNCT
aiua-6590	6	28	qol	qol	NOUN
aiua-6590	6	29	)	)	PUNCT
aiua-6590	6	30	questionnaires	questionnaire	NOUN
aiua-6590	6	31	were	be	AUX
aiua-6590	6	32	used	use	VERB
aiua-6590	6	33	.	.	PUNCT
aiua-6590	7	1	the	the	DET
aiua-6590	7	2	development	development	NOUN
aiua-6590	7	3	of	of	ADP
aiua-6590	7	4	adverse	adverse	ADJ
aiua-6590	7	5	drug	drug	NOUN
aiua-6590	7	6	reactions	reaction	NOUN
aiua-6590	7	7	(	(	PUNCT
aiua-6590	7	8	adrs	adrs	PROPN
aiua-6590	7	9	)	)	PUNCT
aiua-6590	7	10	and	and	CCONJ
aiua-6590	7	11	drug	drug	NOUN
aiua-6590	7	12	interactions	interaction	NOUN
aiua-6590	7	13	(	(	PUNCT
aiua-6590	7	14	ddis	ddi	NOUN
aiua-6590	7	15	)	)	PUNCT
aiua-6590	7	16	were	be	AUX
aiua-6590	7	17	recorded	record	VERB
aiua-6590	7	18	using	use	VERB
aiua-6590	7	19	the	the	DET
aiua-6590	7	20	naranjo	naranjo	PROPN
aiua-6590	7	21	scale	scale	NOUN
aiua-6590	7	22	and	and	CCONJ
aiua-6590	7	23	drug	drug	NOUN
aiua-6590	7	24	interaction	interaction	NOUN
aiua-6590	7	25	probability	probability	NOUN
aiua-6590	7	26	scale	scale	NOUN
aiua-6590	7	27	.	.	PUNCT
aiua-6590	8	1	student	student	NOUN
aiua-6590	8	2	’s	’s	PART
aiua-6590	8	3	t	t	PROPN
aiua-6590	8	4	test	test	NOUN
aiua-6590	8	5	and	and	CCONJ
aiua-6590	8	6	anova	anova	PROPN
aiua-6590	8	7	test	test	NOUN
aiua-6590	8	8	were	be	AUX
aiua-6590	8	9	used	use	VERB
aiua-6590	8	10	for	for	ADP
aiua-6590	8	11	statistical	statistical	ADJ
aiua-6590	8	12	analysis	analysis	NOUN
aiua-6590	8	13	,	,	PUNCT
aiua-6590	8	14	and	and	CCONJ
aiua-6590	8	15	the	the	DET
aiua-6590	8	16	threshold	threshold	NOUN
aiua-6590	8	17	of	of	ADP
aiua-6590	8	18	statistical	statistical	ADJ
aiua-6590	8	19	significance	significance	NOUN
aiua-6590	8	20	was	be	AUX
aiua-6590	8	21	set	set	VERB
aiua-6590	8	22	at	at	ADP
aiua-6590	8	23	p	p	NOUN
aiua-6590	8	24	<	<	X
aiua-6590	8	25	0.05	0.05	NUM
aiua-6590	8	26	.	.	PUNCT
aiua-6590	9	1	results	result	NOUN
aiua-6590	9	2	:	:	PUNCT
aiua-6590	9	3	we	we	PRON
aiua-6590	9	4	enrolled	enrol	VERB
aiua-6590	9	5	71	71	NUM
aiua-6590	9	6	patients	patient	NOUN
aiua-6590	9	7	,	,	PUNCT
aiua-6590	9	8	62	62	NUM
aiua-6590	9	9	(	(	PUNCT
aiua-6590	9	10	87.3	87.3	NUM
aiua-6590	9	11	%	%	NOUN
aiua-6590	9	12	)	)	PUNCT
aiua-6590	9	13	completed	complete	VERB
aiua-6590	9	14	the	the	DET
aiua-6590	9	15	follow	follow	NOUN
aiua-6590	9	16	-	-	PUNCT
aiua-6590	9	17	up	up	NOUN
aiua-6590	9	18	and	and	CCONJ
aiua-6590	9	19	we	we	PRON
aiua-6590	9	20	documented	document	VERB
aiua-6590	9	21	a	a	DET
aiua-6590	9	22	significant	significant	ADJ
aiua-6590	9	23	differences	difference	NOUN
aiua-6590	9	24	between	between	ADP
aiua-6590	9	25	t0	t0	PROPN
aiua-6590	9	26	and	and	CCONJ
aiua-6590	9	27	t1	t1	VERB
aiua-6590	9	28	in	in	ADP
aiua-6590	9	29	terms	term	NOUN
aiua-6590	9	30	of	of	ADP
aiua-6590	9	31	ipss	ipss	PROPN
aiua-6590	10	1	[	[	X
aiua-6590	10	2	21.5	21.5	NUM
aiua-6590	10	3	±	±	NUM
aiua-6590	10	4	1.2	1.2	NUM
aiua-6590	10	5	vs	vs	ADP
aiua-6590	10	6	16.2	16.2	NUM
aiua-6590	10	7	±	±	NUM
aiua-6590	10	8	1.5	1.5	NUM
aiua-6590	10	9	;	;	PUNCT
aiua-6590	10	10	(	(	PUNCT
aiua-6590	10	11	-4.8	-4.8	VERB
aiua-6590	10	12	)	)	PUNCT
aiua-6590	10	13	;	;	PUNCT
aiua-6590	10	14	p	p	X
aiua-6590	10	15	<	<	X
aiua-6590	10	16	0.001	0.001	NUM
aiua-6590	10	17	]	]	PUNCT
aiua-6590	10	18	,	,	PUNCT
aiua-6590	10	19	cmax	cmax	VERB
aiua-6590	10	20	[	[	PUNCT
aiua-6590	10	21	9.7	9.7	NUM
aiua-6590	10	22	±	±	NUM
aiua-6590	10	23	3.7vs	3.7vs	NUM
aiua-6590	10	24	15.3	15.3	NUM
aiua-6590	10	25	±	±	NUM
aiua-6590	10	26	2.5	2.5	NUM
aiua-6590	10	27	;	;	PUNCT
aiua-6590	10	28	(	(	PUNCT
aiua-6590	10	29	+5.6	+5.6	PROPN
aiua-6590	10	30	)	)	PUNCT
aiua-6590	10	31	;	;	PUNCT
aiua-6590	10	32	p	p	X
aiua-6590	10	33	<	<	X
aiua-6590	10	34	0.001	0.001	NUM
aiua-6590	10	35	]	]	PUNCT
aiua-6590	10	36	and	and	CCONJ
aiua-6590	10	37	qol	qol	X
aiua-6590	11	1	[	[	X
aiua-6590	11	2	0.56	0.56	NUM
aiua-6590	11	3	±	±	NUM
aiua-6590	11	4	0.15	0.15	NUM
aiua-6590	11	5	vs	vs	ADP
aiua-6590	11	6	0.84	0.84	NUM
aiua-6590	11	7	±	±	NUM
aiua-6590	11	8	0.19	0.19	NUM
aiua-6590	11	9	;	;	PUNCT
aiua-6590	11	10	(	(	PUNCT
aiua-6590	11	11	+0.28	+0.28	NOUN
aiua-6590	11	12	)	)	PUNCT
aiua-6590	11	13	;	;	PUNCT
aiua-6590	11	14	p	p	X
aiua-6590	11	15	<	<	X
aiua-6590	11	16	0.001	0.001	NUM
aiua-6590	11	17	]	]	PUNCT
aiua-6590	11	18	.	.	PUNCT
aiua-6590	12	1	in	in	ADP
aiua-6590	12	2	contrast	contrast	NOUN
aiua-6590	12	3	,	,	PUNCT
aiua-6590	12	4	no	no	DET
aiua-6590	12	5	significant	significant	ADJ
aiua-6590	12	6	difference	difference	NOUN
aiua-6590	12	7	were	be	AUX
aiua-6590	12	8	recorded	record	VERB
aiua-6590	12	9	in	in	ADP
aiua-6590	12	10	terms	term	NOUN
aiua-6590	12	11	of	of	ADP
aiua-6590	12	12	iief-5	iief-5	PRON
aiua-6590	12	13	[	[	X
aiua-6590	12	14	p	p	X
aiua-6590	12	15	=	=	NOUN
aiua-6590	12	16	0.50	0.50	NUM
aiua-6590	12	17	]	]	PUNCT
aiua-6590	12	18	and	and	CCONJ
aiua-6590	12	19	psa	psa	VERB
aiua-6590	12	20	[	[	X
aiua-6590	12	21	p	p	X
aiua-6590	12	22	=	=	NOUN
aiua-6590	12	23	0.67	0.67	NUM
aiua-6590	12	24	]	]	PUNCT
aiua-6590	12	25	.	.	PUNCT
aiua-6590	13	1	finally	finally	ADV
aiua-6590	13	2	,	,	PUNCT
aiua-6590	13	3	we	we	PRON
aiua-6590	13	4	did	do	AUX
aiua-6590	13	5	not	not	PART
aiua-6590	13	6	record	record	VERB
aiua-6590	13	7	any	any	DET
aiua-6590	13	8	significant	significant	ADJ
aiua-6590	13	9	adrs	adr	NOUN
aiua-6590	13	10	or	or	CCONJ
aiua-6590	13	11	ddis	ddi	NOUN
aiua-6590	13	12	during	during	ADP
aiua-6590	13	13	the	the	DET
aiua-6590	13	14	study	study	NOUN
aiua-6590	13	15	.	.	PUNCT
aiua-6590	14	1	conclusions	conclusion	NOUN
aiua-6590	14	2	:	:	PUNCT
aiua-6590	14	3	in	in	ADP
aiua-6590	14	4	this	this	DET
aiua-6590	14	5	study	study	NOUN
aiua-6590	14	6	,	,	PUNCT
aiua-6590	14	7	we	we	PRON
aiua-6590	14	8	documented	document	VERB
aiua-6590	14	9	that	that	SCONJ
aiua-6590	14	10	a	a	DET
aiua-6590	14	11	combination	combination	NOUN
aiua-6590	14	12	of	of	ADP
aiua-6590	14	13	daidzein	daidzein	NOUN
aiua-6590	14	14	with	with	ADP
aiua-6590	14	15	isolase	isolase	NOUN
aiua-6590	14	16	and	and	CCONJ
aiua-6590	14	17	zinc	zinc	NOUN
aiua-6590	14	18	,	,	PUNCT
aiua-6590	14	19	reduces	reduce	VERB
aiua-6590	14	20	the	the	DET
aiua-6590	14	21	clinical	clinical	ADJ
aiua-6590	14	22	symptoms	symptom	NOUN
aiua-6590	14	23	of	of	ADP
aiua-6590	14	24	luts	luts	PROPN
aiua-6590	14	25	and	and	CCONJ
aiua-6590	14	26	improves	improve	VERB
aiua-6590	14	27	the	the	DET
aiua-6590	14	28	quality	quality	NOUN
aiua-6590	14	29	of	of	ADP
aiua-6590	14	30	life	life	NOUN
aiua-6590	14	31	in	in	ADP
aiua-6590	14	32	patients	patient	NOUN
aiua-6590	14	33	with	with	ADP
aiua-6590	14	34	bph	bph	NOUN
aiua-6590	14	35	,	,	PUNCT
aiua-6590	14	36	without	without	ADP
aiua-6590	14	37	the	the	DET
aiua-6590	14	38	development	development	NOUN
aiua-6590	14	39	of	of	ADP
aiua-6590	14	40	adrs	adr	NOUN
aiua-6590	14	41	or	or	CCONJ
aiua-6590	14	42	ddis	ddi	NOUN
aiua-6590	14	43	.	.	PUNCT
aiua-6590	15	1	key	key	ADJ
aiua-6590	15	2	words	word	NOUN
aiua-6590	15	3	:	:	PUNCT
aiua-6590	15	4	bph	bph	NOUN
aiua-6590	15	5	;	;	PUNCT
aiua-6590	15	6	zinc	zinc	NOUN
aiua-6590	15	7	;	;	PUNCT
aiua-6590	15	8	luts	luts	PROPN
aiua-6590	15	9	;	;	PUNCT
aiua-6590	15	10	equol	equol	NOUN
aiua-6590	15	11	;	;	PUNCT
aiua-6590	15	12	isoflavones	isoflavone	NOUN
aiua-6590	15	13	;	;	PUNCT
aiua-6590	15	14	medical	medical	ADJ
aiua-6590	15	15	treatment	treatment	NOUN
aiua-6590	15	16	.	.	PUNCT
aiua-6590	15	17	submitted	submit	VERB
aiua-6590	15	18	20	20	NUM
aiua-6590	15	19	january	january	PROPN
aiua-6590	15	20	2017	2017	NUM
aiua-6590	15	21	;	;	PUNCT
aiua-6590	15	22	accepted	accept	VERB
aiua-6590	15	23	18	18	NUM
aiua-6590	15	24	february	february	NUM
aiua-6590	15	25	2017	2017	NUM
aiua-6590	15	26	summary	summary	NOUN
aiua-6590	15	27	no	no	DET
aiua-6590	15	28	conflict	conflict	NOUN
aiua-6590	15	29	of	of	ADP
aiua-6590	15	30	interest	interest	NOUN
aiua-6590	15	31	declared	declare	VERB
aiua-6590	15	32	.	.	PUNCT
aiua-6590	16	1	vant	vant	PROPN
aiua-6590	16	2	lower	low	ADJ
aiua-6590	16	3	urinary	urinary	ADJ
aiua-6590	16	4	tract	tract	NOUN
aiua-6590	16	5	symptoms	symptom	NOUN
aiua-6590	16	6	(	(	PUNCT
aiua-6590	16	7	luts	luts	PROPN
aiua-6590	16	8	)	)	PUNCT
aiua-6590	16	9	that	that	PRON
aiua-6590	16	10	can	can	AUX
aiua-6590	16	11	reduce	reduce	VERB
aiua-6590	16	12	the	the	DET
aiua-6590	16	13	quality	quality	NOUN
aiua-6590	16	14	of	of	ADP
aiua-6590	16	15	life	life	NOUN
aiua-6590	16	16	(	(	PUNCT
aiua-6590	16	17	qol	qol	NOUN
aiua-6590	16	18	)	)	PUNCT
aiua-6590	16	19	leading	lead	VERB
aiua-6590	16	20	to	to	ADP
aiua-6590	16	21	serious	serious	ADJ
aiua-6590	16	22	clinical	clinical	ADJ
aiua-6590	16	23	manifestations	manifestation	NOUN
aiua-6590	16	24	,	,	PUNCT
aiua-6590	16	25	e.g.	e.g.	ADV
aiua-6590	16	26	acute	acute	ADJ
aiua-6590	16	27	urinary	urinary	ADJ
aiua-6590	16	28	retention	retention	NOUN
aiua-6590	16	29	,	,	PUNCT
aiua-6590	16	30	urinary	urinary	ADJ
aiua-6590	16	31	incontinence	incontinence	NOUN
aiua-6590	16	32	,	,	PUNCT
aiua-6590	16	33	recurrent	recurrent	ADJ
aiua-6590	16	34	urinary	urinary	ADJ
aiua-6590	16	35	tract	tract	NOUN
aiua-6590	16	36	infection	infection	NOUN
aiua-6590	16	37	,	,	PUNCT
aiua-6590	16	38	obstructive	obstructive	ADJ
aiua-6590	16	39	uropathy	uropathy	NOUN
aiua-6590	16	40	,	,	PUNCT
aiua-6590	16	41	up	up	ADP
aiua-6590	16	42	to	to	ADP
aiua-6590	16	43	surgery	surgery	NOUN
aiua-6590	16	44	(	(	PUNCT
aiua-6590	16	45	2	2	NUM
aiua-6590	16	46	)	)	PUNCT
aiua-6590	16	47	.	.	PUNCT
aiua-6590	17	1	to	to	ADP
aiua-6590	17	2	date	date	NOUN
aiua-6590	17	3	,	,	PUNCT
aiua-6590	17	4	two	two	NUM
aiua-6590	17	5	main	main	ADJ
aiua-6590	17	6	categories	category	NOUN
aiua-6590	17	7	of	of	ADP
aiua-6590	17	8	drugs	drug	NOUN
aiua-6590	17	9	are	be	AUX
aiua-6590	17	10	prescribed	prescribe	VERB
aiua-6590	17	11	to	to	PART
aiua-6590	17	12	treat	treat	VERB
aiua-6590	17	13	patients	patient	NOUN
aiua-6590	17	14	with	with	ADP
aiua-6590	17	15	symptomatic	symptomatic	ADJ
aiua-6590	17	16	bph	bph	NOUN
aiua-6590	17	17	:	:	PUNCT
aiua-6590	18	1	1	1	NUM
aiua-6590	18	2	)	)	PUNCT
aiua-6590	18	3	α1	α1	ADJ
aiua-6590	18	4	-	-	PUNCT
aiua-6590	18	5	adrenoreceptor	adrenoreceptor	NOUN
aiua-6590	18	6	antagonists	antagonist	NOUN
aiua-6590	18	7	that	that	PRON
aiua-6590	18	8	improve	improve	VERB
aiua-6590	18	9	the	the	DET
aiua-6590	18	10	dynamic	dynamic	ADJ
aiua-6590	18	11	component	component	NOUN
aiua-6590	18	12	of	of	ADP
aiua-6590	18	13	urination	urination	NOUN
aiua-6590	18	14	(	(	PUNCT
aiua-6590	18	15	activation	activation	NOUN
aiua-6590	18	16	of	of	ADP
aiua-6590	18	17	bladder	bladder	NOUN
aiua-6590	18	18	smooth	smooth	ADJ
aiua-6590	18	19	muscles	muscle	NOUN
aiua-6590	18	20	)	)	PUNCT
aiua-6590	18	21	and	and	CCONJ
aiua-6590	18	22	relieve	relieve	VERB
aiua-6590	18	23	the	the	DET
aiua-6590	18	24	symptoms	symptom	NOUN
aiua-6590	18	25	(	(	PUNCT
aiua-6590	18	26	3	3	NUM
aiua-6590	18	27	)	)	PUNCT
aiua-6590	18	28	;	;	PUNCT
aiua-6590	18	29	2	2	X
aiua-6590	18	30	)	)	PUNCT
aiua-6590	18	31	5	5	NUM
aiua-6590	18	32	-	-	PUNCT
aiua-6590	18	33	aris	aris	NOUN
aiua-6590	18	34	that	that	PRON
aiua-6590	18	35	block	block	VERB
aiua-6590	18	36	the	the	DET
aiua-6590	18	37	conversion	conversion	NOUN
aiua-6590	18	38	of	of	ADP
aiua-6590	18	39	testosterone	testosterone	NOUN
aiua-6590	18	40	to	to	ADP
aiua-6590	18	41	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-6590	18	42	,	,	PUNCT
aiua-6590	18	43	and	and	CCONJ
aiua-6590	18	44	deprive	deprive	VERB
aiua-6590	18	45	the	the	DET
aiua-6590	18	46	prostatic	prostatic	ADJ
aiua-6590	18	47	tissue	tissue	NOUN
aiua-6590	18	48	of	of	ADP
aiua-6590	18	49	trophic	trophic	ADJ
aiua-6590	18	50	androgenic	androgenic	ADJ
aiua-6590	18	51	influence	influence	NOUN
aiua-6590	18	52	(	(	PUNCT
aiua-6590	18	53	3	3	NUM
aiua-6590	18	54	)	)	PUNCT
aiua-6590	18	55	.	.	PUNCT
aiua-6590	19	1	the	the	DET
aiua-6590	19	2	guidelines	guideline	NOUN
aiua-6590	19	3	for	for	ADP
aiua-6590	19	4	bph	bph	NOUN
aiua-6590	19	5	/	/	SYM
aiua-6590	19	6	luts	luts	PROPN
aiua-6590	19	7	recommend	recommend	VERB
aiua-6590	19	8	a	a	DET
aiua-6590	19	9	combination	combination	NOUN
aiua-6590	19	10	therapy	therapy	NOUN
aiua-6590	19	11	with	with	ADP
aiua-6590	19	12	α	α	NOUN
aiua-6590	19	13	-	-	PUNCT
aiua-6590	19	14	blockers	blocker	NOUN
aiua-6590	19	15	and	and	CCONJ
aiua-6590	19	16	5ari	5ari	ADJ
aiua-6590	19	17	in	in	ADP
aiua-6590	19	18	patients	patient	NOUN
aiua-6590	19	19	with	with	ADP
aiua-6590	19	20	moderate	moderate	ADJ
aiua-6590	19	21	-	-	PUNCT
aiua-6590	19	22	tosevere	tosevere	NOUN
aiua-6590	19	23	luts	luts	PROPN
aiua-6590	19	24	and	and	CCONJ
aiua-6590	19	25	enlarged	enlarge	VERB
aiua-6590	19	26	prostates	prostate	NOUN
aiua-6590	19	27	(	(	PUNCT
aiua-6590	19	28	3	3	NUM
aiua-6590	19	29	)	)	PUNCT
aiua-6590	19	30	.	.	PUNCT
aiua-6590	20	1	unfortunately	unfortunately	ADV
aiua-6590	20	2	,	,	PUNCT
aiua-6590	20	3	these	these	DET
aiua-6590	20	4	treatments	treatment	NOUN
aiua-6590	20	5	may	may	AUX
aiua-6590	20	6	be	be	AUX
aiua-6590	20	7	related	relate	VERB
aiua-6590	20	8	with	with	ADP
aiua-6590	20	9	the	the	DET
aiua-6590	20	10	development	development	NOUN
aiua-6590	20	11	of	of	ADP
aiua-6590	20	12	adrs	adr	NOUN
aiua-6590	20	13	that	that	PRON
aiua-6590	20	14	can	can	AUX
aiua-6590	20	15	induce	induce	VERB
aiua-6590	20	16	the	the	DET
aiua-6590	20	17	discontinuation	discontinuation	NOUN
aiua-6590	20	18	of	of	ADP
aiua-6590	20	19	the	the	DET
aiua-6590	20	20	current	current	ADJ
aiua-6590	20	21	therapy	therapy	NOUN
aiua-6590	20	22	with	with	ADP
aiua-6590	20	23	an	an	DET
aiua-6590	20	24	impaired	impaired	ADJ
aiua-6590	20	25	of	of	ADP
aiua-6590	20	26	both	both	CCONJ
aiua-6590	20	27	clinical	clinical	ADJ
aiua-6590	20	28	symptoms	symptom	NOUN
aiua-6590	20	29	and	and	CCONJ
aiua-6590	20	30	quality	quality	NOUN
aiua-6590	20	31	of	of	ADP
aiua-6590	20	32	life	life	NOUN
aiua-6590	20	33	(	(	PUNCT
aiua-6590	20	34	4	4	NUM
aiua-6590	20	35	)	)	PUNCT
aiua-6590	20	36	.	.	PUNCT
aiua-6590	21	1	even	even	ADV
aiua-6590	21	2	if	if	SCONJ
aiua-6590	21	3	the	the	DET
aiua-6590	21	4	current	current	ADJ
aiua-6590	21	5	therapeutic	therapeutic	ADJ
aiua-6590	21	6	strategies	strategy	NOUN
aiua-6590	21	7	for	for	ADP
aiua-6590	21	8	the	the	DET
aiua-6590	21	9	management	management	NOUN
aiua-6590	21	10	of	of	ADP
aiua-6590	21	11	patients	patient	NOUN
aiua-6590	21	12	affected	affect	VERB
aiua-6590	21	13	by	by	ADP
aiua-6590	21	14	luts	luts	PROPN
aiua-6590	21	15	associated	associate	VERB
aiua-6590	21	16	to	to	ADP
aiua-6590	21	17	bph	bph	NOUN
aiua-6590	21	18	are	be	AUX
aiua-6590	21	19	able	able	ADJ
aiua-6590	21	20	to	to	PART
aiua-6590	21	21	both	both	PRON
aiua-6590	21	22	control	control	VERB
aiua-6590	21	23	the	the	DET
aiua-6590	21	24	progression	progression	NOUN
aiua-6590	21	25	of	of	ADP
aiua-6590	21	26	the	the	DET
aiua-6590	21	27	disease	disease	NOUN
aiua-6590	21	28	and	and	CCONJ
aiua-6590	21	29	relief	relief	VERB
aiua-6590	21	30	the	the	DET
aiua-6590	21	31	symptoms	symptom	NOUN
aiua-6590	21	32	,	,	PUNCT
aiua-6590	21	33	their	their	PRON
aiua-6590	21	34	use	use	NOUN
aiua-6590	21	35	is	be	AUX
aiua-6590	21	36	related	relate	VERB
aiua-6590	21	37	with	with	ADP
aiua-6590	21	38	the	the	DET
aiua-6590	21	39	development	development	NOUN
aiua-6590	21	40	of	of	ADP
aiua-6590	21	41	adverse	adverse	ADJ
aiua-6590	21	42	drug	drug	NOUN
aiua-6590	21	43	reactions	reaction	NOUN
aiua-6590	21	44	(	(	PUNCT
aiua-6590	21	45	adrs	adrs	PROPN
aiua-6590	21	46	)	)	PUNCT
aiua-6590	21	47	particularly	particularly	ADV
aiua-6590	21	48	on	on	ADP
aiua-6590	21	49	sexual	sexual	ADJ
aiua-6590	21	50	function	function	NOUN
aiua-6590	21	51	(	(	PUNCT
aiua-6590	21	52	5	5	NUM
aiua-6590	21	53	)	)	PUNCT
aiua-6590	21	54	.	.	PUNCT
aiua-6590	22	1	in	in	ADP
aiua-6590	22	2	a	a	DET
aiua-6590	22	3	recent	recent	ADJ
aiua-6590	22	4	meta	meta	ADJ
aiua-6590	22	5	-	-	PUNCT
aiua-6590	22	6	analysis	analysis	NOUN
aiua-6590	22	7	liu	liu	NOUN
aiua-6590	22	8	and	and	CCONJ
aiua-6590	22	9	co	co	NOUN
aiua-6590	22	10	-	-	NOUN
aiua-6590	22	11	workers	worker	NOUN
aiua-6590	22	12	,	,	PUNCT
aiua-6590	22	13	evaluating	evaluate	VERB
aiua-6590	22	14	the	the	DET
aiua-6590	22	15	effects	effect	NOUN
aiua-6590	22	16	of	of	ADP
aiua-6590	22	17	5α	5α	ADJ
aiua-6590	22	18	-	-	PUNCT
aiua-6590	22	19	reductase	reductase	NOUN
aiua-6590	22	20	inhibitors	inhibitor	NOUN
aiua-6590	22	21	(	(	PUNCT
aiua-6590	22	22	5aris	5aris	NUM
aiua-6590	22	23	)	)	PUNCT
aiua-6590	22	24	on	on	ADP
aiua-6590	22	25	sexual	sexual	ADJ
aiua-6590	22	26	function	function	NOUN
aiua-6590	22	27	in	in	ADP
aiua-6590	22	28	men	man	NOUN
aiua-6590	22	29	with	with	ADP
aiua-6590	22	30	bph	bph	NOUN
aiua-6590	22	31	,	,	PUNCT
aiua-6590	22	32	documented	document	VERB
aiua-6590	22	33	that	that	SCONJ
aiua-6590	22	34	both	both	CCONJ
aiua-6590	22	35	dutasteride	dutasteride	NOUN
aiua-6590	22	36	and	and	CCONJ
aiua-6590	22	37	finasteride	finasteride	ADV
aiua-6590	22	38	compared	compare	VERB
aiua-6590	22	39	with	with	ADP
aiua-6590	22	40	placebo	placebo	NOUN
aiua-6590	22	41	were	be	AUX
aiua-6590	22	42	associated	associate	VERB
aiua-6590	22	43	with	with	ADP
aiua-6590	22	44	the	the	DET
aiua-6590	22	45	development	development	NOUN
aiua-6590	22	46	of	of	ADP
aiua-6590	22	47	sexual	sexual	ADJ
aiua-6590	22	48	dysfunction	dysfunction	NOUN
aiua-6590	22	49	(	(	PUNCT
aiua-6590	22	50	6	6	NUM
aiua-6590	22	51	)	)	PUNCT
aiua-6590	22	52	.	.	PUNCT
aiua-6590	23	1	the	the	DET
aiua-6590	23	2	development	development	NOUN
aiua-6590	23	3	of	of	ADP
aiua-6590	23	4	adrs	adrs	PROPN
aiua-6590	23	5	represents	represent	VERB
aiua-6590	23	6	a	a	DET
aiua-6590	23	7	common	common	ADJ
aiua-6590	23	8	problem	problem	NOUN
aiua-6590	23	9	during	during	ADP
aiua-6590	23	10	drug	drug	NOUN
aiua-6590	23	11	administration	administration	NOUN
aiua-6590	23	12	and	and	CCONJ
aiua-6590	23	13	represents	represent	VERB
aiua-6590	23	14	the	the	DET
aiua-6590	23	15	most	most	ADV
aiua-6590	23	16	common	common	ADJ
aiua-6590	23	17	cause	cause	NOUN
aiua-6590	23	18	of	of	ADP
aiua-6590	23	19	low	low	ADJ
aiua-6590	23	20	adherence	adherence	NOUN
aiua-6590	23	21	to	to	ADP
aiua-6590	23	22	the	the	DET
aiua-6590	23	23	treatment	treatment	NOUN
aiua-6590	23	24	(	(	PUNCT
aiua-6590	23	25	7	7	NUM
aiua-6590	23	26	)	)	PUNCT
aiua-6590	23	27	.	.	PUNCT
aiua-6590	24	1	in	in	ADP
aiua-6590	24	2	the	the	DET
aiua-6590	24	3	last	last	ADJ
aiua-6590	24	4	years	year	NOUN
aiua-6590	24	5	,	,	PUNCT
aiua-6590	24	6	there	there	PRON
aiua-6590	24	7	is	be	VERB
aiua-6590	24	8	a	a	DET
aiua-6590	24	9	grow	grow	NOUN
aiua-6590	24	10	interest	interest	NOUN
aiua-6590	24	11	for	for	ADP
aiua-6590	24	12	nutraceutical	nutraceutical	ADJ
aiua-6590	24	13	agents	agent	NOUN
aiua-6590	24	14	in	in	ADP
aiua-6590	24	15	several	several	ADJ
aiua-6590	24	16	clinical	clinical	ADJ
aiua-6590	24	17	manifestations	manifestation	NOUN
aiua-6590	24	18	for	for	ADP
aiua-6590	24	19	several	several	ADJ
aiua-6590	24	20	reasons	reason	NOUN
aiua-6590	24	21	,	,	PUNCT
aiua-6590	24	22	e.g.	e.g.	ADV
aiua-6590	24	23	low	low	ADJ
aiua-6590	24	24	side	side	NOUN
aiua-6590	24	25	-	-	PUNCT
aiua-6590	24	26	effect	effect	NOUN
aiua-6590	24	27	and	and	CCONJ
aiua-6590	24	28	costs	cost	NOUN
aiua-6590	24	29	,	,	PUNCT
aiua-6590	24	30	high	high	ADJ
aiua-6590	24	31	level	level	NOUN
aiua-6590	24	32	of	of	ADP
aiua-6590	24	33	adherence	adherence	NOUN
aiua-6590	24	34	and	and	CCONJ
aiua-6590	24	35	a	a	DET
aiua-6590	24	36	low	low	ADJ
aiua-6590	24	37	rate	rate	NOUN
aiua-6590	24	38	of	of	ADP
aiua-6590	24	39	efficacy	efficacy	NOUN
aiua-6590	24	40	of	of	ADP
aiua-6590	24	41	standard	standard	ADJ
aiua-6590	24	42	treatments	treatment	NOUN
aiua-6590	24	43	with	with	ADP
aiua-6590	24	44	subsequent	subsequent	ADJ
aiua-6590	24	45	patient	patient	ADJ
aiua-6590	24	46	disappointment	disappointment	NOUN
aiua-6590	24	47	and	and	CCONJ
aiua-6590	24	48	drop	drop	NOUN
aiua-6590	24	49	-	-	PUNCT
aiua-6590	24	50	out	out	ADP
aiua-6590	24	51	(	(	PUNCT
aiua-6590	24	52	8	8	NUM
aiua-6590	24	53	-	-	SYM
aiua-6590	24	54	9	9	NUM
aiua-6590	24	55	)	)	PUNCT
aiua-6590	24	56	.	.	PUNCT
aiua-6590	25	1	several	several	ADJ
aiua-6590	25	2	nutraceutical	nutraceutical	ADJ
aiua-6590	25	3	products	product	NOUN
aiua-6590	25	4	for	for	ADP
aiua-6590	25	5	the	the	DET
aiua-6590	25	6	management	management	NOUN
aiua-6590	25	7	of	of	ADP
aiua-6590	25	8	bph	bph	NOUN
aiua-6590	25	9	have	have	AUX
aiua-6590	25	10	been	be	AUX
aiua-6590	25	11	commercialised	commercialise	VERB
aiua-6590	25	12	in	in	ADP
aiua-6590	25	13	italy	italy	PROPN
aiua-6590	25	14	(	(	PUNCT
aiua-6590	25	15	10	10	NUM
aiua-6590	25	16	)	)	PUNCT
aiua-6590	25	17	and	and	CCONJ
aiua-6590	25	18	between	between	ADP
aiua-6590	25	19	these	these	PRON
aiua-6590	25	20	,	,	PUNCT
aiua-6590	25	21	a	a	DET
aiua-6590	25	22	new	new	ADJ
aiua-6590	25	23	nutraceutical	nutraceutical	NOUN
aiua-6590	25	24	is	be	AUX
aiua-6590	25	25	migar	migar	ADJ
aiua-6590	25	26	®	®	PROPN
aiua-6590	25	27	mg	mg	PROPN
aiua-6590	25	28	,	,	PUNCT
aiua-6590	25	29	an	an	DET
aiua-6590	25	30	association	association	NOUN
aiua-6590	25	31	between	between	ADP
aiua-6590	25	32	daidzein	daidzein	ADJ
aiua-6590	25	33	,	,	PUNCT
aiua-6590	25	34	isolase	isolase	NOUN
aiua-6590	25	35	and	and	CCONJ
aiua-6590	25	36	zinc	zinc	NOUN
aiua-6590	25	37	.	.	PUNCT
aiua-6590	26	1	the	the	DET
aiua-6590	26	2	effects	effect	NOUN
aiua-6590	26	3	of	of	ADP
aiua-6590	26	4	each	each	DET
aiua-6590	26	5	component	component	NOUN
aiua-6590	26	6	have	have	AUX
aiua-6590	26	7	been	be	AUX
aiua-6590	26	8	well	well	ADV
aiua-6590	26	9	-	-	PUNCT
aiua-6590	26	10	reported	report	VERB
aiua-6590	26	11	in	in	ADP
aiua-6590	26	12	literature	literature	NOUN
aiua-6590	26	13	.	.	PUNCT
aiua-6590	27	1	doi	doi	NOUN
aiua-6590	27	2	:	:	PUNCT
aiua-6590	27	3	10.4081	10.4081	NUM
aiua-6590	27	4	/	/	SYM
aiua-6590	27	5	aiua.2017.1.12	aiua.2017.1.12	PROPN
aiua-6590	27	6	introduction	introduction	NOUN
aiua-6590	27	7	benign	benign	ADJ
aiua-6590	27	8	prostatic	prostatic	ADJ
aiua-6590	27	9	hyperplasia	hyperplasia	NOUN
aiua-6590	27	10	(	(	PUNCT
aiua-6590	27	11	bph	bph	NOUN
aiua-6590	27	12	)	)	PUNCT
aiua-6590	27	13	is	be	AUX
aiua-6590	27	14	one	one	NUM
aiua-6590	27	15	of	of	ADP
aiua-6590	27	16	the	the	DET
aiua-6590	27	17	most	most	ADV
aiua-6590	27	18	common	common	ADJ
aiua-6590	27	19	diseases	disease	NOUN
aiua-6590	27	20	affecting	affect	VERB
aiua-6590	27	21	the	the	DET
aiua-6590	27	22	elderly	elderly	ADJ
aiua-6590	27	23	male	male	NOUN
aiua-6590	27	24	and	and	CCONJ
aiua-6590	27	25	is	be	AUX
aiua-6590	27	26	the	the	DET
aiua-6590	27	27	most	most	ADV
aiua-6590	27	28	common	common	ADJ
aiua-6590	27	29	clinical	clinical	ADJ
aiua-6590	27	30	condition	condition	NOUN
aiua-6590	27	31	among	among	ADP
aiua-6590	27	32	all	all	DET
aiua-6590	27	33	urological	urological	ADJ
aiua-6590	27	34	outpatients	outpatient	NOUN
aiua-6590	27	35	(	(	PUNCT
aiua-6590	27	36	1	1	NUM
aiua-6590	27	37	)	)	PUNCT
aiua-6590	27	38	.	.	PUNCT
aiua-6590	28	1	bph	bph	NOUN
aiua-6590	28	2	is	be	AUX
aiua-6590	28	3	characterized	characterize	VERB
aiua-6590	28	4	by	by	ADP
aiua-6590	28	5	clinically	clinically	ADV
aiua-6590	28	6	reletiscione_stesura	reletiscione_stesura	PROPN
aiua-6590	28	7	seveso	seveso	NOUN
aiua-6590	28	8	04/04/17	04/04/17	PROPN
aiua-6590	28	9	09:05	09:05	NUM
aiua-6590	28	10	pagina	pagina	NOUN
aiua-6590	28	11	12	12	NUM
aiua-6590	28	12	13archivio	13archivio	NUM
aiua-6590	28	13	italiano	italiano	PROPN
aiua-6590	28	14	di	di	X
aiua-6590	28	15	urologia	urologia	PROPN
aiua-6590	28	16	e	e	PROPN
aiua-6590	28	17	andrologia	andrologia	NOUN
aiua-6590	28	18	2017	2017	NUM
aiua-6590	28	19	;	;	PUNCT
aiua-6590	28	20	89	89	NUM
aiua-6590	28	21	,	,	PUNCT
aiua-6590	28	22	1	1	NUM
aiua-6590	28	23	nutraceuticals	nutraceutical	NOUN
aiua-6590	28	24	for	for	ADP
aiua-6590	28	25	the	the	DET
aiua-6590	28	26	management	management	NOUN
aiua-6590	28	27	of	of	ADP
aiua-6590	28	28	luts	luts	PROPN
aiua-6590	28	29	related	relate	VERB
aiua-6590	28	30	to	to	ADP
aiua-6590	28	31	bph	bph	NOUN
aiua-6590	28	32	daidzein	daidzein	NOUN
aiua-6590	28	33	is	be	AUX
aiua-6590	28	34	a	a	DET
aiua-6590	28	35	soy	soy	NOUN
aiua-6590	28	36	isoflavone	isoflavone	NOUN
aiua-6590	28	37	,	,	PUNCT
aiua-6590	28	38	after	after	ADP
aiua-6590	28	39	oral	oral	ADJ
aiua-6590	28	40	intake	intake	NOUN
aiua-6590	28	41	it	it	PRON
aiua-6590	28	42	crosses	cross	VERB
aiua-6590	28	43	the	the	DET
aiua-6590	28	44	enterocytes	enterocyte	NOUN
aiua-6590	28	45	,	,	PUNCT
aiua-6590	28	46	is	be	AUX
aiua-6590	28	47	reduced	reduce	VERB
aiua-6590	28	48	to	to	PART
aiua-6590	28	49	s-(-)equol	s-(-)equol	VERB
aiua-6590	28	50	through	through	ADP
aiua-6590	28	51	the	the	DET
aiua-6590	28	52	intermediate	intermediate	ADJ
aiua-6590	28	53	dihydrodaidzein	dihydrodaidzein	NOUN
aiua-6590	28	54	,	,	PUNCT
aiua-6590	28	55	and	and	CCONJ
aiua-6590	28	56	then	then	ADV
aiua-6590	28	57	is	be	AUX
aiua-6590	28	58	converted	convert	VERB
aiua-6590	28	59	by	by	ADP
aiua-6590	28	60	deoxygenation	deoxygenation	NOUN
aiua-6590	28	61	to	to	PART
aiua-6590	28	62	yield	yield	VERB
aiua-6590	28	63	the	the	DET
aiua-6590	28	64	bioactive	bioactive	NOUN
aiua-6590	28	65	s-(-)equol	s-(-)equol	NOUN
aiua-6590	28	66	by	by	ADP
aiua-6590	28	67	intestinal	intestinal	ADJ
aiua-6590	28	68	bacteria	bacteria	NOUN
aiua-6590	28	69	(	(	PUNCT
aiua-6590	28	70	11	11	NUM
aiua-6590	28	71	)	)	PUNCT
aiua-6590	28	72	.	.	PUNCT
aiua-6590	29	1	several	several	ADJ
aiua-6590	29	2	bacteria	bacteria	NOUN
aiua-6590	29	3	are	be	AUX
aiua-6590	29	4	able	able	ADJ
aiua-6590	29	5	to	to	PART
aiua-6590	29	6	perform	perform	VERB
aiua-6590	29	7	this	this	DET
aiua-6590	29	8	reaction	reaction	NOUN
aiua-6590	29	9	and	and	CCONJ
aiua-6590	29	10	one	one	NUM
aiua-6590	29	11	of	of	ADP
aiua-6590	29	12	these	these	PRON
aiua-6590	29	13	,	,	PUNCT
aiua-6590	29	14	lactococcus	lactococcus	PROPN
aiua-6590	29	15	garvieae	garvieae	PROPN
aiua-6590	29	16	,	,	PUNCT
aiua-6590	29	17	was	be	AUX
aiua-6590	29	18	found	find	VERB
aiua-6590	29	19	in	in	ADP
aiua-6590	29	20	some	some	DET
aiua-6590	29	21	italian	italian	ADJ
aiua-6590	29	22	cheeses	cheese	NOUN
aiua-6590	29	23	and	and	CCONJ
aiua-6590	29	24	has	have	AUX
aiua-6590	29	25	been	be	AUX
aiua-6590	29	26	used	use	VERB
aiua-6590	29	27	to	to	PART
aiua-6590	29	28	produce	produce	VERB
aiua-6590	29	29	the	the	DET
aiua-6590	29	30	first	first	ADJ
aiua-6590	29	31	natural	natural	ADJ
aiua-6590	29	32	s-(-	s-(-	PROPN
aiua-6590	29	33	)	)	PUNCT
aiua-6590	29	34	equol	equol	NOUN
aiua-6590	29	35	-	-	PUNCT
aiua-6590	29	36	containing	contain	VERB
aiua-6590	29	37	nutraceutical	nutraceutical	NOUN
aiua-6590	29	38	(	(	PUNCT
aiua-6590	29	39	12	12	NUM
aiua-6590	29	40	)	)	PUNCT
aiua-6590	29	41	.	.	PUNCT
aiua-6590	30	1	the	the	DET
aiua-6590	30	2	bioactivation	bioactivation	NOUN
aiua-6590	30	3	of	of	ADP
aiua-6590	30	4	daidzein	daidzein	NOUN
aiua-6590	30	5	to	to	ADP
aiua-6590	30	6	s-(-)equol	s-(-)equol	PROPN
aiua-6590	30	7	is	be	AUX
aiua-6590	30	8	related	relate	VERB
aiua-6590	30	9	to	to	ADP
aiua-6590	30	10	gender	gender	NOUN
aiua-6590	30	11	,	,	PUNCT
aiua-6590	30	12	race	race	NOUN
aiua-6590	30	13	and	and	CCONJ
aiua-6590	30	14	age	age	NOUN
aiua-6590	30	15	and	and	CCONJ
aiua-6590	30	16	requires	require	VERB
aiua-6590	30	17	:	:	PUNCT
aiua-6590	30	18	specific	specific	ADJ
aiua-6590	30	19	equol	equol	NOUN
aiua-6590	30	20	-	-	PUNCT
aiua-6590	30	21	producing	produce	VERB
aiua-6590	30	22	bacteria	bacteria	NOUN
aiua-6590	30	23	and	and	CCONJ
aiua-6590	30	24	an	an	DET
aiua-6590	30	25	optimum	optimum	ADJ
aiua-6590	30	26	intraluminal	intraluminal	ADJ
aiua-6590	30	27	conditions	condition	NOUN
aiua-6590	30	28	in	in	ADP
aiua-6590	30	29	terms	term	NOUN
aiua-6590	30	30	of	of	ADP
aiua-6590	30	31	redox	redox	ADJ
aiua-6590	30	32	potential	potential	NOUN
aiua-6590	30	33	for	for	ADP
aiua-6590	30	34	the	the	DET
aiua-6590	30	35	above	above	ADJ
aiua-6590	30	36	described	describe	VERB
aiua-6590	30	37	reactions	reaction	NOUN
aiua-6590	30	38	(	(	PUNCT
aiua-6590	30	39	13	13	NUM
aiua-6590	30	40	)	)	PUNCT
aiua-6590	30	41	.	.	PUNCT
aiua-6590	31	1	therefore	therefore	ADV
aiua-6590	31	2	,	,	PUNCT
aiua-6590	31	3	the	the	DET
aiua-6590	31	4	aim	aim	NOUN
aiua-6590	31	5	of	of	ADP
aiua-6590	31	6	this	this	DET
aiua-6590	31	7	study	study	NOUN
aiua-6590	31	8	is	be	AUX
aiua-6590	31	9	to	to	PART
aiua-6590	31	10	evaluate	evaluate	VERB
aiua-6590	31	11	the	the	DET
aiua-6590	31	12	efficacy	efficacy	NOUN
aiua-6590	31	13	and	and	CCONJ
aiua-6590	31	14	safety	safety	NOUN
aiua-6590	31	15	of	of	ADP
aiua-6590	31	16	migar	migar	ADJ
aiua-6590	31	17	®	®	NOUN
aiua-6590	31	18	mg	mg	PROPN
aiua-6590	31	19	retard	retard	VERB
aiua-6590	31	20	in	in	ADP
aiua-6590	31	21	patients	patient	NOUN
aiua-6590	31	22	affected	affect	VERB
aiua-6590	31	23	by	by	ADP
aiua-6590	31	24	luts	luts	PROPN
aiua-6590	31	25	related	relate	VERB
aiua-6590	31	26	to	to	ADP
aiua-6590	31	27	bph	bph	NOUN
aiua-6590	31	28	.	.	PUNCT
aiua-6590	32	1	methods	method	NOUN
aiua-6590	32	2	study	study	NOUN
aiua-6590	32	3	design	design	NOUN
aiua-6590	32	4	we	we	PRON
aiua-6590	32	5	performed	perform	VERB
aiua-6590	32	6	a	a	DET
aiua-6590	32	7	non	non	ADJ
aiua-6590	32	8	-	-	ADJ
aiua-6590	32	9	sponsored	sponsor	VERB
aiua-6590	32	10	phase	phase	NOUN
aiua-6590	32	11	i	i	PRON
aiua-6590	32	12	-	-	PUNCT
aiua-6590	32	13	ii	ii	PROPN
aiua-6590	32	14	study	study	NOUN
aiua-6590	32	15	in	in	ADP
aiua-6590	32	16	a	a	DET
aiua-6590	32	17	single	single	ADJ
aiua-6590	32	18	urological	urological	ADJ
aiua-6590	32	19	institution	institution	NOUN
aiua-6590	32	20	between	between	ADP
aiua-6590	32	21	january	january	PROPN
aiua-6590	32	22	to	to	ADP
aiua-6590	32	23	june	june	PROPN
aiua-6590	32	24	2016	2016	NUM
aiua-6590	32	25	.	.	PUNCT
aiua-6590	33	1	the	the	DET
aiua-6590	33	2	study	study	NOUN
aiua-6590	33	3	was	be	AUX
aiua-6590	33	4	conducted	conduct	VERB
aiua-6590	33	5	according	accord	VERB
aiua-6590	33	6	in	in	ADP
aiua-6590	33	7	line	line	NOUN
aiua-6590	33	8	with	with	ADP
aiua-6590	33	9	good	good	ADJ
aiua-6590	33	10	clinical	clinical	ADJ
aiua-6590	33	11	practice	practice	NOUN
aiua-6590	33	12	guidelines	guideline	NOUN
aiua-6590	33	13	and	and	CCONJ
aiua-6590	33	14	with	with	ADP
aiua-6590	33	15	the	the	DET
aiua-6590	33	16	ethical	ethical	ADJ
aiua-6590	33	17	principles	principle	NOUN
aiua-6590	33	18	of	of	ADP
aiua-6590	33	19	the	the	DET
aiua-6590	33	20	declaration	declaration	NOUN
aiua-6590	33	21	of	of	ADP
aiua-6590	33	22	helsinki	helsinki	PROPN
aiua-6590	33	23	.	.	PUNCT
aiua-6590	34	1	before	before	ADP
aiua-6590	34	2	the	the	DET
aiua-6590	34	3	beginning	beginning	NOUN
aiua-6590	34	4	of	of	ADP
aiua-6590	34	5	the	the	DET
aiua-6590	34	6	study	study	NOUN
aiua-6590	34	7	,	,	PUNCT
aiua-6590	34	8	all	all	DET
aiua-6590	34	9	participants	participant	NOUN
aiua-6590	34	10	signed	sign	VERB
aiua-6590	34	11	the	the	DET
aiua-6590	34	12	written	write	VERB
aiua-6590	34	13	informed	inform	VERB
aiua-6590	34	14	consent	consent	NOUN
aiua-6590	34	15	.	.	PUNCT
aiua-6590	35	1	no	no	DET
aiua-6590	35	2	placebo	placebo	NOUN
aiua-6590	35	3	run	run	NOUN
aiua-6590	35	4	-	-	PUNCT
aiua-6590	35	5	in	in	ADP
aiua-6590	35	6	period	period	NOUN
aiua-6590	35	7	was	be	AUX
aiua-6590	35	8	performed	perform	VERB
aiua-6590	35	9	.	.	PUNCT
aiua-6590	36	1	experimental	experimental	ADJ
aiua-6590	36	2	protocol	protocol	NOUN
aiua-6590	36	3	patients	patient	NOUN
aiua-6590	36	4	with	with	ADP
aiua-6590	36	5	clinical	clinical	ADJ
aiua-6590	36	6	and	and	CCONJ
aiua-6590	36	7	instrumental	instrumental	ADJ
aiua-6590	36	8	diagnosis	diagnosis	NOUN
aiua-6590	36	9	of	of	ADP
aiua-6590	36	10	moderated	moderated	ADJ
aiua-6590	36	11	-	-	PUNCT
aiua-6590	36	12	severe	severe	ADJ
aiua-6590	36	13	luts	luts	PROPN
aiua-6590	36	14	related	relate	VERB
aiua-6590	36	15	to	to	ADP
aiua-6590	36	16	bph	bph	NOUN
aiua-6590	36	17	were	be	AUX
aiua-6590	36	18	recruited	recruit	VERB
aiua-6590	36	19	.	.	PUNCT
aiua-6590	37	1	we	we	PRON
aiua-6590	37	2	considered	consider	VERB
aiua-6590	37	3	patients	patient	NOUN
aiua-6590	37	4	with	with	ADP
aiua-6590	37	5	moderate	moderate	ADJ
aiua-6590	37	6	-	-	PUNCT
aiua-6590	37	7	severe	severe	ADJ
aiua-6590	37	8	luts	lut	NOUN
aiua-6590	37	9	and	and	CCONJ
aiua-6590	37	10	with	with	ADP
aiua-6590	37	11	an	an	DET
aiua-6590	37	12	international	international	ADJ
aiua-6590	37	13	prostatic	prostatic	ADJ
aiua-6590	37	14	symptom	symptom	NOUN
aiua-6590	37	15	score	score	NOUN
aiua-6590	37	16	(	(	PUNCT
aiua-6590	37	17	ipss	ipss	PROPN
aiua-6590	37	18	)	)	PUNCT
aiua-6590	37	19	score	score	NOUN
aiua-6590	37	20	>	>	X
aiua-6590	37	21	8	8	NUM
aiua-6590	37	22	.	.	PUNCT
aiua-6590	38	1	at	at	ADP
aiua-6590	38	2	the	the	DET
aiua-6590	38	3	time	time	NOUN
aiua-6590	38	4	of	of	ADP
aiua-6590	38	5	admission	admission	NOUN
aiua-6590	38	6	(	(	PUNCT
aiua-6590	38	7	t0	t0	NOUN
aiua-6590	38	8	)	)	PUNCT
aiua-6590	38	9	,	,	PUNCT
aiua-6590	38	10	the	the	DET
aiua-6590	38	11	patients	patient	NOUN
aiua-6590	38	12	underwent	undergo	VERB
aiua-6590	38	13	selfadministered	selfadministered	ADJ
aiua-6590	38	14	baseline	baseline	ADJ
aiua-6590	38	15	questionnaire	questionnaire	NOUN
aiua-6590	38	16	[	[	X
aiua-6590	38	17	ipss	ipss	PROPN
aiua-6590	38	18	,	,	PUNCT
aiua-6590	38	19	international	international	ADJ
aiua-6590	38	20	index	index	NOUN
aiua-6590	38	21	of	of	ADP
aiua-6590	38	22	erectile	erectile	NOUN
aiua-6590	38	23	function	function	NOUN
aiua-6590	38	24	(	(	PUNCT
aiua-6590	38	25	iief-5	iief-5	NUM
aiua-6590	38	26	)	)	PUNCT
aiua-6590	38	27	and	and	CCONJ
aiua-6590	38	28	quality	quality	NOUN
aiua-6590	38	29	of	of	ADP
aiua-6590	38	30	well	well	ADV
aiua-6590	38	31	-	-	PUNCT
aiua-6590	38	32	being	be	AUX
aiua-6590	38	33	(	(	PUNCT
aiua-6590	38	34	qol	qol	NOUN
aiua-6590	38	35	)	)	PUNCT
aiua-6590	38	36	]	]	X
aiua-6590	38	37	,	,	PUNCT
aiua-6590	38	38	urological	urological	ADJ
aiua-6590	38	39	examination	examination	NOUN
aiua-6590	38	40	with	with	ADP
aiua-6590	38	41	history	history	NOUN
aiua-6590	38	42	interview	interview	NOUN
aiua-6590	38	43	,	,	PUNCT
aiua-6590	38	44	prostate	prostate	NOUN
aiua-6590	38	45	ultrasound	ultrasound	NOUN
aiua-6590	38	46	and	and	CCONJ
aiua-6590	38	47	uroflowmetry	uroflowmetry	NOUN
aiua-6590	38	48	(	(	PUNCT
aiua-6590	38	49	cmax	cmax	NOUN
aiua-6590	38	50	)	)	PUNCT
aiua-6590	38	51	with	with	ADP
aiua-6590	38	52	evaluation	evaluation	NOUN
aiua-6590	38	53	of	of	ADP
aiua-6590	38	54	post	post	ADJ
aiua-6590	38	55	-	-	ADJ
aiua-6590	38	56	voided	void	VERB
aiua-6590	38	57	residual	residual	ADJ
aiua-6590	38	58	volume	volume	NOUN
aiua-6590	38	59	(	(	PUNCT
aiua-6590	38	60	pvr	pvr	NOUN
aiua-6590	38	61	)	)	PUNCT
aiua-6590	38	62	,	,	PUNCT
aiua-6590	38	63	in	in	ADP
aiua-6590	38	64	accordance	accordance	NOUN
aiua-6590	38	65	with	with	ADP
aiua-6590	38	66	the	the	DET
aiua-6590	38	67	procedure	procedure	NOUN
aiua-6590	38	68	described	describe	VERB
aiua-6590	38	69	in	in	ADP
aiua-6590	38	70	eau	eau	PROPN
aiua-6590	38	71	guidelines	guideline	NOUN
aiua-6590	38	72	(	(	PUNCT
aiua-6590	38	73	3	3	NUM
aiua-6590	38	74	)	)	PUNCT
aiua-6590	38	75	.	.	PUNCT
aiua-6590	39	1	all	all	DET
aiua-6590	39	2	patients	patient	NOUN
aiua-6590	39	3	who	who	PRON
aiua-6590	39	4	met	meet	VERB
aiua-6590	39	5	the	the	DET
aiua-6590	39	6	inclusion	inclusion	NOUN
aiua-6590	39	7	criteria	criterion	NOUN
aiua-6590	39	8	were	be	AUX
aiua-6590	39	9	enrolled	enrol	VERB
aiua-6590	39	10	and	and	CCONJ
aiua-6590	39	11	received	receive	VERB
aiua-6590	39	12	1	1	NUM
aiua-6590	39	13	tablet	tablet	NOUN
aiua-6590	39	14	/	/	SYM
aiua-6590	39	15	day	day	NOUN
aiua-6590	39	16	of	of	ADP
aiua-6590	39	17	a	a	DET
aiua-6590	39	18	combination	combination	NOUN
aiua-6590	39	19	of	of	ADP
aiua-6590	39	20	daidzein	daidzein	NOUN
aiua-6590	39	21	with	with	ADP
aiua-6590	39	22	isolase	isolase	NOUN
aiua-6590	39	23	and	and	CCONJ
aiua-6590	39	24	zinc	zinc	NOUN
aiua-6590	39	25	(	(	PUNCT
aiua-6590	39	26	migar	migar	NOUN
aiua-6590	39	27	®	®	NOUN
aiua-6590	39	28	mg	mg	PROPN
aiua-6590	39	29	retard	retard	PROPN
aiua-6590	39	30	)	)	PUNCT
aiua-6590	39	31	.	.	PUNCT
aiua-6590	40	1	the	the	DET
aiua-6590	40	2	follow	follow	NOUN
aiua-6590	40	3	-	-	PUNCT
aiua-6590	40	4	up	up	NOUN
aiua-6590	40	5	was	be	AUX
aiua-6590	40	6	performed	perform	VERB
aiua-6590	40	7	6	6	NUM
aiua-6590	40	8	months	month	NOUN
aiua-6590	40	9	after	after	ADP
aiua-6590	40	10	the	the	DET
aiua-6590	40	11	end	end	NOUN
aiua-6590	40	12	of	of	ADP
aiua-6590	40	13	therapy	therapy	NOUN
aiua-6590	40	14	(	(	PUNCT
aiua-6590	40	15	t1	t1	PROPN
aiua-6590	40	16	)	)	PUNCT
aiua-6590	40	17	when	when	SCONJ
aiua-6590	40	18	patients	patient	NOUN
aiua-6590	40	19	underwent	undergo	VERB
aiua-6590	40	20	ipss	ipss	PROPN
aiua-6590	40	21	,	,	PUNCT
aiua-6590	40	22	iief-5qol	iief-5qol	PUNCT
aiua-6590	40	23	questionnaires	questionnaire	NOUN
aiua-6590	40	24	and	and	CCONJ
aiua-6590	40	25	urological	urological	ADJ
aiua-6590	40	26	examination	examination	NOUN
aiua-6590	40	27	with	with	ADP
aiua-6590	40	28	laboratory	laboratory	NOUN
aiua-6590	40	29	and	and	CCONJ
aiua-6590	40	30	instrumental	instrumental	ADJ
aiua-6590	40	31	examinations	examination	NOUN
aiua-6590	40	32	.	.	PUNCT
aiua-6590	41	1	inclusion	inclusion	NOUN
aiua-6590	41	2	and	and	CCONJ
aiua-6590	41	3	exclusion	exclusion	NOUN
aiua-6590	41	4	criteria	criterion	NOUN
aiua-6590	41	5	patients	patient	NOUN
aiua-6590	41	6	male	male	VERB
aiua-6590	41	7	who	who	PRON
aiua-6590	41	8	were	be	AUX
aiua-6590	41	9	>	>	X
aiua-6590	41	10	45	45	NUM
aiua-6590	41	11	years	year	NOUN
aiua-6590	41	12	,	,	PUNCT
aiua-6590	41	13	sexually	sexually	ADV
aiua-6590	41	14	active	active	ADJ
aiua-6590	41	15	,	,	PUNCT
aiua-6590	41	16	with	with	ADP
aiua-6590	41	17	a	a	DET
aiua-6590	41	18	maximal	maximal	ADJ
aiua-6590	41	19	urinary	urinary	ADJ
aiua-6590	41	20	flow	flow	NOUN
aiua-6590	41	21	rate	rate	NOUN
aiua-6590	41	22	(	(	PUNCT
aiua-6590	41	23	cmax	cmax	NOUN
aiua-6590	41	24	)	)	PUNCT
aiua-6590	41	25	<	<	X
aiua-6590	41	26	15	15	NUM
aiua-6590	41	27	ml	ml	NOUN
aiua-6590	41	28	/	/	SYM
aiua-6590	41	29	s	s	NOUN
aiua-6590	41	30	and	and	CCONJ
aiua-6590	41	31	with	with	ADP
aiua-6590	41	32	a	a	DET
aiua-6590	41	33	post	post	ADJ
aiua-6590	41	34	-	-	ADJ
aiua-6590	41	35	residual	residual	ADJ
aiua-6590	41	36	voided	void	VERB
aiua-6590	41	37	volume	volume	NOUN
aiua-6590	41	38	<	<	X
aiua-6590	41	39	100	100	NUM
aiua-6590	41	40	cc	cc	NOUN
aiua-6590	41	41	,	,	PUNCT
aiua-6590	41	42	with	with	ADP
aiua-6590	41	43	ipss	ipss	PROPN
aiua-6590	41	44	=	=	SYM
aiua-6590	41	45	8	8	NUM
aiua-6590	41	46	or	or	CCONJ
aiua-6590	41	47	greater	great	ADJ
aiua-6590	41	48	,	,	PUNCT
aiua-6590	41	49	with	with	ADP
aiua-6590	41	50	prostate	prostate	NOUN
aiua-6590	41	51	specific	specific	ADJ
aiua-6590	41	52	antigen	antigen	NOUN
aiua-6590	41	53	(	(	PUNCT
aiua-6590	41	54	psa	psa	NOUN
aiua-6590	41	55	)	)	PUNCT
aiua-6590	41	56	<	<	X
aiua-6590	41	57	4	4	NUM
aiua-6590	41	58	ng	ng	PROPN
aiua-6590	41	59	/	/	SYM
aiua-6590	41	60	ml	ml	PROPN
aiua-6590	41	61	(	(	PUNCT
aiua-6590	41	62	or	or	CCONJ
aiua-6590	41	63	higher	high	ADJ
aiua-6590	41	64	in	in	ADP
aiua-6590	41	65	presence	presence	NOUN
aiua-6590	41	66	of	of	ADP
aiua-6590	41	67	negative	negative	ADJ
aiua-6590	41	68	prostate	prostate	NOUN
aiua-6590	41	69	biopsy	biopsy	NOUN
aiua-6590	41	70	)	)	PUNCT
aiua-6590	41	71	and	and	CCONJ
aiua-6590	41	72	iief-5	iief-5	NUM
aiua-6590	41	73	score	score	VERB
aiua-6590	41	74	>	>	X
aiua-6590	41	75	21	21	NUM
aiua-6590	41	76	were	be	AUX
aiua-6590	41	77	enclosed	enclose	VERB
aiua-6590	41	78	in	in	ADP
aiua-6590	41	79	this	this	DET
aiua-6590	41	80	study	study	NOUN
aiua-6590	41	81	.	.	PUNCT
aiua-6590	42	1	on	on	ADP
aiua-6590	42	2	the	the	DET
aiua-6590	42	3	other	other	ADJ
aiua-6590	42	4	hand	hand	NOUN
aiua-6590	42	5	,	,	PUNCT
aiua-6590	42	6	patients	patient	NOUN
aiua-6590	42	7	with	with	ADP
aiua-6590	42	8	diabetes	diabetes	NOUN
aiua-6590	42	9	,	,	PUNCT
aiua-6590	42	10	liver	liver	NOUN
aiua-6590	42	11	,	,	PUNCT
aiua-6590	42	12	and/or	and/or	CCONJ
aiua-6590	42	13	renal	renal	ADJ
aiua-6590	42	14	failure	failure	NOUN
aiua-6590	42	15	,	,	PUNCT
aiua-6590	42	16	cancer	cancer	NOUN
aiua-6590	42	17	,	,	PUNCT
aiua-6590	42	18	prostatitis	prostatitis	NOUN
aiua-6590	42	19	,	,	PUNCT
aiua-6590	42	20	active	active	ADJ
aiua-6590	42	21	urinary	urinary	ADJ
aiua-6590	42	22	tract	tract	NOUN
aiua-6590	42	23	infection	infection	NOUN
aiua-6590	42	24	,	,	PUNCT
aiua-6590	42	25	chronic	chronic	ADJ
aiua-6590	42	26	retention	retention	NOUN
aiua-6590	42	27	or	or	CCONJ
aiua-6590	42	28	polycystic	polycystic	ADJ
aiua-6590	42	29	kidney	kidney	NOUN
aiua-6590	42	30	disease	disease	NOUN
aiua-6590	42	31	were	be	AUX
aiua-6590	42	32	excluded	exclude	VERB
aiua-6590	42	33	from	from	ADP
aiua-6590	42	34	the	the	DET
aiua-6590	42	35	study	study	NOUN
aiua-6590	42	36	.	.	PUNCT
aiua-6590	43	1	moreover	moreover	ADV
aiua-6590	43	2	,	,	PUNCT
aiua-6590	43	3	we	we	PRON
aiua-6590	43	4	also	also	ADV
aiua-6590	43	5	excluded	exclude	VERB
aiua-6590	43	6	patients	patient	NOUN
aiua-6590	43	7	with	with	ADP
aiua-6590	43	8	urethral	urethral	ADJ
aiua-6590	43	9	stenosis	stenosis	NOUN
aiua-6590	43	10	or	or	CCONJ
aiua-6590	43	11	anatomical	anatomical	ADJ
aiua-6590	43	12	abnormality	abnormality	NOUN
aiua-6590	43	13	interfering	interfere	VERB
aiua-6590	43	14	with	with	ADP
aiua-6590	43	15	the	the	DET
aiua-6590	43	16	evaluation	evaluation	NOUN
aiua-6590	43	17	of	of	ADP
aiua-6590	43	18	voiding	void	VERB
aiua-6590	43	19	function	function	NOUN
aiua-6590	43	20	.	.	PUNCT
aiua-6590	44	1	patients	patient	NOUN
aiua-6590	44	2	with	with	ADP
aiua-6590	44	3	a	a	DET
aiua-6590	44	4	history	history	NOUN
aiua-6590	44	5	of	of	ADP
aiua-6590	44	6	transurethral	transurethral	ADJ
aiua-6590	44	7	resections	resection	NOUN
aiua-6590	44	8	of	of	ADP
aiua-6590	44	9	the	the	DET
aiua-6590	44	10	prostate	prostate	NOUN
aiua-6590	44	11	,	,	PUNCT
aiua-6590	44	12	laser	laser	NOUN
aiua-6590	44	13	therapy	therapy	NOUN
aiua-6590	44	14	,	,	PUNCT
aiua-6590	44	15	or	or	CCONJ
aiua-6590	44	16	thermo	thermo	NOUN
aiua-6590	44	17	therapy	therapy	NOUN
aiua-6590	44	18	or	or	CCONJ
aiua-6590	44	19	with	with	ADP
aiua-6590	44	20	allergy	allergy	NOUN
aiua-6590	44	21	to	to	ADP
aiua-6590	44	22	one	one	NUM
aiua-6590	44	23	or	or	CCONJ
aiua-6590	44	24	more	more	ADJ
aiua-6590	44	25	compounds	compound	NOUN
aiua-6590	44	26	of	of	ADP
aiua-6590	44	27	migar	migar	ADJ
aiua-6590	44	28	®	®	NOUN
aiua-6590	44	29	mg	mg	PROPN
aiua-6590	44	30	retard	retard	PROPN
aiua-6590	44	31	were	be	AUX
aiua-6590	44	32	also	also	ADV
aiua-6590	44	33	excluded	exclude	VERB
aiua-6590	44	34	.	.	PUNCT
aiua-6590	45	1	finally	finally	ADV
aiua-6590	45	2	,	,	PUNCT
aiua-6590	45	3	were	be	AUX
aiua-6590	45	4	also	also	ADV
aiua-6590	45	5	excluded	exclude	VERB
aiua-6590	45	6	from	from	ADP
aiua-6590	45	7	the	the	DET
aiua-6590	45	8	study	study	NOUN
aiua-6590	45	9	the	the	DET
aiua-6590	45	10	patients	patient	NOUN
aiua-6590	45	11	that	that	PRON
aiua-6590	45	12	received	receive	VERB
aiua-6590	45	13	a	a	DET
aiua-6590	45	14	treatment	treatment	NOUN
aiua-6590	45	15	for	for	ADP
aiua-6590	45	16	luts	luts	PROPN
aiua-6590	45	17	/	/	SYM
aiua-6590	45	18	bph	bph	NOUN
aiua-6590	45	19	in	in	ADP
aiua-6590	45	20	the	the	DET
aiua-6590	45	21	last	last	ADJ
aiua-6590	45	22	6	6	NUM
aiua-6590	45	23	months	month	NOUN
aiua-6590	45	24	.	.	PUNCT
aiua-6590	46	1	questionnaires	questionnaire	NOUN
aiua-6590	46	2	and	and	CCONJ
aiua-6590	46	3	urological	urological	ADJ
aiua-6590	46	4	examinations	examination	NOUN
aiua-6590	46	5	the	the	DET
aiua-6590	46	6	validated	validate	VERB
aiua-6590	46	7	italian	italian	ADJ
aiua-6590	46	8	versions	version	NOUN
aiua-6590	46	9	of	of	ADP
aiua-6590	46	10	the	the	DET
aiua-6590	46	11	ipss	ipss	PROPN
aiua-6590	46	12	(	(	PUNCT
aiua-6590	46	13	14	14	NUM
aiua-6590	46	14	)	)	PUNCT
aiua-6590	46	15	,	,	PUNCT
aiua-6590	46	16	iief-5	iief-5	NUM
aiua-6590	46	17	(	(	PUNCT
aiua-6590	46	18	15	15	NUM
aiua-6590	46	19	)	)	PUNCT
aiua-6590	46	20	and	and	CCONJ
aiua-6590	46	21	qol	qol	INTJ
aiua-6590	46	22	(	(	PUNCT
aiua-6590	46	23	16	16	NUM
aiua-6590	46	24	)	)	PUNCT
aiua-6590	46	25	were	be	AUX
aiua-6590	46	26	self	self	NOUN
aiua-6590	46	27	-	-	PUNCT
aiua-6590	46	28	administered	administer	VERB
aiua-6590	46	29	to	to	ADP
aiua-6590	46	30	each	each	DET
aiua-6590	46	31	patient	patient	NOUN
aiua-6590	46	32	at	at	ADP
aiua-6590	46	33	the	the	DET
aiua-6590	46	34	arrival	arrival	NOUN
aiua-6590	46	35	to	to	ADP
aiua-6590	46	36	the	the	DET
aiua-6590	46	37	urological	urological	ADJ
aiua-6590	46	38	institution	institution	NOUN
aiua-6590	46	39	.	.	PUNCT
aiua-6590	47	1	the	the	DET
aiua-6590	47	2	qol	qol	PROPN
aiua-6590	47	3	scale	scale	NOUN
aiua-6590	47	4	was	be	AUX
aiua-6590	47	5	selected	select	VERB
aiua-6590	47	6	because	because	SCONJ
aiua-6590	47	7	it	it	PRON
aiua-6590	47	8	has	have	AUX
aiua-6590	47	9	been	be	AUX
aiua-6590	47	10	successfully	successfully	ADV
aiua-6590	47	11	applied	apply	VERB
aiua-6590	47	12	to	to	ADP
aiua-6590	47	13	acute	acute	ADJ
aiua-6590	47	14	illnesses	illness	NOUN
aiua-6590	47	15	,	,	PUNCT
aiua-6590	47	16	whereas	whereas	SCONJ
aiua-6590	47	17	other	other	ADJ
aiua-6590	47	18	quality	quality	NOUN
aiua-6590	47	19	of	of	ADP
aiua-6590	47	20	life	life	NOUN
aiua-6590	47	21	scales	scale	NOUN
aiua-6590	47	22	,	,	PUNCT
aiua-6590	47	23	including	include	VERB
aiua-6590	47	24	the	the	DET
aiua-6590	47	25	short	short	PROPN
aiua-6590	47	26	form-36	form-36	PROPN
aiua-6590	47	27	(	(	PUNCT
aiua-6590	47	28	sf-36	sf-36	NOUN
aiua-6590	47	29	)	)	PUNCT
aiua-6590	47	30	health	health	NOUN
aiua-6590	47	31	survey	survey	NOUN
aiua-6590	47	32	,	,	PUNCT
aiua-6590	47	33	are	be	AUX
aiua-6590	47	34	more	more	ADV
aiua-6590	47	35	suitable	suitable	ADJ
aiua-6590	47	36	in	in	ADP
aiua-6590	47	37	chronic	chronic	ADJ
aiua-6590	47	38	cases	case	NOUN
aiua-6590	47	39	(	(	PUNCT
aiua-6590	47	40	17	17	NUM
aiua-6590	47	41	)	)	PUNCT
aiua-6590	47	42	.	.	PUNCT
aiua-6590	48	1	higher	high	ADJ
aiua-6590	48	2	scores	score	NOUN
aiua-6590	48	3	on	on	ADP
aiua-6590	48	4	the	the	DET
aiua-6590	48	5	qol	qol	PROPN
aiua-6590	48	6	scale	scale	NOUN
aiua-6590	48	7	reflect	reflect	VERB
aiua-6590	48	8	a	a	DET
aiua-6590	48	9	higher	high	ADJ
aiua-6590	48	10	quality	quality	NOUN
aiua-6590	48	11	of	of	ADP
aiua-6590	48	12	life	life	NOUN
aiua-6590	48	13	(	(	PUNCT
aiua-6590	48	14	16	16	NUM
aiua-6590	48	15	)	)	PUNCT
aiua-6590	48	16	.	.	PUNCT
aiua-6590	49	1	the	the	DET
aiua-6590	49	2	iief-5	iief-5	NUM
aiua-6590	49	3	questionnaire	questionnaire	NOUN
aiua-6590	49	4	was	be	AUX
aiua-6590	49	5	used	use	VERB
aiua-6590	49	6	for	for	ADP
aiua-6590	49	7	exclude	exclude	VERB
aiua-6590	49	8	all	all	DET
aiua-6590	49	9	patients	patient	NOUN
aiua-6590	49	10	with	with	ADP
aiua-6590	49	11	concomitant	concomitant	ADJ
aiua-6590	49	12	erectile	erectile	NOUN
aiua-6590	49	13	dysfunction	dysfunction	NOUN
aiua-6590	49	14	and	and	CCONJ
aiua-6590	49	15	for	for	ADP
aiua-6590	49	16	evaluating	evaluate	VERB
aiua-6590	49	17	the	the	DET
aiua-6590	49	18	impact	impact	NOUN
aiua-6590	49	19	of	of	ADP
aiua-6590	49	20	treatment	treatment	NOUN
aiua-6590	49	21	on	on	ADP
aiua-6590	49	22	sexual	sexual	ADJ
aiua-6590	49	23	function	function	NOUN
aiua-6590	49	24	at	at	ADP
aiua-6590	49	25	the	the	DET
aiua-6590	49	26	end	end	NOUN
aiua-6590	49	27	of	of	ADP
aiua-6590	49	28	the	the	DET
aiua-6590	49	29	follow	follow	NOUN
aiua-6590	49	30	-	-	PUNCT
aiua-6590	49	31	up	up	ADP
aiua-6590	49	32	therapy	therapy	NOUN
aiua-6590	49	33	.	.	PUNCT
aiua-6590	50	1	composition	composition	NOUN
aiua-6590	50	2	and	and	CCONJ
aiua-6590	50	3	characterization	characterization	NOUN
aiua-6590	50	4	of	of	ADP
aiua-6590	50	5	the	the	DET
aiua-6590	50	6	extracts	extract	NOUN
aiua-6590	50	7	used	use	VERB
aiua-6590	50	8	migar	migar	NOUN
aiua-6590	50	9	®	®	NOUN
aiua-6590	50	10	mg	mg	PROPN
aiua-6590	50	11	retard	retard	VERB
aiua-6590	50	12	each	each	DET
aiua-6590	50	13	tablet	tablet	NOUN
aiua-6590	50	14	contains	contain	VERB
aiua-6590	50	15	daidzein	daidzein	ADJ
aiua-6590	50	16	20	20	NUM
aiua-6590	50	17	mg	mg	NOUN
aiua-6590	50	18	,	,	PUNCT
aiua-6590	50	19	genistein	genistein	NOUN
aiua-6590	50	20	20	20	NUM
aiua-6590	50	21	mg	mg	PROPN
aiua-6590	50	22	,	,	PUNCT
aiua-6590	50	23	isolase	isolase	NOUN
aiua-6590	50	24	®	®	NOUN
aiua-6590	50	25	40	40	NUM
aiua-6590	50	26	mg	mg	NOUN
aiua-6590	50	27	,	,	PUNCT
aiua-6590	50	28	zinc	zinc	NOUN
aiua-6590	50	29	10	10	NUM
aiua-6590	50	30	mg	mg	NOUN
aiua-6590	50	31	.	.	PUNCT
aiua-6590	51	1	instrumental	instrumental	ADJ
aiua-6590	51	2	,	,	PUNCT
aiua-6590	51	3	laboratory	laboratory	NOUN
aiua-6590	51	4	and	and	CCONJ
aiua-6590	51	5	urological	urological	ADJ
aiua-6590	51	6	evaluation	evaluation	NOUN
aiua-6590	51	7	at	at	ADP
aiua-6590	51	8	the	the	DET
aiua-6590	51	9	time	time	NOUN
aiua-6590	51	10	of	of	ADP
aiua-6590	51	11	the	the	DET
aiua-6590	51	12	enrolment	enrolment	NOUN
aiua-6590	51	13	(	(	PUNCT
aiua-6590	51	14	t0	t0	NOUN
aiua-6590	51	15	)	)	PUNCT
aiua-6590	51	16	and	and	CCONJ
aiua-6590	51	17	during	during	ADP
aiua-6590	51	18	the	the	DET
aiua-6590	51	19	followup	followup	NOUN
aiua-6590	51	20	(	(	PUNCT
aiua-6590	51	21	t1	t1	NOUN
aiua-6590	51	22	)	)	PUNCT
aiua-6590	51	23	,	,	PUNCT
aiua-6590	51	24	all	all	DET
aiua-6590	51	25	patients	patient	NOUN
aiua-6590	51	26	underwent	undergo	VERB
aiua-6590	51	27	urological	urological	ADJ
aiua-6590	51	28	examinations	examination	NOUN
aiua-6590	51	29	with	with	ADP
aiua-6590	51	30	the	the	DET
aiua-6590	51	31	prostate	prostate	NOUN
aiua-6590	51	32	volume	volume	NOUN
aiua-6590	51	33	ultrasound	ultrasound	NOUN
aiua-6590	51	34	evaluation	evaluation	NOUN
aiua-6590	51	35	.	.	PUNCT
aiua-6590	52	1	ultrasound	ultrasound	NOUN
aiua-6590	52	2	prostate	prostate	NOUN
aiua-6590	52	3	evaluation	evaluation	NOUN
aiua-6590	52	4	was	be	AUX
aiua-6590	52	5	performed	perform	VERB
aiua-6590	52	6	during	during	ADP
aiua-6590	52	7	the	the	DET
aiua-6590	52	8	urological	urological	ADJ
aiua-6590	52	9	examination	examination	NOUN
aiua-6590	52	10	with	with	ADP
aiua-6590	52	11	a	a	DET
aiua-6590	52	12	trans	trans	ADJ
aiua-6590	52	13	-	-	ADJ
aiua-6590	52	14	abdominal	abdominal	ADJ
aiua-6590	52	15	approach	approach	NOUN
aiua-6590	52	16	.	.	PUNCT
aiua-6590	53	1	the	the	DET
aiua-6590	53	2	trans	trans	ADJ
aiua-6590	53	3	-	-	ADJ
aiua-6590	53	4	abdominal	abdominal	ADJ
aiua-6590	53	5	scan	scan	NOUN
aiua-6590	53	6	was	be	AUX
aiua-6590	53	7	performed	perform	VERB
aiua-6590	53	8	with	with	ADP
aiua-6590	53	9	the	the	DET
aiua-6590	53	10	patient	patient	NOUN
aiua-6590	53	11	's	's	PART
aiua-6590	53	12	supine	supine	NOUN
aiua-6590	53	13	after	after	ADP
aiua-6590	53	14	applying	apply	VERB
aiua-6590	53	15	ultrasonic	ultrasonic	ADJ
aiua-6590	53	16	gel	gel	NOUN
aiua-6590	53	17	to	to	ADP
aiua-6590	53	18	the	the	DET
aiua-6590	53	19	suprapubic	suprapubic	ADJ
aiua-6590	53	20	regions	region	NOUN
aiua-6590	53	21	(	(	PUNCT
aiua-6590	53	22	3	3	NUM
aiua-6590	53	23	)	)	PUNCT
aiua-6590	53	24	.	.	PUNCT
aiua-6590	54	1	moreover	moreover	ADV
aiua-6590	54	2	,	,	PUNCT
aiua-6590	54	3	an	an	DET
aiua-6590	54	4	uroflowmetry	uroflowmetry	NOUN
aiua-6590	54	5	(	(	PUNCT
aiua-6590	54	6	cmax	cmax	NOUN
aiua-6590	54	7	)	)	PUNCT
aiua-6590	54	8	with	with	ADP
aiua-6590	54	9	ultrasound	ultrasound	ADJ
aiua-6590	54	10	evaluation	evaluation	NOUN
aiua-6590	54	11	of	of	ADP
aiua-6590	54	12	post	post	ADJ
aiua-6590	54	13	-	-	ADJ
aiua-6590	54	14	voided	void	VERB
aiua-6590	54	15	residual	residual	ADJ
aiua-6590	54	16	volume	volume	NOUN
aiua-6590	54	17	was	be	AUX
aiua-6590	54	18	performed	perform	VERB
aiua-6590	54	19	by	by	ADP
aiua-6590	54	20	using	use	VERB
aiua-6590	54	21	urodyn	urodyn	NOUN
aiua-6590	54	22	®	®	NOUN
aiua-6590	54	23	1000	1000	NUM
aiua-6590	54	24	system	system	NOUN
aiua-6590	54	25	(	(	PUNCT
aiua-6590	54	26	medtronic	medtronic	ADJ
aiua-6590	54	27	functional	functional	ADJ
aiua-6590	54	28	diagnostics	diagnostic	NOUN
aiua-6590	54	29	a	a	PRON
aiua-6590	54	30	/	/	SYM
aiua-6590	54	31	s.	s.	PROPN
aiua-6590	54	32	)	)	PUNCT
aiua-6590	54	33	(	(	PUNCT
aiua-6590	54	34	3	3	NUM
aiua-6590	54	35	)	)	PUNCT
aiua-6590	54	36	.	.	PUNCT
aiua-6590	55	1	all	all	DET
aiua-6590	55	2	patients	patient	NOUN
aiua-6590	55	3	were	be	AUX
aiua-6590	55	4	asked	ask	VERB
aiua-6590	55	5	to	to	PART
aiua-6590	55	6	do	do	VERB
aiua-6590	55	7	the	the	DET
aiua-6590	55	8	psa	psa	NOUN
aiua-6590	55	9	dosage	dosage	NOUN
aiua-6590	55	10	.	.	PUNCT
aiua-6590	56	1	in	in	ADP
aiua-6590	56	2	order	order	NOUN
aiua-6590	56	3	to	to	PART
aiua-6590	56	4	exclude	exclude	VERB
aiua-6590	56	5	urinary	urinary	ADJ
aiua-6590	56	6	tract	tract	NOUN
aiua-6590	56	7	infection	infection	NOUN
aiua-6590	56	8	,	,	PUNCT
aiua-6590	56	9	both	both	PRON
aiua-6590	56	10	leukocyte	leukocyte	ADJ
aiua-6590	56	11	esterase	esterase	NOUN
aiua-6590	56	12	and	and	CCONJ
aiua-6590	56	13	nitrite	nitrite	NOUN
aiua-6590	56	14	levels	level	NOUN
aiua-6590	56	15	were	be	AUX
aiua-6590	56	16	measured	measure	VERB
aiua-6590	56	17	in	in	ADP
aiua-6590	56	18	urine	urine	NOUN
aiua-6590	56	19	samples	sample	NOUN
aiua-6590	56	20	through	through	ADP
aiua-6590	56	21	dipstick	dipstick	PROPN
aiua-6590	56	22	assay	assay	PROPN
aiua-6590	56	23	(	(	PUNCT
aiua-6590	56	24	bayer	bayer	NOUN
aiua-6590	56	25	multistik	multistik	NOUN
aiua-6590	56	26	pro	pro	ADJ
aiua-6590	56	27	reagent	reagent	ADJ
aiua-6590	56	28	strips	strip	NOUN
aiua-6590	56	29	)	)	PUNCT
aiua-6590	56	30	(	(	PUNCT
aiua-6590	56	31	3	3	NUM
aiua-6590	56	32	)	)	PUNCT
aiua-6590	56	33	.	.	PUNCT
aiua-6590	57	1	main	main	ADJ
aiua-6590	57	2	outcome	outcome	NOUN
aiua-6590	57	3	measure	measure	NOUN
aiua-6590	57	4	the	the	DET
aiua-6590	57	5	main	main	ADJ
aiua-6590	57	6	outcome	outcome	NOUN
aiua-6590	57	7	measure	measure	NOUN
aiua-6590	57	8	was	be	AUX
aiua-6590	57	9	the	the	DET
aiua-6590	57	10	improvement	improvement	NOUN
aiua-6590	57	11	of	of	ADP
aiua-6590	57	12	quality	quality	NOUN
aiua-6590	57	13	of	of	ADP
aiua-6590	57	14	life	life	NOUN
aiua-6590	57	15	at	at	ADP
aiua-6590	57	16	the	the	DET
aiua-6590	57	17	end	end	NOUN
aiua-6590	57	18	of	of	ADP
aiua-6590	57	19	the	the	DET
aiua-6590	57	20	whole	whole	ADJ
aiua-6590	57	21	study	study	NOUN
aiua-6590	57	22	period	period	NOUN
aiua-6590	57	23	,	,	PUNCT
aiua-6590	57	24	in	in	ADP
aiua-6590	57	25	terms	term	NOUN
aiua-6590	57	26	of	of	ADP
aiua-6590	57	27	changes	change	NOUN
aiua-6590	57	28	in	in	ADP
aiua-6590	57	29	ipss	ipss	PROPN
aiua-6590	57	30	,	,	PUNCT
aiua-6590	57	31	ipss	ipss	PROPN
aiua-6590	57	32	-	-	PUNCT
aiua-6590	57	33	qol	qol	PROPN
aiua-6590	57	34	,	,	PUNCT
aiua-6590	57	35	cmax	cmax	NOUN
aiua-6590	57	36	,	,	PUNCT
aiua-6590	57	37	pvr	pvr	NOUN
aiua-6590	57	38	,	,	PUNCT
aiua-6590	57	39	and	and	CCONJ
aiua-6590	57	40	qol	qol	VERB
aiua-6590	57	41	from	from	ADP
aiua-6590	57	42	baseline	baseline	NOUN
aiua-6590	57	43	to	to	ADP
aiua-6590	57	44	the	the	DET
aiua-6590	57	45	evaluation	evaluation	NOUN
aiua-6590	57	46	point	point	NOUN
aiua-6590	57	47	,	,	PUNCT
aiua-6590	57	48	that	that	ADV
aiua-6590	57	49	is	is	ADV
aiua-6590	57	50	,	,	PUNCT
aiua-6590	57	51	6	6	NUM
aiua-6590	57	52	months	month	NOUN
aiua-6590	57	53	.	.	PUNCT
aiua-6590	58	1	as	as	ADP
aiua-6590	58	2	secondary	secondary	ADJ
aiua-6590	58	3	endpoints	endpoint	NOUN
aiua-6590	58	4	we	we	PRON
aiua-6590	58	5	considered	consider	VERB
aiua-6590	58	6	a	a	DET
aiua-6590	58	7	change	change	NOUN
aiua-6590	58	8	between	between	ADP
aiua-6590	58	9	t0	t0	PROPN
aiua-6590	58	10	and	and	CCONJ
aiua-6590	58	11	t1	t1	VERB
aiua-6590	58	12	in	in	ADP
aiua-6590	58	13	the	the	DET
aiua-6590	58	14	following	follow	VERB
aiua-6590	58	15	parameters	parameter	NOUN
aiua-6590	58	16	:	:	PUNCT
aiua-6590	58	17	psa	psa	VERB
aiua-6590	58	18	values	value	NOUN
aiua-6590	58	19	,	,	PUNCT
aiua-6590	58	20	prostate	prostate	NOUN
aiua-6590	58	21	volume	volume	NOUN
aiua-6590	58	22	,	,	PUNCT
aiua-6590	58	23	progression	progression	NOUN
aiua-6590	58	24	of	of	ADP
aiua-6590	58	25	disease	disease	NOUN
aiua-6590	58	26	,	,	PUNCT
aiua-6590	58	27	and	and	CCONJ
aiua-6590	58	28	surgical	surgical	ADJ
aiua-6590	58	29	treatment	treatment	NOUN
aiua-6590	58	30	.	.	PUNCT
aiua-6590	59	1	clinical	clinical	ADJ
aiua-6590	59	2	failure	failure	NOUN
aiua-6590	59	3	was	be	AUX
aiua-6590	59	4	defined	define	VERB
aiua-6590	59	5	as	as	ADP
aiua-6590	59	6	the	the	DET
aiua-6590	59	7	persistence	persistence	NOUN
aiua-6590	59	8	of	of	ADP
aiua-6590	59	9	symptoms	symptom	NOUN
aiua-6590	59	10	after	after	ADP
aiua-6590	59	11	the	the	DET
aiua-6590	59	12	treatment	treatment	NOUN
aiua-6590	59	13	or	or	CCONJ
aiua-6590	59	14	the	the	DET
aiua-6590	59	15	suspension	suspension	NOUN
aiua-6590	59	16	of	of	ADP
aiua-6590	59	17	therapy	therapy	NOUN
aiua-6590	59	18	for	for	ADP
aiua-6590	59	19	significant	significant	ADJ
aiua-6590	59	20	reported	report	VERB
aiua-6590	59	21	adrs	adr	NOUN
aiua-6590	59	22	,	,	PUNCT
aiua-6590	59	23	in	in	ADP
aiua-6590	59	24	particular	particular	ADJ
aiua-6590	59	25	on	on	ADP
aiua-6590	59	26	sexual	sexual	ADJ
aiua-6590	59	27	function	function	NOUN
aiua-6590	59	28	(	(	PUNCT
aiua-6590	59	29	3	3	NUM
aiua-6590	59	30	)	)	PUNCT
aiua-6590	59	31	.	.	PUNCT
aiua-6590	60	1	finally	finally	ADV
aiua-6590	60	2	,	,	PUNCT
aiua-6590	60	3	from	from	ADP
aiua-6590	60	4	the	the	DET
aiua-6590	60	5	beginning	beginning	NOUN
aiua-6590	60	6	of	of	ADP
aiua-6590	60	7	the	the	DET
aiua-6590	60	8	study	study	NOUN
aiua-6590	60	9	(	(	PUNCT
aiua-6590	60	10	t0	t0	NOUN
aiua-6590	60	11	)	)	PUNCT
aiua-6590	60	12	and	and	CCONJ
aiua-6590	60	13	up	up	ADP
aiua-6590	60	14	to	to	ADP
aiua-6590	60	15	its	its	PRON
aiua-6590	60	16	ending	end	VERB
aiua-6590	60	17	(	(	PUNCT
aiua-6590	60	18	t1	t1	NOUN
aiua-6590	60	19	)	)	PUNCT
aiua-6590	60	20	,	,	PUNCT
aiua-6590	60	21	the	the	DET
aiua-6590	60	22	development	development	NOUN
aiua-6590	60	23	of	of	ADP
aiua-6590	60	24	adrs	adrs	PROPN
aiua-6590	60	25	or	or	CCONJ
aiua-6590	60	26	of	of	ADP
aiua-6590	60	27	drug	drug	NOUN
aiua-6590	60	28	-	-	PUNCT
aiua-6590	60	29	drug	drug	NOUN
aiua-6590	60	30	interactions	interaction	NOUN
aiua-6590	60	31	(	(	PUNCT
aiua-6590	60	32	ddis	ddi	NOUN
aiua-6590	60	33	)	)	PUNCT
aiua-6590	60	34	were	be	AUX
aiua-6590	60	35	recorded	record	VERB
aiua-6590	60	36	in	in	ADP
aiua-6590	60	37	agreement	agreement	NOUN
aiua-6590	60	38	with	with	ADP
aiua-6590	60	39	our	our	PRON
aiua-6590	60	40	previous	previous	ADJ
aiua-6590	60	41	paper	paper	NOUN
aiua-6590	60	42	(	(	PUNCT
aiua-6590	60	43	18	18	NUM
aiua-6590	60	44	)	)	PUNCT
aiua-6590	60	45	using	use	VERB
aiua-6590	60	46	the	the	DET
aiua-6590	60	47	naranjo	naranjo	PROPN
aiua-6590	60	48	scale	scale	NOUN
aiua-6590	60	49	and	and	CCONJ
aiua-6590	60	50	the	the	DET
aiua-6590	60	51	drug	drug	NOUN
aiua-6590	60	52	interaction	interaction	NOUN
aiua-6590	60	53	probability	probability	NOUN
aiua-6590	60	54	scale	scale	NOUN
aiua-6590	60	55	,	,	PUNCT
aiua-6590	60	56	in	in	ADP
aiua-6590	60	57	agreement	agreement	NOUN
aiua-6590	60	58	with	with	ADP
aiua-6590	60	59	the	the	DET
aiua-6590	60	60	common	common	ADJ
aiua-6590	60	61	terminology	terminology	NOUN
aiua-6590	60	62	criteria	criterion	NOUN
aiua-6590	60	63	for	for	ADP
aiua-6590	60	64	adverse	adverse	ADJ
aiua-6590	60	65	events	event	NOUN
aiua-6590	60	66	(	(	PUNCT
aiua-6590	60	67	ctcae	ctcae	NOUN
aiua-6590	60	68	)	)	PUNCT
aiua-6590	60	69	guidelines	guideline	NOUN
aiua-6590	60	70	(	(	PUNCT
aiua-6590	60	71	19	19	NUM
aiua-6590	60	72	)	)	PUNCT
aiua-6590	60	73	.	.	PUNCT
aiua-6590	61	1	safety	safety	NOUN
aiua-6590	61	2	assessments	assessment	NOUN
aiua-6590	61	3	included	include	VERB
aiua-6590	61	4	treatment	treatment	NOUN
aiua-6590	61	5	-	-	PUNCT
aiua-6590	61	6	emergent	emergent	ADJ
aiua-6590	61	7	adverse	adverse	ADJ
aiua-6590	61	8	events	event	NOUN
aiua-6590	61	9	(	(	PUNCT
aiua-6590	61	10	teaes	teaes	ADV
aiua-6590	61	11	)	)	PUNCT
aiua-6590	61	12	and	and	CCONJ
aiua-6590	61	13	serious	serious	ADJ
aiua-6590	61	14	aes	aes	PROPN
aiua-6590	61	15	(	(	PUNCT
aiua-6590	61	16	saes	saes	PROPN
aiua-6590	61	17	)	)	PUNCT
aiua-6590	61	18	.	.	PUNCT
aiua-6590	62	1	the	the	DET
aiua-6590	62	2	study	study	NOUN
aiua-6590	62	3	design	design	NOUN
aiua-6590	62	4	is	be	AUX
aiua-6590	62	5	reported	report	VERB
aiua-6590	62	6	in	in	ADP
aiua-6590	62	7	figure	figure	NOUN
aiua-6590	62	8	1	1	NUM
aiua-6590	62	9	.	.	PUNCT
aiua-6590	63	1	tiscione_stesura	tiscione_stesura	PROPN
aiua-6590	63	2	seveso	seveso	VERB
aiua-6590	63	3	04/04/17	04/04/17	PROPN
aiua-6590	63	4	09:05	09:05	NUM
aiua-6590	63	5	pagina	pagina	X
aiua-6590	63	6	13	13	NUM
aiua-6590	63	7	archivio	archivio	NOUN
aiua-6590	63	8	italiano	italiano	X
aiua-6590	63	9	di	di	X
aiua-6590	63	10	urologia	urologia	PROPN
aiua-6590	63	11	e	e	PROPN
aiua-6590	63	12	andrologia	andrologia	NOUN
aiua-6590	63	13	2017	2017	NUM
aiua-6590	63	14	;	;	PUNCT
aiua-6590	63	15	89	89	NUM
aiua-6590	63	16	,	,	PUNCT
aiua-6590	63	17	1	1	NUM
aiua-6590	63	18	d.	d.	PROPN
aiua-6590	63	19	tiscione	tiscione	PROPN
aiua-6590	63	20	,	,	PUNCT
aiua-6590	63	21	l.	l.	PROPN
aiua-6590	63	22	gallelli	gallelli	PROPN
aiua-6590	63	23	,	,	PUNCT
aiua-6590	63	24	i.	i.	PROPN
aiua-6590	63	25	tamanini	tamanini	PROPN
aiua-6590	63	26	,	,	PUNCT
aiua-6590	63	27	l.g	l.g	PROPN
aiua-6590	63	28	.	.	PROPN
aiua-6590	63	29	luciani	luciani	PROPN
aiua-6590	63	30	,	,	PUNCT
aiua-6590	63	31	p.	p.	NOUN
aiua-6590	63	32	verze	verze	PROPN
aiua-6590	63	33	,	,	PUNCT
aiua-6590	63	34	a.	a.	NOUN
aiua-6590	63	35	palmieri	palmieri	PROPN
aiua-6590	63	36	,	,	PUNCT
aiua-6590	63	37	v.	v.	ADP
aiua-6590	63	38	mirone	mirone	PROPN
aiua-6590	63	39	,	,	PUNCT
aiua-6590	63	40	r.	r.	PROPN
aiua-6590	63	41	bartoletti	bartoletti	PROPN
aiua-6590	63	42	,	,	PUNCT
aiua-6590	63	43	g.	g.	PROPN
aiua-6590	63	44	malossini1	malossini1	PROPN
aiua-6590	63	45	,	,	PUNCT
aiua-6590	63	46	t.	t.	PROPN
aiua-6590	63	47	cai	cai	PROPN
aiua-6590	63	48	14	14	NUM
aiua-6590	63	49	efficacy	efficacy	NOUN
aiua-6590	63	50	outcome	outcome	VERB
aiua-6590	63	51	the	the	DET
aiua-6590	63	52	efficacy	efficacy	NOUN
aiua-6590	63	53	outcome	outcome	NOUN
aiua-6590	63	54	was	be	AUX
aiua-6590	63	55	identified	identify	VERB
aiua-6590	63	56	as	as	ADP
aiua-6590	63	57	a	a	DET
aiua-6590	63	58	statistically	statistically	ADV
aiua-6590	63	59	significant	significant	ADJ
aiua-6590	63	60	difference	difference	NOUN
aiua-6590	63	61	between	between	ADP
aiua-6590	63	62	clinical	clinical	ADJ
aiua-6590	63	63	data	datum	NOUN
aiua-6590	63	64	recorded	record	VERB
aiua-6590	63	65	at	at	ADP
aiua-6590	63	66	the	the	DET
aiua-6590	63	67	time	time	NOUN
aiua-6590	63	68	of	of	ADP
aiua-6590	63	69	admission	admission	NOUN
aiua-6590	63	70	(	(	PUNCT
aiua-6590	63	71	t0	t0	NOUN
aiua-6590	63	72	)	)	PUNCT
aiua-6590	63	73	and	and	CCONJ
aiua-6590	63	74	those	those	PRON
aiua-6590	63	75	recorded	record	VERB
aiua-6590	63	76	at	at	ADP
aiua-6590	63	77	the	the	DET
aiua-6590	63	78	end	end	NOUN
aiua-6590	63	79	of	of	ADP
aiua-6590	63	80	the	the	DET
aiua-6590	63	81	study	study	NOUN
aiua-6590	63	82	(	(	PUNCT
aiua-6590	63	83	t1	t1	PROPN
aiua-6590	63	84	)	)	PUNCT
aiua-6590	63	85	.	.	PUNCT
aiua-6590	64	1	drug	drug	NOUN
aiua-6590	64	2	adherence	adherence	NOUN
aiua-6590	64	3	at	at	ADP
aiua-6590	64	4	the	the	DET
aiua-6590	64	5	end	end	NOUN
aiua-6590	64	6	of	of	ADP
aiua-6590	64	7	the	the	DET
aiua-6590	64	8	study	study	NOUN
aiua-6590	64	9	,	,	PUNCT
aiua-6590	64	10	the	the	DET
aiua-6590	64	11	adherence	adherence	NOUN
aiua-6590	64	12	to	to	ADP
aiua-6590	64	13	the	the	DET
aiua-6590	64	14	treatment	treatment	NOUN
aiua-6590	64	15	was	be	AUX
aiua-6590	64	16	calculated	calculate	VERB
aiua-6590	64	17	using	use	VERB
aiua-6590	64	18	a	a	DET
aiua-6590	64	19	formula	formula	NOUN
aiua-6590	64	20	based	base	VERB
aiua-6590	64	21	on	on	ADP
aiua-6590	64	22	the	the	DET
aiua-6590	64	23	number	number	NOUN
aiua-6590	64	24	of	of	ADP
aiua-6590	64	25	tablets	tablet	NOUN
aiua-6590	64	26	consigned	consign	VERB
aiua-6590	64	27	at	at	ADP
aiua-6590	64	28	the	the	DET
aiua-6590	64	29	time	time	NOUN
aiua-6590	64	30	of	of	ADP
aiua-6590	64	31	admission	admission	NOUN
aiua-6590	64	32	and	and	CCONJ
aiua-6590	64	33	on	on	ADP
aiua-6590	64	34	the	the	DET
aiua-6590	64	35	number	number	NOUN
aiua-6590	64	36	of	of	ADP
aiua-6590	64	37	tablets	tablet	NOUN
aiua-6590	64	38	returned	return	VERB
aiua-6590	64	39	unused	unused	ADJ
aiua-6590	64	40	at	at	ADP
aiua-6590	64	41	the	the	DET
aiua-6590	64	42	end	end	NOUN
aiua-6590	64	43	of	of	ADP
aiua-6590	64	44	the	the	DET
aiua-6590	64	45	study	study	NOUN
aiua-6590	64	46	.	.	PUNCT
aiua-6590	65	1	statistical	statistical	ADJ
aiua-6590	65	2	analysis	analysis	NOUN
aiua-6590	65	3	the	the	DET
aiua-6590	65	4	required	required	ADJ
aiua-6590	65	5	sample	sample	NOUN
aiua-6590	65	6	size	size	NOUN
aiua-6590	65	7	for	for	ADP
aiua-6590	65	8	the	the	DET
aiua-6590	65	9	present	present	ADJ
aiua-6590	65	10	study	study	NOUN
aiua-6590	65	11	was	be	AUX
aiua-6590	65	12	calculated	calculate	VERB
aiua-6590	65	13	under	under	ADP
aiua-6590	65	14	the	the	DET
aiua-6590	65	15	following	following	ADJ
aiua-6590	65	16	conditions	condition	NOUN
aiua-6590	65	17	:	:	PUNCT
aiua-6590	65	18	difference	difference	NOUN
aiua-6590	65	19	between	between	ADP
aiua-6590	65	20	t0	t0	PROPN
aiua-6590	65	21	and	and	CCONJ
aiua-6590	65	22	t1	t1	NOUN
aiua-6590	65	23	,	,	PUNCT
aiua-6590	65	24	4	4	NUM
aiua-6590	65	25	±	±	NUM
aiua-6590	65	26	1	1	NUM
aiua-6590	65	27	score	score	NOUN
aiua-6590	65	28	points	point	NOUN
aiua-6590	65	29	in	in	ADP
aiua-6590	65	30	the	the	DET
aiua-6590	65	31	ipss	ipss	PROPN
aiua-6590	65	32	score	score	NOUN
aiua-6590	65	33	;	;	PUNCT
aiua-6590	65	34	α	α	PRON
aiua-6590	65	35	error	error	NOUN
aiua-6590	65	36	level	level	NOUN
aiua-6590	65	37	,	,	PUNCT
aiua-6590	65	38	0.05	0.05	NUM
aiua-6590	65	39	two	two	NUM
aiua-6590	65	40	-	-	PUNCT
aiua-6590	65	41	sided	sided	ADJ
aiua-6590	65	42	;	;	PUNCT
aiua-6590	65	43	statistical	statistical	ADJ
aiua-6590	65	44	power	power	NOUN
aiua-6590	65	45	,	,	PUNCT
aiua-6590	65	46	80	80	NUM
aiua-6590	65	47	%	%	NOUN
aiua-6590	65	48	;	;	PUNCT
aiua-6590	65	49	and	and	CCONJ
aiua-6590	65	50	anticipated	anticipate	VERB
aiua-6590	65	51	effect	effect	NOUN
aiua-6590	65	52	size	size	NOUN
aiua-6590	65	53	,	,	PUNCT
aiua-6590	65	54	cohen	cohen	PROPN
aiua-6590	65	55	’s	’s	PART
aiua-6590	66	1	d	d	X
aiua-6590	66	2	=	=	SYM
aiua-6590	66	3	0.5	0.5	NUM
aiua-6590	66	4	.	.	PUNCT
aiua-6590	67	1	the	the	DET
aiua-6590	67	2	calculation	calculation	NOUN
aiua-6590	67	3	yielded	yield	VERB
aiua-6590	67	4	45	45	NUM
aiua-6590	67	5	individuals	individual	NOUN
aiua-6590	67	6	.	.	PUNCT
aiua-6590	68	1	at	at	ADP
aiua-6590	68	2	baseline	baseline	NOUN
aiua-6590	68	3	,	,	PUNCT
aiua-6590	68	4	the	the	DET
aiua-6590	68	5	independent	independent	ADJ
aiua-6590	68	6	sample	sample	NOUN
aiua-6590	68	7	2tailed	2tailed	NUM
aiua-6590	68	8	t	t	NOUN
aiua-6590	68	9	-	-	PUNCT
aiua-6590	68	10	test	test	NOUN
aiua-6590	68	11	was	be	AUX
aiua-6590	68	12	used	use	VERB
aiua-6590	68	13	to	to	PART
aiua-6590	68	14	compare	compare	VERB
aiua-6590	68	15	variables	variable	NOUN
aiua-6590	68	16	.	.	PUNCT
aiua-6590	69	1	for	for	ADP
aiua-6590	69	2	categorical	categorical	ADJ
aiua-6590	69	3	parameters	parameter	NOUN
aiua-6590	69	4	,	,	PUNCT
aiua-6590	69	5	chisquare	chisquare	PROPN
aiua-6590	69	6	test	test	NOUN
aiua-6590	69	7	was	be	AUX
aiua-6590	69	8	applied	apply	VERB
aiua-6590	69	9	.	.	PUNCT
aiua-6590	70	1	changes	change	NOUN
aiua-6590	70	2	from	from	ADP
aiua-6590	70	3	baseline	baseline	NOUN
aiua-6590	70	4	to	to	ADP
aiua-6590	70	5	end	end	NOUN
aiua-6590	70	6	of	of	ADP
aiua-6590	70	7	therapy	therapy	NOUN
aiua-6590	70	8	were	be	AUX
aiua-6590	70	9	analyzed	analyze	VERB
aiua-6590	70	10	using	using	AUX
aiua-6590	70	11	ranked	rank	VERB
aiua-6590	70	12	one	one	NUM
aiua-6590	70	13	-	-	PUNCT
aiua-6590	70	14	way	way	NOUN
aiua-6590	70	15	analysis	analysis	NOUN
aiua-6590	70	16	of	of	ADP
aiua-6590	70	17	variance	variance	NOUN
aiua-6590	70	18	(	(	PUNCT
aiua-6590	70	19	anova	anova	PROPN
aiua-6590	70	20	)	)	PUNCT
aiua-6590	70	21	with	with	ADP
aiua-6590	70	22	a	a	DET
aiua-6590	70	23	term	term	NOUN
aiua-6590	70	24	for	for	ADP
aiua-6590	70	25	treatment	treatment	NOUN
aiua-6590	70	26	group	group	NOUN
aiua-6590	70	27	.	.	PUNCT
aiua-6590	71	1	all	all	DET
aiua-6590	71	2	data	datum	NOUN
aiua-6590	71	3	are	be	AUX
aiua-6590	71	4	expressed	express	VERB
aiua-6590	71	5	as	as	ADP
aiua-6590	71	6	mean	mean	NOUN
aiua-6590	71	7	±	±	NUM
aiua-6590	71	8	standard	standard	ADJ
aiua-6590	71	9	deviation	deviation	NOUN
aiua-6590	71	10	.	.	PUNCT
aiua-6590	72	1	the	the	DET
aiua-6590	72	2	threshold	threshold	NOUN
aiua-6590	72	3	of	of	ADP
aiua-6590	72	4	statistical	statistical	ADJ
aiua-6590	72	5	significance	significance	NOUN
aiua-6590	72	6	was	be	AUX
aiua-6590	72	7	set	set	VERB
aiua-6590	72	8	at	at	ADP
aiua-6590	72	9	p	p	NOUN
aiua-6590	72	10	<	<	X
aiua-6590	72	11	0.05	0.05	NUM
aiua-6590	72	12	.	.	PUNCT
aiua-6590	73	1	all	all	PRON
aiua-6590	73	2	reported	report	VERB
aiua-6590	73	3	p	p	NOUN
aiua-6590	73	4	-	-	PUNCT
aiua-6590	73	5	values	value	NOUN
aiua-6590	73	6	are	be	AUX
aiua-6590	73	7	two	two	NUM
aiua-6590	73	8	-	-	PUNCT
aiua-6590	73	9	sided	sided	ADJ
aiua-6590	73	10	.	.	PUNCT
aiua-6590	74	1	all	all	DET
aiua-6590	74	2	statistical	statistical	ADJ
aiua-6590	74	3	analyses	analysis	NOUN
aiua-6590	74	4	were	be	AUX
aiua-6590	74	5	performed	perform	VERB
aiua-6590	74	6	by	by	ADP
aiua-6590	74	7	using	use	VERB
aiua-6590	74	8	spss	spss	PROPN
aiua-6590	74	9	21.0	21.0	NUM
aiua-6590	74	10	(	(	PUNCT
aiua-6590	74	11	ibm	ibm	PROPN
aiua-6590	74	12	corporation	corporation	PROPN
aiua-6590	74	13	,	,	PUNCT
aiua-6590	74	14	armonk	armonk	PROPN
aiua-6590	74	15	,	,	PUNCT
aiua-6590	74	16	ny	ny	PROPN
aiua-6590	74	17	,	,	PUNCT
aiua-6590	74	18	usa	usa	PROPN
aiua-6590	74	19	)	)	PUNCT
aiua-6590	74	20	,	,	PUNCT
aiua-6590	74	21	while	while	SCONJ
aiua-6590	74	22	g*power	g*power	PROPN
aiua-6590	74	23	(	(	PUNCT
aiua-6590	74	24	institut	institut	PROPN
aiua-6590	74	25	für	für	AUX
aiua-6590	74	26	experimentelle	experimentelle	PROPN
aiua-6590	74	27	psychologie	psychologie	PROPN
aiua-6590	74	28	,	,	PUNCT
aiua-6590	74	29	heinrich	heinrich	PROPN
aiua-6590	74	30	heine	heine	PROPN
aiua-6590	74	31	universität	universität	PROPN
aiua-6590	74	32	,	,	PUNCT
aiua-6590	74	33	dusseldorf	dusseldorf	PROPN
aiua-6590	74	34	,	,	PUNCT
aiua-6590	74	35	germany	germany	PROPN
aiua-6590	74	36	)	)	PUNCT
aiua-6590	74	37	was	be	AUX
aiua-6590	74	38	used	use	VERB
aiua-6590	74	39	for	for	ADP
aiua-6590	74	40	power	power	NOUN
aiua-6590	74	41	calculation	calculation	NOUN
aiua-6590	74	42	.	.	PUNCT
aiua-6590	75	1	results	result	NOUN
aiua-6590	75	2	during	during	ADP
aiua-6590	75	3	the	the	DET
aiua-6590	75	4	study	study	NOUN
aiua-6590	75	5	period	period	NOUN
aiua-6590	75	6	,	,	PUNCT
aiua-6590	75	7	71	71	NUM
aiua-6590	75	8	patients	patient	NOUN
aiua-6590	75	9	were	be	AUX
aiua-6590	75	10	enrolled	enrol	VERB
aiua-6590	75	11	.	.	PUNCT
aiua-6590	76	1	nine	nine	NUM
aiua-6590	76	2	patients	patient	NOUN
aiua-6590	76	3	(	(	PUNCT
aiua-6590	76	4	12.7	12.7	NUM
aiua-6590	76	5	%	%	NOUN
aiua-6590	76	6	)	)	PUNCT
aiua-6590	76	7	were	be	AUX
aiua-6590	76	8	lost	lose	VERB
aiua-6590	76	9	during	during	ADP
aiua-6590	76	10	the	the	DET
aiua-6590	76	11	follow	follow	NOUN
aiua-6590	76	12	-	-	PUNCT
aiua-6590	76	13	up	up	NOUN
aiua-6590	76	14	and	and	CCONJ
aiua-6590	76	15	excluded	exclude	VERB
aiua-6590	76	16	from	from	ADP
aiua-6590	76	17	the	the	DET
aiua-6590	76	18	analysis	analysis	NOUN
aiua-6590	76	19	,	,	PUNCT
aiua-6590	76	20	while	while	SCONJ
aiua-6590	76	21	62	62	NUM
aiua-6590	76	22	patients	patient	NOUN
aiua-6590	76	23	(	(	PUNCT
aiua-6590	76	24	87.3	87.3	NUM
aiua-6590	76	25	%	%	NOUN
aiua-6590	76	26	)	)	PUNCT
aiua-6590	76	27	completed	complete	VERB
aiua-6590	76	28	the	the	DET
aiua-6590	76	29	study	study	NOUN
aiua-6590	76	30	(	(	PUNCT
aiua-6590	76	31	mean	mean	VERB
aiua-6590	76	32	age	age	NOUN
aiua-6590	76	33	65.4	65.4	NUM
aiua-6590	76	34	±	±	NUM
aiua-6590	76	35	5.6	5.6	NUM
aiua-6590	76	36	years	year	NOUN
aiua-6590	76	37	)	)	PUNCT
aiua-6590	76	38	.	.	PUNCT
aiua-6590	77	1	baseline	baseline	PROPN
aiua-6590	77	2	characteristics	characteristic	NOUN
aiua-6590	77	3	history	history	NOUN
aiua-6590	77	4	,	,	PUNCT
aiua-6590	77	5	clinical	clinical	ADJ
aiua-6590	77	6	,	,	PUNCT
aiua-6590	77	7	laboratory	laboratory	NOUN
aiua-6590	77	8	,	,	PUNCT
aiua-6590	77	9	instrumental	instrumental	ADJ
aiua-6590	77	10	and	and	CCONJ
aiua-6590	77	11	questionnaires	questionnaire	VERB
aiua-6590	77	12	data	datum	NOUN
aiua-6590	77	13	at	at	ADP
aiua-6590	77	14	the	the	DET
aiua-6590	77	15	time	time	NOUN
aiua-6590	77	16	of	of	ADP
aiua-6590	77	17	admission	admission	NOUN
aiua-6590	77	18	are	be	AUX
aiua-6590	77	19	reported	report	VERB
aiua-6590	77	20	in	in	ADP
aiua-6590	77	21	table	table	NOUN
aiua-6590	77	22	1	1	NUM
aiua-6590	77	23	.	.	PUNCT
aiua-6590	78	1	follow	follow	VERB
aiua-6590	78	2	-	-	PUNCT
aiua-6590	78	3	up	up	ADP
aiua-6590	78	4	examination	examination	NOUN
aiua-6590	78	5	at	at	ADP
aiua-6590	78	6	t1	t1	NOUN
aiua-6590	78	7	we	we	PRON
aiua-6590	78	8	recorded	record	VERB
aiua-6590	78	9	a	a	DET
aiua-6590	78	10	significant	significant	ADJ
aiua-6590	78	11	difference	difference	NOUN
aiua-6590	78	12	in	in	ADP
aiua-6590	78	13	terms	term	NOUN
aiua-6590	78	14	of	of	ADP
aiua-6590	78	15	ipss	ipss	PROPN
aiua-6590	78	16	in	in	ADP
aiua-6590	78	17	all	all	DET
aiua-6590	78	18	patients	patient	NOUN
aiua-6590	78	19	[	[	PUNCT
aiua-6590	78	20	21.5	21.5	NUM
aiua-6590	78	21	±	±	NUM
aiua-6590	78	22	1.2	1.2	NUM
aiua-6590	78	23	vs	vs	ADP
aiua-6590	78	24	16.2	16.2	NUM
aiua-6590	78	25	±	±	NUM
aiua-6590	78	26	1.5	1.5	NUM
aiua-6590	78	27	;	;	PUNCT
aiua-6590	78	28	(	(	PUNCT
aiua-6590	78	29	-4.8	-4.8	VERB
aiua-6590	78	30	)	)	PUNCT
aiua-6590	78	31	;	;	PUNCT
aiua-6590	78	32	p	p	X
aiua-6590	78	33	<	<	X
aiua-6590	78	34	0.001	0.001	NUM
aiua-6590	78	35	]	]	PUNCT
aiua-6590	78	36	,	,	PUNCT
aiua-6590	78	37	and	and	CCONJ
aiua-6590	78	38	cmax	cmax	VERB
aiua-6590	78	39	[	[	PUNCT
aiua-6590	78	40	9.7	9.7	NUM
aiua-6590	78	41	±	±	NUM
aiua-6590	78	42	3.7	3.7	NUM
aiua-6590	78	43	vs	vs	ADP
aiua-6590	78	44	15.3	15.3	NUM
aiua-6590	78	45	±	±	NUM
aiua-6590	78	46	2.5	2.5	NUM
aiua-6590	78	47	;	;	PUNCT
aiua-6590	78	48	(	(	PUNCT
aiua-6590	78	49	+5.6	+5.6	PROPN
aiua-6590	78	50	)	)	PUNCT
aiua-6590	78	51	;	;	PUNCT
aiua-6590	78	52	p	p	X
aiua-6590	78	53	<	<	X
aiua-6590	78	54	0.001	0.001	NUM
aiua-6590	78	55	]	]	PUNCT
aiua-6590	78	56	,	,	PUNCT
aiua-6590	78	57	post	post	ADJ
aiua-6590	78	58	-	-	ADJ
aiua-6590	78	59	voiding	voiding	ADJ
aiua-6590	78	60	residual	residual	ADJ
aiua-6590	78	61	volume	volume	NOUN
aiua-6590	78	62	[	[	X
aiua-6590	78	63	85	85	NUM
aiua-6590	78	64	±	±	NUM
aiua-6590	78	65	20.6	20.6	NUM
aiua-6590	78	66	vs	vs	ADP
aiua-6590	78	67	50	50	NUM
aiua-6590	78	68	±	±	NUM
aiua-6590	78	69	18.5	18.5	NUM
aiua-6590	78	70	;	;	PUNCT
aiua-6590	78	71	(	(	PUNCT
aiua-6590	78	72	-35	-35	NUM
aiua-6590	78	73	)	)	PUNCT
aiua-6590	78	74	;	;	PUNCT
aiua-6590	78	75	p	p	X
aiua-6590	78	76	<	<	X
aiua-6590	78	77	0.001	0.001	NUM
aiua-6590	78	78	]	]	PUNCT
aiua-6590	78	79	,	,	PUNCT
aiua-6590	78	80	qol	qol	PROPN
aiua-6590	79	1	[	[	X
aiua-6590	79	2	0.56	0.56	NUM
aiua-6590	79	3	±	±	NUM
aiua-6590	79	4	0.15	0.15	NUM
aiua-6590	79	5	vs	vs	ADP
aiua-6590	79	6	0.84	0.84	NUM
aiua-6590	79	7	±	±	NUM
aiua-6590	79	8	0.19	0.19	NUM
aiua-6590	79	9	;	;	PUNCT
aiua-6590	79	10	(	(	PUNCT
aiua-6590	79	11	+0.28	+0.28	NOUN
aiua-6590	79	12	)	)	PUNCT
aiua-6590	79	13	;	;	PUNCT
aiua-6590	79	14	p	p	X
aiua-6590	79	15	<	<	X
aiua-6590	79	16	0.001	0.001	NUM
aiua-6590	79	17	]	]	PUNCT
aiua-6590	79	18	.	.	PUNCT
aiua-6590	80	1	we	we	PRON
aiua-6590	80	2	did	do	AUX
aiua-6590	80	3	not	not	PART
aiua-6590	80	4	record	record	VERB
aiua-6590	80	5	any	any	PRON
aiua-6590	80	6	in	in	ADP
aiua-6590	80	7	terms	term	NOUN
aiua-6590	80	8	of	of	ADP
aiua-6590	80	9	psa	psa	NOUN
aiua-6590	80	10	evaluation	evaluation	NOUN
aiua-6590	80	11	[	[	PUNCT
aiua-6590	80	12	2.47	2.47	NUM
aiua-6590	80	13	±	±	NUM
aiua-6590	80	14	5.6	5.6	NUM
aiua-6590	80	15	vs	vs	ADP
aiua-6590	80	16	2.09	2.09	NUM
aiua-6590	80	17	±	±	NUM
aiua-6590	80	18	4.3	4.3	NUM
aiua-6590	80	19	;	;	PUNCT
aiua-6590	80	20	p	p	X
aiua-6590	80	21	=	=	NOUN
aiua-6590	80	22	0.67	0.67	NUM
aiua-6590	80	23	]	]	PUNCT
aiua-6590	80	24	,	,	PUNCT
aiua-6590	80	25	prostate	prostate	NOUN
aiua-6590	80	26	volume	volume	NOUN
aiua-6590	80	27	[	[	X
aiua-6590	80	28	41.5	41.5	NUM
aiua-6590	80	29	±	±	NUM
aiua-6590	80	30	5.8	5.8	NUM
aiua-6590	80	31	vs	vs	ADP
aiua-6590	80	32	42.1	42.1	NUM
aiua-6590	80	33	±	±	NUM
aiua-6590	80	34	7.5	7.5	NUM
aiua-6590	80	35	p	p	NOUN
aiua-6590	80	36	=	=	NOUN
aiua-6590	80	37	0.61	0.61	NUM
aiua-6590	80	38	]	]	PUNCT
aiua-6590	80	39	and	and	CCONJ
aiua-6590	80	40	iief-5	iief-5	NUM
aiua-6590	80	41	[	[	PUNCT
aiua-6590	80	42	22.1	22.1	NUM
aiua-6590	80	43	±	±	NUM
aiua-6590	80	44	1.8	1.8	NUM
aiua-6590	80	45	vs	vs	ADP
aiua-6590	80	46	22.3	22.3	NUM
aiua-6590	80	47	±	±	NUM
aiua-6590	80	48	1.5	1.5	NUM
aiua-6590	80	49	p	p	NOUN
aiua-6590	80	50	=	=	NOUN
aiua-6590	80	51	0.50	0.50	NUM
aiua-6590	80	52	]	]	PUNCT
aiua-6590	80	53	between	between	ADP
aiua-6590	80	54	t0	t0	PROPN
aiua-6590	80	55	and	and	CCONJ
aiua-6590	80	56	t1	t1	NOUN
aiua-6590	80	57	(	(	PUNCT
aiua-6590	80	58	table	table	NOUN
aiua-6590	80	59	2	2	NUM
aiua-6590	80	60	)	)	PUNCT
aiua-6590	80	61	.	.	PUNCT
aiua-6590	81	1	figure	figure	NOUN
aiua-6590	81	2	1	1	NUM
aiua-6590	81	3	.	.	PUNCT
aiua-6590	82	1	the	the	DET
aiua-6590	82	2	figure	figure	NOUN
aiua-6590	82	3	shows	show	VERB
aiua-6590	82	4	the	the	DET
aiua-6590	82	5	study	study	NOUN
aiua-6590	82	6	schedule	schedule	NOUN
aiua-6590	82	7	.	.	PUNCT
aiua-6590	83	1	ipss	ipss	PROPN
aiua-6590	83	2	:	:	PUNCT
aiua-6590	83	3	international	international	ADJ
aiua-6590	83	4	prostatic	prostatic	ADJ
aiua-6590	83	5	symptom	symptom	NOUN
aiua-6590	83	6	score	score	NOUN
aiua-6590	83	7	;	;	PUNCT
aiua-6590	83	8	iief-5	iief-5	NOUN
aiua-6590	83	9	*	*	NUM
aiua-6590	83	10	:	:	PUNCT
aiua-6590	83	11	international	international	ADJ
aiua-6590	83	12	index	index	NOUN
aiua-6590	83	13	of	of	ADP
aiua-6590	83	14	erectile	erectile	NOUN
aiua-6590	83	15	function	function	NOUN
aiua-6590	83	16	;	;	PUNCT
aiua-6590	83	17	qol	qol	NOUN
aiua-6590	83	18	:	:	PUNCT
aiua-6590	83	19	quality	quality	NOUN
aiua-6590	83	20	of	of	ADP
aiua-6590	83	21	well	well	ADV
aiua-6590	83	22	-	-	PUNCT
aiua-6590	83	23	being	being	NOUN
aiua-6590	83	24	.	.	PUNCT
aiua-6590	84	1	v1	v1	NOUN
aiua-6590	84	2	:	:	PUNCT
aiua-6590	84	3	visit	visit	NOUN
aiua-6590	84	4	1	1	NUM
aiua-6590	84	5	,	,	PUNCT
aiua-6590	84	6	at	at	ADP
aiua-6590	84	7	the	the	DET
aiua-6590	84	8	enrolment	enrolment	NOUN
aiua-6590	84	9	;	;	PUNCT
aiua-6590	84	10	v2	v2	NOUN
aiua-6590	84	11	:	:	PUNCT
aiua-6590	84	12	visit	visit	NOUN
aiua-6590	84	13	2	2	NUM
aiua-6590	84	14	at	at	ADP
aiua-6590	84	15	the	the	DET
aiua-6590	84	16	second	second	ADJ
aiua-6590	84	17	follow	follow	NOUN
aiua-6590	84	18	-	-	PUNCT
aiua-6590	84	19	up	up	NOUN
aiua-6590	84	20	(	(	PUNCT
aiua-6590	84	21	6	6	NUM
aiua-6590	84	22	months	month	NOUN
aiua-6590	84	23	)	)	PUNCT
aiua-6590	84	24	.	.	PUNCT
aiua-6590	85	1	table	table	NOUN
aiua-6590	85	2	2	2	NUM
aiua-6590	85	3	.	.	X
aiua-6590	85	4	questionnaire	questionnaire	NOUN
aiua-6590	85	5	results	result	NOUN
aiua-6590	85	6	at	at	ADP
aiua-6590	85	7	the	the	DET
aiua-6590	85	8	first	first	ADJ
aiua-6590	85	9	follow	follow	VERB
aiua-6590	85	10	-	-	PUNCT
aiua-6590	85	11	up	up	ADP
aiua-6590	85	12	visit	visit	NOUN
aiua-6590	85	13	(	(	PUNCT
aiua-6590	85	14	6	6	NUM
aiua-6590	85	15	months	month	NOUN
aiua-6590	85	16	)	)	PUNCT
aiua-6590	85	17	.	.	PUNCT
aiua-6590	86	1	table	table	NOUN
aiua-6590	86	2	1	1	NUM
aiua-6590	86	3	.	.	PUNCT
aiua-6590	87	1	clinical	clinical	ADJ
aiua-6590	87	2	,	,	PUNCT
aiua-6590	87	3	instrumental	instrumental	ADJ
aiua-6590	87	4	and	and	CCONJ
aiua-6590	87	5	laboratory	laboratory	NOUN
aiua-6590	87	6	patient	patient	NOUN
aiua-6590	87	7	’s	’s	PART
aiua-6590	87	8	data	datum	NOUN
aiua-6590	87	9	at	at	ADP
aiua-6590	87	10	the	the	DET
aiua-6590	87	11	enrolment	enrolment	NOUN
aiua-6590	87	12	time	time	NOUN
aiua-6590	87	13	.	.	PUNCT
aiua-6590	88	1	the	the	DET
aiua-6590	88	2	table	table	NOUN
aiua-6590	88	3	shows	show	VERB
aiua-6590	88	4	the	the	DET
aiua-6590	88	5	mean	mean	ADJ
aiua-6590	88	6	change	change	NOUN
aiua-6590	88	7	differences	difference	NOUN
aiua-6590	88	8	from	from	ADP
aiua-6590	88	9	baseline	baseline	NOUN
aiua-6590	88	10	to	to	ADP
aiua-6590	88	11	6	6	NUM
aiua-6590	88	12	months	month	NOUN
aiua-6590	88	13	relative	relative	ADJ
aiua-6590	88	14	to	to	ADP
aiua-6590	88	15	main	main	ADJ
aiua-6590	88	16	outcome	outcome	NOUN
aiua-6590	88	17	measures	measure	NOUN
aiua-6590	88	18	.	.	PUNCT
aiua-6590	89	1	ipss†	ipss†	ADJ
aiua-6590	89	2	:	:	PUNCT
aiua-6590	89	3	international	international	ADJ
aiua-6590	89	4	prostatic	prostatic	ADJ
aiua-6590	89	5	symptom	symptom	NOUN
aiua-6590	89	6	score	score	NOUN
aiua-6590	89	7	;	;	PUNCT
aiua-6590	89	8	iief-5	iief-5	NOUN
aiua-6590	89	9	*	*	NUM
aiua-6590	89	10	:	:	PUNCT
aiua-6590	89	11	international	international	ADJ
aiua-6590	89	12	index	index	NOUN
aiua-6590	89	13	of	of	ADP
aiua-6590	89	14	erectile	erectile	NOUN
aiua-6590	89	15	function	function	NOUN
aiua-6590	89	16	;	;	PUNCT
aiua-6590	90	1	qol‡	qol‡	ADV
aiua-6590	90	2	:	:	PUNCT
aiua-6590	90	3	quality	quality	NOUN
aiua-6590	90	4	of	of	ADP
aiua-6590	90	5	well	well	ADV
aiua-6590	90	6	-	-	PUNCT
aiua-6590	90	7	being	being	NOUN
aiua-6590	90	8	.	.	PUNCT
aiua-6590	91	1	the	the	DET
aiua-6590	91	2	table	table	NOUN
aiua-6590	91	3	shows	show	VERB
aiua-6590	91	4	all	all	DET
aiua-6590	91	5	anamnestic	anamnestic	ADJ
aiua-6590	91	6	,	,	PUNCT
aiua-6590	91	7	clinical	clinical	ADJ
aiua-6590	91	8	and	and	CCONJ
aiua-6590	91	9	questionnaires	questionnaire	VERB
aiua-6590	91	10	data	datum	NOUN
aiua-6590	91	11	at	at	ADP
aiua-6590	91	12	enrolment	enrolment	NOUN
aiua-6590	91	13	.	.	PUNCT
aiua-6590	92	1	sd	sd	NOUN
aiua-6590	92	2	#	#	SYM
aiua-6590	92	3	:	:	PUNCT
aiua-6590	92	4	standard	standard	ADJ
aiua-6590	92	5	deviation	deviation	NOUN
aiua-6590	92	6	;	;	PUNCT
aiua-6590	92	7	ipss†	ipss†	ADJ
aiua-6590	92	8	:	:	PUNCT
aiua-6590	92	9	international	international	ADJ
aiua-6590	92	10	prostatic	prostatic	ADJ
aiua-6590	92	11	symptom	symptom	NOUN
aiua-6590	92	12	score	score	NOUN
aiua-6590	92	13	;	;	PUNCT
aiua-6590	92	14	iief-5	iief-5	NOUN
aiua-6590	92	15	*	*	NUM
aiua-6590	92	16	:	:	PUNCT
aiua-6590	92	17	international	international	ADJ
aiua-6590	92	18	index	index	NOUN
aiua-6590	92	19	of	of	ADP
aiua-6590	92	20	erectile	erectile	NOUN
aiua-6590	92	21	function	function	NOUN
aiua-6590	92	22	;	;	PUNCT
aiua-6590	93	1	qol‡	qol‡	ADV
aiua-6590	93	2	:	:	PUNCT
aiua-6590	93	3	quality	quality	NOUN
aiua-6590	93	4	of	of	ADP
aiua-6590	93	5	well	well	ADV
aiua-6590	93	6	-	-	PUNCT
aiua-6590	93	7	being	be	AUX
aiua-6590	93	8	baseline	baseline	ADJ
aiua-6590	93	9	values	value	NOUN
aiua-6590	93	10	follow	follow	VERB
aiua-6590	93	11	-	-	PUNCT
aiua-6590	93	12	up	up	ADP
aiua-6590	93	13	values	value	NOUN
aiua-6590	93	14	(	(	PUNCT
aiua-6590	93	15	sd	sd	NOUN
aiua-6590	93	16	*	*	PUNCT
aiua-6590	93	17	or	or	CCONJ
aiua-6590	93	18	%	%	INTJ
aiua-6590	93	19	)	)	PUNCT
aiua-6590	93	20	(	(	PUNCT
aiua-6590	93	21	sd	sd	NOUN
aiua-6590	93	22	*	*	PUNCT
aiua-6590	93	23	or	or	CCONJ
aiua-6590	93	24	%	%	INTJ
aiua-6590	93	25	)	)	PUNCT
aiua-6590	93	26	efficacy	efficacy	NOUN
aiua-6590	93	27	outcomes	outcome	NOUN
aiua-6590	93	28	ipss†	ipss†	PRON
aiua-6590	93	29	21.5	21.5	NUM
aiua-6590	93	30	±	±	NUM
aiua-6590	93	31	1.2	1.2	NUM
aiua-6590	93	32	16.2	16.2	NUM
aiua-6590	93	33	±	±	NUM
aiua-6590	93	34	1.5	1.5	NUM
aiua-6590	93	35	treatment	treatment	NOUN
aiua-6590	93	36	difference	difference	NOUN
aiua-6590	93	37	-4.8	-4.8	PUNCT
aiua-6590	93	38	±	±	NUM
aiua-6590	93	39	1.1	1.1	NUM
aiua-6590	93	40	(	(	PUNCT
aiua-6590	93	41	p	p	X
aiua-6590	93	42	<	<	X
aiua-6590	93	43	0.001	0.001	NUM
aiua-6590	93	44	)	)	PUNCT
aiua-6590	93	45	iief-5	iief-5	SYM
aiua-6590	93	46	*	*	NUM
aiua-6590	93	47	22.1	22.1	NUM
aiua-6590	93	48	±	±	NUM
aiua-6590	93	49	1.8	1.8	NUM
aiua-6590	93	50	22.3	22.3	NUM
aiua-6590	93	51	±	±	NUM
aiua-6590	93	52	1.5	1.5	NUM
aiua-6590	93	53	treatment	treatment	NOUN
aiua-6590	93	54	difference	difference	NOUN
aiua-6590	93	55	0.1	0.1	NUM
aiua-6590	93	56	±	±	NUM
aiua-6590	93	57	0.2	0.2	NUM
aiua-6590	93	58	(	(	PUNCT
aiua-6590	93	59	p	p	X
aiua-6590	93	60	=	=	NOUN
aiua-6590	93	61	0.50	0.50	NUM
aiua-6590	93	62	)	)	PUNCT
aiua-6590	93	63	qol§	qol§	VERB
aiua-6590	93	64	0.56	0.56	NUM
aiua-6590	93	65	±	±	NUM
aiua-6590	93	66	0.15	0.15	NUM
aiua-6590	93	67	0.84	0.84	NUM
aiua-6590	93	68	±	±	NUM
aiua-6590	93	69	0.19	0.19	NUM
aiua-6590	93	70	treatment	treatment	NOUN
aiua-6590	93	71	difference	difference	NOUN
aiua-6590	93	72	0.28	0.28	NUM
aiua-6590	93	73	±	±	NUM
aiua-6590	93	74	0.02	0.02	NUM
aiua-6590	93	75	(	(	PUNCT
aiua-6590	93	76	p	p	X
aiua-6590	93	77	<	<	X
aiua-6590	93	78	0.001	0.001	NUM
aiua-6590	93	79	)	)	PUNCT
aiua-6590	93	80	maximal	maximal	ADJ
aiua-6590	93	81	urinary	urinary	ADJ
aiua-6590	93	82	flow	flow	NOUN
aiua-6590	93	83	rate	rate	NOUN
aiua-6590	93	84	(	(	PUNCT
aiua-6590	93	85	ml	ml	PROPN
aiua-6590	93	86	/	/	SYM
aiua-6590	93	87	sec	sec	PROPN
aiua-6590	93	88	)	)	PUNCT
aiua-6590	93	89	9.7	9.7	NUM
aiua-6590	93	90	±	±	NUM
aiua-6590	93	91	3.7	3.7	NUM
aiua-6590	93	92	15.3	15.3	NUM
aiua-6590	93	93	±	±	NUM
aiua-6590	93	94	2.5	2.5	NUM
aiua-6590	93	95	treatment	treatment	NOUN
aiua-6590	93	96	difference	difference	NOUN
aiua-6590	93	97	5.6	5.6	NUM
aiua-6590	93	98	±	±	NOUN
aiua-6590	93	99	0.8	0.8	NUM
aiua-6590	93	100	(	(	PUNCT
aiua-6590	93	101	p	p	X
aiua-6590	93	102	<	<	X
aiua-6590	93	103	0.001	0.001	NUM
aiua-6590	93	104	)	)	PUNCT
aiua-6590	93	105	post	post	ADJ
aiua-6590	93	106	-	-	ADJ
aiua-6590	93	107	voiding	voiding	ADJ
aiua-6590	93	108	residual	residual	ADJ
aiua-6590	93	109	volume	volume	NOUN
aiua-6590	93	110	(	(	PUNCT
aiua-6590	93	111	ml	ml	NOUN
aiua-6590	93	112	)	)	PUNCT
aiua-6590	93	113	85	85	NUM
aiua-6590	93	114	±	±	NUM
aiua-6590	93	115	20.6	20.6	NUM
aiua-6590	93	116	50	50	NUM
aiua-6590	93	117	±	±	NUM
aiua-6590	93	118	18.5	18.5	NUM
aiua-6590	93	119	treatment	treatment	NOUN
aiua-6590	93	120	difference	difference	NOUN
aiua-6590	93	121	-35	-35	PROPN
aiua-6590	93	122	±	±	NOUN
aiua-6590	93	123	1.9	1.9	NUM
aiua-6590	93	124	(	(	PUNCT
aiua-6590	93	125	p	p	X
aiua-6590	93	126	<	<	X
aiua-6590	93	127	0.001	0.001	NUM
aiua-6590	93	128	)	)	PUNCT
aiua-6590	93	129	patients	patient	NOUN
aiua-6590	93	130	(	(	PUNCT
aiua-6590	93	131	n	n	CCONJ
aiua-6590	93	132	°	°	PROPN
aiua-6590	93	133	)	)	PUNCT
aiua-6590	93	134	62	62	NUM
aiua-6590	93	135	age	age	NOUN
aiua-6590	93	136	(	(	PUNCT
aiua-6590	93	137	mean	mean	NOUN
aiua-6590	93	138	±	±	NUM
aiua-6590	93	139	sd	sd	NOUN
aiua-6590	93	140	#	#	NOUN
aiua-6590	93	141	)	)	PUNCT
aiua-6590	93	142	65.4	65.4	NUM
aiua-6590	93	143	±	±	NUM
aiua-6590	93	144	5.6	5.6	NUM
aiua-6590	93	145	marital	marital	ADJ
aiua-6590	93	146	status	status	NOUN
aiua-6590	93	147	married	marry	VERB
aiua-6590	93	148	56	56	NUM
aiua-6590	93	149	(	(	PUNCT
aiua-6590	93	150	90.3	90.3	NUM
aiua-6590	93	151	)	)	PUNCT
aiua-6590	93	152	unmarried	unmarried	ADJ
aiua-6590	93	153	6	6	NUM
aiua-6590	93	154	(	(	PUNCT
aiua-6590	93	155	9.7	9.7	NUM
aiua-6590	93	156	)	)	PUNCT
aiua-6590	93	157	educational	educational	ADJ
aiua-6590	93	158	qualification	qualification	NOUN
aiua-6590	93	159	primary	primary	ADJ
aiua-6590	93	160	school	school	NOUN
aiua-6590	93	161	31	31	NUM
aiua-6590	93	162	(	(	PUNCT
aiua-6590	93	163	50	50	NUM
aiua-6590	93	164	)	)	PUNCT
aiua-6590	93	165	high	high	ADJ
aiua-6590	93	166	school	school	NOUN
aiua-6590	93	167	20	20	NUM
aiua-6590	93	168	(	(	PUNCT
aiua-6590	93	169	32.2	32.2	NUM
aiua-6590	93	170	)	)	PUNCT
aiua-6590	93	171	university	university	NOUN
aiua-6590	93	172	11	11	NUM
aiua-6590	93	173	(	(	PUNCT
aiua-6590	93	174	17.8	17.8	NUM
aiua-6590	93	175	)	)	PUNCT
aiua-6590	93	176	sexually	sexually	ADV
aiua-6590	93	177	active	active	ADJ
aiua-6590	93	178	(	(	PUNCT
aiua-6590	93	179	past	past	ADJ
aiua-6590	93	180	month	month	NOUN
aiua-6590	93	181	)	)	PUNCT
aiua-6590	93	182	62	62	NUM
aiua-6590	93	183	(	(	PUNCT
aiua-6590	93	184	100	100	NUM
aiua-6590	93	185	)	)	PUNCT
aiua-6590	93	186	symptoms	symptom	NOUN
aiua-6590	93	187	score	score	VERB
aiua-6590	93	188	at	at	ADP
aiua-6590	93	189	baseline	baseline	NOUN
aiua-6590	93	190	(	(	PUNCT
aiua-6590	93	191	mean	mean	PROPN
aiua-6590	93	192	±	±	NUM
aiua-6590	93	193	sd	sd	NOUN
aiua-6590	93	194	#	#	NOUN
aiua-6590	93	195	)	)	PUNCT
aiua-6590	93	196	ipss†	ipss†	PRON
aiua-6590	93	197	21.5	21.5	NUM
aiua-6590	93	198	±	±	NUM
aiua-6590	93	199	1.2	1.2	NUM
aiua-6590	93	200	iief-5	iief-5	NOUN
aiua-6590	93	201	*	*	NUM
aiua-6590	93	202	22.1	22.1	NUM
aiua-6590	93	203	±	±	NUM
aiua-6590	93	204	1.8	1.8	NUM
aiua-6590	93	205	qol‡	qol‡	ADV
aiua-6590	93	206	0.56	0.56	NUM
aiua-6590	93	207	±	±	NUM
aiua-6590	93	208	0.15	0.15	NUM
aiua-6590	93	209	charlson	charlson	NOUN
aiua-6590	93	210	comorbidity	comorbidity	NOUN
aiua-6590	93	211	index	index	NOUN
aiua-6590	93	212	0	0	NUM
aiua-6590	93	213	-	-	SYM
aiua-6590	93	214	1	1	NUM
aiua-6590	93	215	62	62	NUM
aiua-6590	93	216	(	(	PUNCT
aiua-6590	93	217	100	100	NUM
aiua-6590	93	218	)	)	PUNCT
aiua-6590	93	219	≥	≥	NOUN
aiua-6590	93	220	2	2	NUM
aiua-6590	93	221	laboratory	laboratory	NOUN
aiua-6590	93	222	serum	serum	NOUN
aiua-6590	93	223	totale	totale	PROPN
aiua-6590	93	224	psa	psa	PROPN
aiua-6590	93	225	(	(	PUNCT
aiua-6590	93	226	ng	ng	PROPN
aiua-6590	93	227	/	/	SYM
aiua-6590	93	228	ml	ml	PROPN
aiua-6590	93	229	)	)	PUNCT
aiua-6590	93	230	2.47	2.47	NUM
aiua-6590	93	231	±	±	NUM
aiua-6590	93	232	5.6	5.6	NUM
aiua-6590	93	233	serum	serum	NOUN
aiua-6590	93	234	creatinine	creatinine	NOUN
aiua-6590	93	235	(	(	PUNCT
aiua-6590	93	236	ng	ng	PROPN
aiua-6590	93	237	/	/	SYM
aiua-6590	93	238	ml	ml	PROPN
aiua-6590	93	239	)	)	PUNCT
aiua-6590	93	240	1.0	1.0	NUM
aiua-6590	93	241	±	±	NUM
aiua-6590	93	242	0.6	0.6	NUM
aiua-6590	93	243	urine	urine	NOUN
aiua-6590	93	244	dipstick	dipstick	VERB
aiua-6590	94	1	negative	negative	ADJ
aiua-6590	94	2	62	62	NUM
aiua-6590	94	3	(	(	PUNCT
aiua-6590	94	4	100	100	NUM
aiua-6590	94	5	)	)	PUNCT
aiua-6590	94	6	positive	positive	ADJ
aiua-6590	94	7	ultrasound	ultrasound	NOUN
aiua-6590	94	8	and	and	CCONJ
aiua-6590	94	9	uroflowmetry	uroflowmetry	NOUN
aiua-6590	94	10	data	datum	NOUN
aiua-6590	94	11	prostate	prostate	NOUN
aiua-6590	94	12	volume	volume	NOUN
aiua-6590	94	13	(	(	PUNCT
aiua-6590	94	14	ml	ml	NOUN
aiua-6590	94	15	)	)	PUNCT
aiua-6590	94	16	41.5	41.5	NUM
aiua-6590	94	17	±	±	NUM
aiua-6590	94	18	5.8	5.8	NUM
aiua-6590	94	19	post	post	ADJ
aiua-6590	94	20	-	-	ADJ
aiua-6590	94	21	voiding	voiding	ADJ
aiua-6590	94	22	residual	residual	ADJ
aiua-6590	94	23	volume	volume	NOUN
aiua-6590	94	24	(	(	PUNCT
aiua-6590	94	25	ml	ml	NOUN
aiua-6590	94	26	)	)	PUNCT
aiua-6590	94	27	85	85	NUM
aiua-6590	94	28	±	±	NUM
aiua-6590	94	29	20.6	20.6	NUM
aiua-6590	94	30	maximal	maximal	ADJ
aiua-6590	94	31	urinary	urinary	ADJ
aiua-6590	94	32	flow	flow	NOUN
aiua-6590	94	33	rate	rate	NOUN
aiua-6590	94	34	(	(	PUNCT
aiua-6590	94	35	ml	ml	PROPN
aiua-6590	94	36	/	/	SYM
aiua-6590	94	37	sec	sec	PROPN
aiua-6590	94	38	)	)	PUNCT
aiua-6590	94	39	9.7	9.7	NUM
aiua-6590	94	40	±	±	NUM
aiua-6590	94	41	3.7	3.7	NUM
aiua-6590	94	42	v1	v1	NOUN
aiua-6590	94	43	clinical	clinical	ADJ
aiua-6590	94	44	,	,	PUNCT
aiua-6590	94	45	instrumental	instrumental	ADJ
aiua-6590	94	46	,	,	PUNCT
aiua-6590	94	47	laboratory	laboratory	NOUN
aiua-6590	94	48	evaluation	evaluation	NOUN
aiua-6590	94	49	,	,	PUNCT
aiua-6590	94	50	ipss	ipss	PROPN
aiua-6590	94	51	,	,	PUNCT
aiua-6590	94	52	iief-5	iief-5	PROPN
aiua-6590	94	53	,	,	PUNCT
aiua-6590	94	54	qol	qol	NOUN
aiua-6590	94	55	and	and	CCONJ
aiua-6590	94	56	enrolment	enrolment	NOUN
aiua-6590	94	57	screening	screening	NOUN
aiua-6590	94	58	(	(	PUNCT
aiua-6590	94	59	up	up	ADP
aiua-6590	94	60	to	to	PART
aiua-6590	94	61	3	3	NUM
aiua-6590	94	62	months	month	NOUN
aiua-6590	94	63	)	)	PUNCT
aiua-6590	94	64	treatment	treatment	NOUN
aiua-6590	94	65	:	:	PUNCT
aiua-6590	94	66	6	6	NUM
aiua-6590	94	67	months	month	NOUN
aiua-6590	94	68	v2	v2	VERB
aiua-6590	94	69	(	(	PUNCT
aiua-6590	94	70	6	6	NUM
aiua-6590	94	71	months	month	NOUN
aiua-6590	94	72	)	)	PUNCT
aiua-6590	94	73	clinical	clinical	ADJ
aiua-6590	94	74	,	,	PUNCT
aiua-6590	94	75	instrumental	instrumental	ADJ
aiua-6590	94	76	,	,	PUNCT
aiua-6590	94	77	laboratory	laboratory	NOUN
aiua-6590	94	78	evaluation	evaluation	NOUN
aiua-6590	94	79	,	,	PUNCT
aiua-6590	94	80	ipss	ipss	PROPN
aiua-6590	94	81	,	,	PUNCT
aiua-6590	94	82	iief-5	iief-5	PROPN
aiua-6590	94	83	,	,	PUNCT
aiua-6590	94	84	qol	qol	PROPN
aiua-6590	94	85	migar	migar	NOUN
aiua-6590	95	1	©	©	PROPN
aiua-6590	95	2	mg	mg	PROPN
aiua-6590	95	3	retard	retard	VERB
aiua-6590	95	4	1	1	NUM
aiua-6590	95	5	tablet	tablet	NOUN
aiua-6590	95	6	q24h	q24h	PROPN
aiua-6590	95	7	tiscione_stesura	tiscione_stesura	PROPN
aiua-6590	95	8	seveso	seveso	VERB
aiua-6590	95	9	04/04/17	04/04/17	PROPN
aiua-6590	95	10	09:05	09:05	NUM
aiua-6590	95	11	pagina	pagina	PROPN
aiua-6590	95	12	14	14	NUM
aiua-6590	95	13	15archivio	15archivio	NUM
aiua-6590	95	14	italiano	italiano	PROPN
aiua-6590	95	15	di	di	X
aiua-6590	95	16	urologia	urologia	PROPN
aiua-6590	95	17	e	e	PROPN
aiua-6590	95	18	andrologia	andrologia	NOUN
aiua-6590	95	19	2017	2017	NUM
aiua-6590	95	20	;	;	PUNCT
aiua-6590	95	21	89	89	NUM
aiua-6590	95	22	,	,	PUNCT
aiua-6590	95	23	1	1	NUM
aiua-6590	95	24	nutraceuticals	nutraceutical	NOUN
aiua-6590	95	25	for	for	ADP
aiua-6590	95	26	the	the	DET
aiua-6590	95	27	management	management	NOUN
aiua-6590	95	28	of	of	ADP
aiua-6590	95	29	luts	luts	PROPN
aiua-6590	95	30	related	relate	VERB
aiua-6590	95	31	to	to	ADP
aiua-6590	95	32	bph	bph	NOUN
aiua-6590	95	33	adrs	adr	NOUN
aiua-6590	95	34	during	during	ADP
aiua-6590	95	35	the	the	DET
aiua-6590	95	36	study	study	NOUN
aiua-6590	95	37	period	period	NOUN
aiua-6590	95	38	,	,	PUNCT
aiua-6590	95	39	1	1	NUM
aiua-6590	95	40	patient	patient	NOUN
aiua-6590	95	41	(	(	PUNCT
aiua-6590	95	42	1.6	1.6	NUM
aiua-6590	95	43	%	%	NOUN
aiua-6590	95	44	)	)	PUNCT
aiua-6590	95	45	developed	develop	VERB
aiua-6590	95	46	a	a	DET
aiua-6590	95	47	mild	mild	ADJ
aiua-6590	95	48	adrs	adr	NOUN
aiua-6590	95	49	(	(	PUNCT
aiua-6590	95	50	nausea	nausea	NOUN
aiua-6590	95	51	)	)	PUNCT
aiua-6590	95	52	that	that	PRON
aiua-6590	95	53	did	do	AUX
aiua-6590	95	54	not	not	PART
aiua-6590	95	55	require	require	VERB
aiua-6590	95	56	drug	drug	NOUN
aiua-6590	95	57	discontinuation	discontinuation	NOUN
aiua-6590	95	58	or	or	CCONJ
aiua-6590	95	59	other	other	ADJ
aiua-6590	95	60	treatments	treatment	NOUN
aiua-6590	95	61	.	.	PUNCT
aiua-6590	96	1	moreover	moreover	ADV
aiua-6590	96	2	,	,	PUNCT
aiua-6590	96	3	did	do	AUX
aiua-6590	96	4	not	not	PART
aiua-6590	96	5	document	document	VERB
aiua-6590	96	6	the	the	DET
aiua-6590	96	7	development	development	NOUN
aiua-6590	96	8	of	of	ADP
aiua-6590	96	9	ddis	ddi	NOUN
aiua-6590	96	10	,	,	PUNCT
aiua-6590	96	11	while	while	SCONJ
aiua-6590	96	12	we	we	PRON
aiua-6590	96	13	recorded	record	VERB
aiua-6590	96	14	a	a	DET
aiua-6590	96	15	100	100	NUM
aiua-6590	96	16	%	%	NOUN
aiua-6590	96	17	adherence	adherence	NOUN
aiua-6590	96	18	to	to	ADP
aiua-6590	96	19	the	the	DET
aiua-6590	96	20	treatment	treatment	NOUN
aiua-6590	96	21	and	and	CCONJ
aiua-6590	96	22	a	a	DET
aiua-6590	96	23	100	100	NUM
aiua-6590	96	24	%	%	NOUN
aiua-6590	96	25	compliance	compliance	NOUN
aiua-6590	96	26	to	to	ADP
aiua-6590	96	27	the	the	DET
aiua-6590	96	28	experimental	experimental	ADJ
aiua-6590	96	29	protocol	protocol	NOUN
aiua-6590	96	30	.	.	PUNCT
aiua-6590	97	1	discussion	discussion	NOUN
aiua-6590	97	2	in	in	ADP
aiua-6590	97	3	this	this	DET
aiua-6590	97	4	phase	phase	NOUN
aiua-6590	97	5	i	i	PROPN
aiua-6590	97	6	-	-	PUNCT
aiua-6590	97	7	ii	ii	PROPN
aiua-6590	97	8	clinical	clinical	ADJ
aiua-6590	97	9	trial	trial	NOUN
aiua-6590	97	10	,	,	PUNCT
aiua-6590	97	11	we	we	PRON
aiua-6590	97	12	evaluated	evaluate	VERB
aiua-6590	97	13	the	the	DET
aiua-6590	97	14	efficacy	efficacy	NOUN
aiua-6590	97	15	and	and	CCONJ
aiua-6590	97	16	the	the	DET
aiua-6590	97	17	safety	safety	NOUN
aiua-6590	97	18	of	of	ADP
aiua-6590	97	19	a	a	DET
aiua-6590	97	20	new	new	ADJ
aiua-6590	97	21	nutraceutical	nutraceutical	ADJ
aiua-6590	97	22	agent	agent	NOUN
aiua-6590	97	23	named	name	VERB
aiua-6590	97	24	migar	migar	NOUN
aiua-6590	97	25	®	®	NOUN
aiua-6590	97	26	mg	mg	NOUN
aiua-6590	97	27	containing	contain	VERB
aiua-6590	97	28	daizein	daizein	NOUN
aiua-6590	97	29	,	,	PUNCT
aiua-6590	97	30	isolase	isolase	NOUN
aiua-6590	97	31	and	and	CCONJ
aiua-6590	97	32	zinc	zinc	NOUN
aiua-6590	97	33	in	in	ADP
aiua-6590	97	34	the	the	DET
aiua-6590	97	35	treatment	treatment	NOUN
aiua-6590	97	36	of	of	ADP
aiua-6590	97	37	luts	luts	PROPN
aiua-6590	97	38	related	relate	VERB
aiua-6590	97	39	to	to	ADP
aiua-6590	97	40	bph	bph	NOUN
aiua-6590	97	41	.	.	PUNCT
aiua-6590	98	1	it	it	PRON
aiua-6590	98	2	has	have	AUX
aiua-6590	98	3	been	be	AUX
aiua-6590	98	4	documented	document	VERB
aiua-6590	98	5	that	that	SCONJ
aiua-6590	98	6	in	in	ADP
aiua-6590	98	7	italy	italy	PROPN
aiua-6590	98	8	,	,	PUNCT
aiua-6590	98	9	about	about	ADV
aiua-6590	98	10	50	50	NUM
aiua-6590	98	11	%	%	NOUN
aiua-6590	98	12	of	of	ADP
aiua-6590	98	13	treatment	treatment	NOUN
aiua-6590	98	14	used	use	VERB
aiua-6590	98	15	in	in	ADP
aiua-6590	98	16	patients	patient	NOUN
aiua-6590	98	17	with	with	ADP
aiua-6590	98	18	bph	bph	NOUN
aiua-6590	98	19	are	be	AUX
aiua-6590	98	20	phytotherapies	phytotherapy	NOUN
aiua-6590	98	21	,	,	PUNCT
aiua-6590	98	22	while	while	SCONJ
aiua-6590	98	23	in	in	ADP
aiua-6590	98	24	germany	germany	PROPN
aiua-6590	98	25	and	and	CCONJ
aiua-6590	98	26	other	other	ADJ
aiua-6590	98	27	european	european	ADJ
aiua-6590	98	28	countries	country	NOUN
aiua-6590	98	29	,	,	PUNCT
aiua-6590	98	30	these	these	PRON
aiua-6590	98	31	represent	represent	VERB
aiua-6590	98	32	the	the	DET
aiua-6590	98	33	firstline	firstline	ADJ
aiua-6590	98	34	treatment	treatment	NOUN
aiua-6590	98	35	for	for	ADP
aiua-6590	98	36	mild	mild	ADJ
aiua-6590	98	37	-	-	PUNCT
aiua-6590	98	38	to	to	ADP
aiua-6590	98	39	-	-	PUNCT
aiua-6590	98	40	moderate	moderate	ADJ
aiua-6590	98	41	luts	luts	PROPN
aiua-6590	98	42	in	in	ADP
aiua-6590	98	43	patients	patient	NOUN
aiua-6590	98	44	with	with	ADP
aiua-6590	98	45	bph	bph	NOUN
aiua-6590	98	46	.	.	PUNCT
aiua-6590	99	1	isoflavones	isoflavone	NOUN
aiua-6590	99	2	show	show	VERB
aiua-6590	99	3	a	a	DET
aiua-6590	99	4	chemical	chemical	NOUN
aiua-6590	99	5	structure	structure	NOUN
aiua-6590	99	6	similar	similar	ADJ
aiua-6590	99	7	to	to	ADP
aiua-6590	99	8	the	the	DET
aiua-6590	99	9	estrogen	estrogen	NOUN
aiua-6590	99	10	which	which	PRON
aiua-6590	99	11	allows	allow	VERB
aiua-6590	99	12	them	they	PRON
aiua-6590	99	13	to	to	PART
aiua-6590	99	14	bind	bind	VERB
aiua-6590	99	15	to	to	ADP
aiua-6590	99	16	both	both	CCONJ
aiua-6590	99	17	alpha	alpha	NOUN
aiua-6590	99	18	and	and	CCONJ
aiua-6590	99	19	beta	beta	ADJ
aiua-6590	99	20	estrogen	estrogen	NOUN
aiua-6590	99	21	receptors	receptor	NOUN
aiua-6590	99	22	,	,	PUNCT
aiua-6590	99	23	exerting	exert	VERB
aiua-6590	99	24	estrogen	estrogen	NOUN
aiua-6590	99	25	-	-	PUNCT
aiua-6590	99	26	like	like	ADJ
aiua-6590	99	27	effects	effect	NOUN
aiua-6590	99	28	and	and	CCONJ
aiua-6590	99	29	so	so	ADV
aiua-6590	99	30	also	also	ADV
aiua-6590	99	31	called	call	VERB
aiua-6590	99	32	as	as	ADP
aiua-6590	99	33	phytoestrogens	phytoestrogen	NOUN
aiua-6590	99	34	(	(	PUNCT
aiua-6590	99	35	21	21	NUM
aiua-6590	99	36	)	)	PUNCT
aiua-6590	99	37	.	.	PUNCT
aiua-6590	100	1	whereas	whereas	SCONJ
aiua-6590	100	2	estrogen	estrogen	NOUN
aiua-6590	100	3	binds	bind	VERB
aiua-6590	100	4	to	to	PART
aiua-6590	100	5	and	and	CCONJ
aiua-6590	100	6	transactivates	transactivate	NOUN
aiua-6590	100	7	both	both	DET
aiua-6590	100	8	estrogen	estrogen	NOUN
aiua-6590	100	9	receptors	receptor	NOUN
aiua-6590	100	10	,	,	PUNCT
aiua-6590	100	11	isoflavones	isoflavone	NOUN
aiua-6590	100	12	preferentially	preferentially	ADV
aiua-6590	100	13	bind	bind	VERB
aiua-6590	100	14	to	to	ADP
aiua-6590	100	15	and	and	CCONJ
aiua-6590	100	16	transactivate	transactivate	VERB
aiua-6590	100	17	estrogen	estrogen	NOUN
aiua-6590	100	18	beta	beta	NOUN
aiua-6590	100	19	receptor	receptor	NOUN
aiua-6590	100	20	exerciting	exercite	VERB
aiua-6590	100	21	tissue	tissue	NOUN
aiua-6590	100	22	-	-	PUNCT
aiua-6590	100	23	selective	selective	ADJ
aiua-6590	100	24	effects	effect	NOUN
aiua-6590	100	25	(	(	PUNCT
aiua-6590	100	26	22	22	NUM
aiua-6590	100	27	)	)	PUNCT
aiua-6590	100	28	that	that	PRON
aiua-6590	100	29	is	be	AUX
aiua-6590	100	30	expressed	express	VERB
aiua-6590	100	31	in	in	ADP
aiua-6590	100	32	prostate	prostate	NOUN
aiua-6590	100	33	epithelial	epithelial	ADJ
aiua-6590	100	34	cells	cell	NOUN
aiua-6590	100	35	and	and	CCONJ
aiua-6590	100	36	plays	play	VERB
aiua-6590	100	37	a	a	DET
aiua-6590	100	38	role	role	NOUN
aiua-6590	100	39	in	in	ADP
aiua-6590	100	40	cellular	cellular	ADJ
aiua-6590	100	41	homeostasis	homeostasis	NOUN
aiua-6590	100	42	inducing	induce	VERB
aiua-6590	100	43	anti	anti	ADJ
aiua-6590	100	44	-	-	ADJ
aiua-6590	100	45	proliferative	proliferative	ADJ
aiua-6590	100	46	,	,	PUNCT
aiua-6590	100	47	pro	pro	ADJ
aiua-6590	100	48	-	-	ADJ
aiua-6590	100	49	differentiative	differentiative	ADJ
aiua-6590	100	50	(	(	PUNCT
aiua-6590	100	51	23	23	NUM
aiua-6590	100	52	)	)	PUNCT
aiua-6590	100	53	,	,	PUNCT
aiua-6590	100	54	and	and	CCONJ
aiua-6590	100	55	pro	pro	ADJ
aiua-6590	100	56	-	-	ADJ
aiua-6590	100	57	apoptotic	apoptotic	ADJ
aiua-6590	100	58	effects	effect	NOUN
aiua-6590	100	59	(	(	PUNCT
aiua-6590	100	60	2324	2324	NUM
aiua-6590	100	61	)	)	PUNCT
aiua-6590	100	62	.	.	PUNCT
aiua-6590	101	1	in	in	ADP
aiua-6590	101	2	this	this	DET
aiua-6590	101	3	concern	concern	NOUN
aiua-6590	101	4	,	,	PUNCT
aiua-6590	101	5	several	several	ADJ
aiua-6590	101	6	clinical	clinical	ADJ
aiua-6590	101	7	trials	trial	NOUN
aiua-6590	101	8	documented	document	VERB
aiua-6590	101	9	that	that	SCONJ
aiua-6590	101	10	isoflavones	isoflavone	NOUN
aiua-6590	101	11	are	be	AUX
aiua-6590	101	12	able	able	ADJ
aiua-6590	101	13	to	to	PART
aiua-6590	101	14	suppress	suppress	VERB
aiua-6590	101	15	psa	psa	NOUN
aiua-6590	101	16	expression	expression	NOUN
aiua-6590	101	17	in	in	ADP
aiua-6590	101	18	patients	patient	NOUN
aiua-6590	101	19	with	with	ADP
aiua-6590	101	20	prostate	prostate	NOUN
aiua-6590	101	21	cancer	cancer	NOUN
aiua-6590	101	22	cells	cell	NOUN
aiua-6590	101	23	.	.	PUNCT
aiua-6590	102	1	in	in	ADP
aiua-6590	102	2	a	a	DET
aiua-6590	102	3	recent	recent	ADJ
aiua-6590	102	4	metaanalysis	metaanalysis	NOUN
aiua-6590	102	5	,	,	PUNCT
aiua-6590	102	6	zhang	zhang	PROPN
aiua-6590	102	7	et	et	PROPN
aiua-6590	102	8	al	al	PROPN
aiua-6590	102	9	.	.	PROPN
aiua-6590	102	10	,	,	PUNCT
aiua-6590	102	11	evaluating	evaluate	VERB
aiua-6590	102	12	the	the	DET
aiua-6590	102	13	effects	effect	NOUN
aiua-6590	102	14	of	of	ADP
aiua-6590	102	15	isoflavones	isoflavone	NOUN
aiua-6590	102	16	on	on	ADP
aiua-6590	102	17	prostate	prostate	NOUN
aiua-6590	102	18	cancer	cancer	NOUN
aiua-6590	102	19	risk	risk	NOUN
aiua-6590	102	20	,	,	PUNCT
aiua-6590	102	21	analyzed	analyze	VERB
aiua-6590	102	22	11.346	11.346	NUM
aiua-6590	102	23	cases	case	NOUN
aiua-6590	102	24	and	and	CCONJ
aiua-6590	102	25	140.177	140.177	NUM
aiua-6590	102	26	controls	control	NOUN
aiua-6590	102	27	and	and	CCONJ
aiua-6590	102	28	documented	document	VERB
aiua-6590	102	29	that	that	SCONJ
aiua-6590	102	30	daidzein	daidzein	ADJ
aiua-6590	102	31	,	,	PUNCT
aiua-6590	102	32	genistein	genistein	NOUN
aiua-6590	102	33	,	,	PUNCT
aiua-6590	102	34	and	and	CCONJ
aiua-6590	102	35	glycitein	glycitein	ADJ
aiua-6590	102	36	were	be	AUX
aiua-6590	102	37	associated	associate	VERB
aiua-6590	102	38	with	with	ADP
aiua-6590	102	39	a	a	DET
aiua-6590	102	40	reduction	reduction	NOUN
aiua-6590	102	41	of	of	ADP
aiua-6590	102	42	prostate	prostate	NOUN
aiua-6590	102	43	cancer	cancer	NOUN
aiua-6590	102	44	risk	risk	NOUN
aiua-6590	102	45	with	with	ADP
aiua-6590	102	46	an	an	DET
aiua-6590	102	47	odds	odd	NOUN
aiua-6590	102	48	ratio	ratio	NOUN
aiua-6590	102	49	:	:	PUNCT
aiua-6590	102	50	0.85	0.85	NUM
aiua-6590	102	51	,	,	PUNCT
aiua-6590	102	52	0.87	0.87	NUM
aiua-6590	102	53	and	and	CCONJ
aiua-6590	102	54	0.89	0.89	NUM
aiua-6590	102	55	,	,	PUNCT
aiua-6590	102	56	respectively	respectively	ADV
aiua-6590	102	57	(	(	PUNCT
aiua-6590	102	58	25	25	NUM
aiua-6590	102	59	)	)	PUNCT
aiua-6590	102	60	.	.	PUNCT
aiua-6590	103	1	in	in	ADP
aiua-6590	103	2	agreement	agreement	NOUN
aiua-6590	103	3	,	,	PUNCT
aiua-6590	103	4	in	in	ADP
aiua-6590	103	5	an	an	DET
aiua-6590	103	6	experimental	experimental	ADJ
aiua-6590	103	7	model	model	NOUN
aiua-6590	103	8	performed	perform	VERB
aiua-6590	103	9	in	in	ADP
aiua-6590	103	10	human	human	ADJ
aiua-6590	103	11	prostate	prostate	NOUN
aiua-6590	103	12	cancer	cancer	NOUN
aiua-6590	103	13	cell	cell	NOUN
aiua-6590	103	14	lines	line	NOUN
aiua-6590	103	15	lu	lu	VERB
aiua-6590	103	16	et	et	PROPN
aiua-6590	103	17	al	al	PROPN
aiua-6590	103	18	.	.	PROPN
aiua-6590	103	19	,	,	PUNCT
aiua-6590	103	20	recorded	record	VERB
aiua-6590	103	21	that	that	SCONJ
aiua-6590	103	22	s	s	NOUN
aiua-6590	103	23	-	-	PUNCT
aiua-6590	103	24	equol	equol	NOUN
aiua-6590	103	25	has	have	VERB
aiua-6590	103	26	significant	significant	ADJ
aiua-6590	103	27	anti	anti	ADJ
aiua-6590	103	28	-	-	ADJ
aiua-6590	103	29	prostate	prostate	ADJ
aiua-6590	103	30	cancer	cancer	NOUN
aiua-6590	103	31	activities	activity	NOUN
aiua-6590	103	32	probably	probably	ADV
aiua-6590	103	33	related	relate	VERB
aiua-6590	103	34	to	to	ADP
aiua-6590	103	35	the	the	DET
aiua-6590	103	36	activation	activation	NOUN
aiua-6590	103	37	of	of	ADP
aiua-6590	103	38	the	the	DET
aiua-6590	103	39	transcription	transcription	NOUN
aiua-6590	103	40	factor	factor	NOUN
aiua-6590	103	41	forkhead	forkhead	PROPN
aiua-6590	103	42	box	box	PROPN
aiua-6590	103	43	o3	o3	PROPN
aiua-6590	103	44	via	via	ADP
aiua-6590	103	45	an	an	DET
aiua-6590	103	46	akt	akt	NOUN
aiua-6590	103	47	-	-	PUNCT
aiua-6590	103	48	specific	specific	ADJ
aiua-6590	103	49	pathway	pathway	NOUN
aiua-6590	103	50	and	and	CCONJ
aiua-6590	103	51	inhibitory	inhibitory	ADJ
aiua-6590	103	52	effects	effect	NOUN
aiua-6590	103	53	on	on	ADP
aiua-6590	103	54	mdm2	mdm2	NOUN
aiua-6590	103	55	expression	expression	NOUN
aiua-6590	103	56	(	(	PUNCT
aiua-6590	103	57	26	26	NUM
aiua-6590	103	58	)	)	PUNCT
aiua-6590	103	59	.	.	PUNCT
aiua-6590	104	1	moreover	moreover	ADV
aiua-6590	104	2	,	,	PUNCT
aiua-6590	104	3	in	in	ADP
aiua-6590	104	4	an	an	DET
aiua-6590	104	5	experimental	experimental	ADJ
aiua-6590	104	6	animal	animal	NOUN
aiua-6590	104	7	model	model	NOUN
aiua-6590	104	8	bae	bae	PROPN
aiua-6590	104	9	et	et	PROPN
aiua-6590	104	10	al	al	PROPN
aiua-6590	104	11	.	.	PROPN
aiua-6590	104	12	reported	report	VERB
aiua-6590	104	13	that	that	SCONJ
aiua-6590	104	14	genistein	genistein	NOUN
aiua-6590	104	15	and	and	CCONJ
aiua-6590	104	16	equol	equol	NOUN
aiua-6590	104	17	are	be	AUX
aiua-6590	104	18	strong	strong	ADJ
aiua-6590	104	19	inhibitors	inhibitor	NOUN
aiua-6590	104	20	of	of	ADP
aiua-6590	104	21	testosterone	testosterone	NOUN
aiua-6590	104	22	5α	5α	ADJ
aiua-6590	104	23	-	-	PUNCT
aiua-6590	104	24	reductase	reductase	NOUN
aiua-6590	104	25	enzyme	enzyme	NOUN
aiua-6590	104	26	,	,	PUNCT
aiua-6590	104	27	suggesting	suggest	VERB
aiua-6590	104	28	that	that	SCONJ
aiua-6590	104	29	isoflavones	isoflavone	NOUN
aiua-6590	104	30	could	could	AUX
aiua-6590	104	31	be	be	AUX
aiua-6590	104	32	used	use	VERB
aiua-6590	104	33	in	in	ADP
aiua-6590	104	34	the	the	DET
aiua-6590	104	35	management	management	NOUN
aiua-6590	104	36	of	of	ADP
aiua-6590	104	37	patients	patient	NOUN
aiua-6590	104	38	with	with	ADP
aiua-6590	104	39	luts	luts	PROPN
aiua-6590	104	40	(	(	PUNCT
aiua-6590	104	41	27	27	NUM
aiua-6590	104	42	)	)	PUNCT
aiua-6590	104	43	.	.	PUNCT
aiua-6590	105	1	in	in	ADP
aiua-6590	105	2	fact	fact	NOUN
aiua-6590	105	3	,	,	PUNCT
aiua-6590	105	4	wong	wong	PROPN
aiua-6590	105	5	et	et	PROPN
aiua-6590	105	6	al	al	PROPN
aiua-6590	105	7	.	.	PROPN
aiua-6590	105	8	documented	document	VERB
aiua-6590	105	9	in	in	ADP
aiua-6590	105	10	elderly	elderly	ADJ
aiua-6590	105	11	men	man	NOUN
aiua-6590	105	12	that	that	SCONJ
aiua-6590	105	13	the	the	DET
aiua-6590	105	14	dietary	dietary	ADJ
aiua-6590	105	15	intake	intake	NOUN
aiua-6590	105	16	of	of	ADP
aiua-6590	105	17	genistein	genistein	NOUN
aiua-6590	105	18	,	,	PUNCT
aiua-6590	105	19	glycitein	glycitein	ADJ
aiua-6590	105	20	or	or	CCONJ
aiua-6590	105	21	daidzein	daidzein	ADJ
aiua-6590	105	22	was	be	AUX
aiua-6590	105	23	related	relate	VERB
aiua-6590	105	24	with	with	ADP
aiua-6590	105	25	a	a	DET
aiua-6590	105	26	significant	significant	ADJ
aiua-6590	105	27	decrease	decrease	NOUN
aiua-6590	105	28	of	of	ADP
aiua-6590	105	29	luts	luts	PROPN
aiua-6590	105	30	(	(	PUNCT
aiua-6590	105	31	28	28	NUM
aiua-6590	105	32	)	)	PUNCT
aiua-6590	105	33	.	.	PUNCT
aiua-6590	106	1	in	in	ADP
aiua-6590	106	2	our	our	PRON
aiua-6590	106	3	study	study	NOUN
aiua-6590	106	4	,	,	PUNCT
aiua-6590	106	5	we	we	PRON
aiua-6590	106	6	documented	document	VERB
aiua-6590	106	7	that	that	DET
aiua-6590	106	8	oral	oral	ADJ
aiua-6590	106	9	intake	intake	NOUN
aiua-6590	106	10	of	of	ADP
aiua-6590	106	11	migar	migar	ADJ
aiua-6590	106	12	®	®	NOUN
aiua-6590	106	13	mg	mg	PROPN
aiua-6590	106	14	reduces	reduce	VERB
aiua-6590	106	15	luts	luts	PROPN
aiua-6590	106	16	with	with	ADP
aiua-6590	106	17	an	an	DET
aiua-6590	106	18	improvement	improvement	NOUN
aiua-6590	106	19	of	of	ADP
aiua-6590	106	20	uroflowmetry	uroflowmetry	NOUN
aiua-6590	106	21	parameters	parameter	NOUN
aiua-6590	106	22	,	,	PUNCT
aiua-6590	106	23	ipss	ipss	PROPN
aiua-6590	106	24	score	score	NOUN
aiua-6590	106	25	and	and	CCONJ
aiua-6590	106	26	qol	qol	NOUN
aiua-6590	106	27	.	.	PUNCT
aiua-6590	107	1	probably	probably	ADV
aiua-6590	107	2	these	these	DET
aiua-6590	107	3	improvements	improvement	NOUN
aiua-6590	107	4	could	could	AUX
aiua-6590	107	5	be	be	AUX
aiua-6590	107	6	related	relate	VERB
aiua-6590	107	7	to	to	ADP
aiua-6590	107	8	a	a	DET
aiua-6590	107	9	potentiating	potentiating	NOUN
aiua-6590	107	10	of	of	ADP
aiua-6590	107	11	daidzein	daidzein	NOUN
aiua-6590	107	12	induced	induce	VERB
aiua-6590	107	13	by	by	ADP
aiua-6590	107	14	isolases	isolase	NOUN
aiua-6590	107	15	that	that	PRON
aiua-6590	107	16	seems	seem	VERB
aiua-6590	107	17	to	to	PART
aiua-6590	107	18	be	be	AUX
aiua-6590	107	19	able	able	ADJ
aiua-6590	107	20	to	to	PART
aiua-6590	107	21	improve	improve	VERB
aiua-6590	107	22	the	the	DET
aiua-6590	107	23	action	action	NOUN
aiua-6590	107	24	time	time	NOUN
aiua-6590	107	25	of	of	ADP
aiua-6590	107	26	equol	equol	NOUN
aiua-6590	107	27	reducing	reduce	VERB
aiua-6590	107	28	its	its	PRON
aiua-6590	107	29	catabolism	catabolism	NOUN
aiua-6590	107	30	and	and	CCONJ
aiua-6590	107	31	increasing	increase	VERB
aiua-6590	107	32	its	its	PRON
aiua-6590	107	33	clinical	clinical	ADJ
aiua-6590	107	34	efficacy	efficacy	NOUN
aiua-6590	107	35	.	.	PUNCT
aiua-6590	108	1	on	on	ADP
aiua-6590	108	2	the	the	DET
aiua-6590	108	3	other	other	ADJ
aiua-6590	108	4	hand	hand	NOUN
aiua-6590	108	5	the	the	DET
aiua-6590	108	6	presence	presence	NOUN
aiua-6590	108	7	of	of	ADP
aiua-6590	108	8	zinc	zinc	NOUN
aiua-6590	108	9	in	in	ADP
aiua-6590	108	10	this	this	DET
aiua-6590	108	11	studied	study	VERB
aiua-6590	108	12	formulation	formulation	NOUN
aiua-6590	108	13	could	could	AUX
aiua-6590	108	14	plays	play	VERB
aiua-6590	108	15	synergic	synergic	ADJ
aiua-6590	108	16	effects	effect	NOUN
aiua-6590	108	17	with	with	ADP
aiua-6590	108	18	daidzein	daidzein	NOUN
aiua-6590	108	19	and	and	CCONJ
aiua-6590	108	20	isolases	isolase	NOUN
aiua-6590	108	21	.	.	PUNCT
aiua-6590	109	1	in	in	ADP
aiua-6590	109	2	fact	fact	NOUN
aiua-6590	109	3	,	,	PUNCT
aiua-6590	109	4	a	a	DET
aiua-6590	109	5	long	long	ADJ
aiua-6590	109	6	period	period	NOUN
aiua-6590	109	7	clinical	clinical	ADJ
aiua-6590	109	8	study	study	NOUN
aiua-6590	109	9	(	(	PUNCT
aiua-6590	109	10	4	4	NUM
aiua-6590	109	11	-	-	PUNCT
aiua-6590	109	12	year	year	NOUN
aiua-6590	109	13	)	)	PUNCT
aiua-6590	109	14	documented	document	VERB
aiua-6590	109	15	that	that	SCONJ
aiua-6590	109	16	chronic	chronic	ADJ
aiua-6590	109	17	prostate	prostate	NOUN
aiua-6590	109	18	inflammation	inflammation	NOUN
aiua-6590	109	19	is	be	AUX
aiua-6590	109	20	related	relate	VERB
aiua-6590	109	21	to	to	ADP
aiua-6590	109	22	both	both	DET
aiua-6590	109	23	severity	severity	NOUN
aiua-6590	109	24	and	and	CCONJ
aiua-6590	109	25	progression	progression	NOUN
aiua-6590	109	26	of	of	ADP
aiua-6590	109	27	bph	bph	NOUN
aiua-6590	109	28	and	and	CCONJ
aiua-6590	109	29	luts	luts	PROPN
aiua-6590	109	30	and	and	CCONJ
aiua-6590	109	31	zinc	zinc	NOUN
aiua-6590	109	32	has	have	VERB
aiua-6590	109	33	antioxidant	antioxidant	ADJ
aiua-6590	109	34	and	and	CCONJ
aiua-6590	109	35	anti	anti	ADJ
aiua-6590	109	36	-	-	ADJ
aiua-6590	109	37	inflammatory	inflammatory	ADJ
aiua-6590	109	38	activity	activity	NOUN
aiua-6590	109	39	and	and	CCONJ
aiua-6590	109	40	changes	change	NOUN
aiua-6590	109	41	in	in	ADP
aiua-6590	109	42	prostate	prostate	NOUN
aiua-6590	109	43	zinc	zinc	NOUN
aiua-6590	109	44	concentrations	concentration	NOUN
aiua-6590	109	45	play	play	VERB
aiua-6590	109	46	a	a	DET
aiua-6590	109	47	role	role	NOUN
aiua-6590	109	48	in	in	ADP
aiua-6590	109	49	the	the	DET
aiua-6590	109	50	improvement	improvement	NOUN
aiua-6590	109	51	of	of	ADP
aiua-6590	109	52	bph	bph	NOUN
aiua-6590	109	53	(	(	PUNCT
aiua-6590	109	54	29	29	NUM
aiua-6590	109	55	)	)	PUNCT
aiua-6590	109	56	.	.	PUNCT
aiua-6590	110	1	take	take	VERB
aiua-6590	110	2	together	together	ADV
aiua-6590	110	3	these	these	DET
aiua-6590	110	4	published	publish	VERB
aiua-6590	110	5	data	datum	NOUN
aiua-6590	110	6	confirm	confirm	VERB
aiua-6590	110	7	our	our	PRON
aiua-6590	110	8	results	result	NOUN
aiua-6590	110	9	documenting	document	VERB
aiua-6590	110	10	the	the	DET
aiua-6590	110	11	efficacy	efficacy	NOUN
aiua-6590	110	12	of	of	ADP
aiua-6590	110	13	this	this	DET
aiua-6590	110	14	new	new	ADJ
aiua-6590	110	15	nutraceutical	nutraceutical	ADJ
aiua-6590	110	16	formulation	formulation	NOUN
aiua-6590	110	17	in	in	ADP
aiua-6590	110	18	patients	patient	NOUN
aiua-6590	110	19	with	with	ADP
aiua-6590	110	20	luts	luts	PROPN
aiua-6590	110	21	.	.	PUNCT
aiua-6590	111	1	however	however	ADV
aiua-6590	111	2	,	,	PUNCT
aiua-6590	111	3	nutraceuticals	nutraceutical	NOUN
aiua-6590	111	4	are	be	AUX
aiua-6590	111	5	dietary	dietary	ADJ
aiua-6590	111	6	supplements	supplement	NOUN
aiua-6590	111	7	,	,	PUNCT
aiua-6590	111	8	and	and	CCONJ
aiua-6590	111	9	it	it	PRON
aiua-6590	111	10	is	be	AUX
aiua-6590	111	11	not	not	PART
aiua-6590	111	12	necessary	necessary	ADJ
aiua-6590	111	13	to	to	PART
aiua-6590	111	14	demonstrate	demonstrate	VERB
aiua-6590	111	15	data	datum	NOUN
aiua-6590	111	16	on	on	ADP
aiua-6590	111	17	efficacy	efficacy	NOUN
aiua-6590	111	18	or	or	CCONJ
aiua-6590	111	19	safety	safety	NOUN
aiua-6590	111	20	before	before	ADP
aiua-6590	111	21	marketing	marketing	NOUN
aiua-6590	111	22	therefore	therefore	ADV
aiua-6590	111	23	could	could	AUX
aiua-6590	111	24	be	be	AUX
aiua-6590	111	25	possible	possible	ADJ
aiua-6590	111	26	the	the	DET
aiua-6590	111	27	development	development	NOUN
aiua-6590	111	28	of	of	ADP
aiua-6590	111	29	adrs	adr	NOUN
aiua-6590	111	30	or	or	CCONJ
aiua-6590	111	31	ddis	ddi	NOUN
aiua-6590	111	32	during	during	ADP
aiua-6590	111	33	their	their	PRON
aiua-6590	111	34	use	use	NOUN
aiua-6590	111	35	.	.	PUNCT
aiua-6590	112	1	in	in	ADP
aiua-6590	112	2	the	the	DET
aiua-6590	112	3	present	present	ADJ
aiua-6590	112	4	study	study	NOUN
aiua-6590	112	5	,	,	PUNCT
aiua-6590	112	6	using	use	VERB
aiua-6590	112	7	the	the	DET
aiua-6590	112	8	naranjo	naranjo	PROPN
aiua-6590	112	9	probability	probability	NOUN
aiua-6590	112	10	scale	scale	NOUN
aiua-6590	112	11	and	and	CCONJ
aiua-6590	112	12	the	the	DET
aiua-6590	112	13	drug	drug	NOUN
aiua-6590	112	14	interaction	interaction	NOUN
aiua-6590	112	15	probability	probability	NOUN
aiua-6590	112	16	scale	scale	NOUN
aiua-6590	112	17	,	,	PUNCT
aiua-6590	112	18	we	we	PRON
aiua-6590	112	19	failed	fail	VERB
aiua-6590	112	20	to	to	PART
aiua-6590	112	21	report	report	VERB
aiua-6590	112	22	the	the	DET
aiua-6590	112	23	development	development	NOUN
aiua-6590	112	24	of	of	ADP
aiua-6590	112	25	severe	severe	ADJ
aiua-6590	112	26	adrs	adr	NOUN
aiua-6590	112	27	or	or	CCONJ
aiua-6590	112	28	ddis	ddi	NOUN
aiua-6590	112	29	during	during	ADP
aiua-6590	112	30	the	the	DET
aiua-6590	112	31	treatment	treatment	NOUN
aiua-6590	112	32	with	with	ADP
aiua-6590	112	33	this	this	DET
aiua-6590	112	34	compound	compound	NOUN
aiua-6590	112	35	.	.	PUNCT
aiua-6590	113	1	in	in	ADP
aiua-6590	113	2	particular	particular	ADJ
aiua-6590	113	3	,	,	PUNCT
aiua-6590	113	4	we	we	PRON
aiua-6590	113	5	recorded	record	VERB
aiua-6590	113	6	the	the	DET
aiua-6590	113	7	development	development	NOUN
aiua-6590	113	8	of	of	ADP
aiua-6590	113	9	a	a	DET
aiua-6590	113	10	probable	probable	ADJ
aiua-6590	113	11	mild	mild	ADJ
aiua-6590	113	12	adr	adr	NOUN
aiua-6590	113	13	in	in	ADP
aiua-6590	113	14	1	1	NUM
aiua-6590	113	15	patient	patient	NOUN
aiua-6590	113	16	only	only	ADV
aiua-6590	113	17	but	but	CCONJ
aiua-6590	113	18	this	this	DET
aiua-6590	113	19	manifestation	manifestation	NOUN
aiua-6590	113	20	did	do	AUX
aiua-6590	113	21	not	not	PART
aiua-6590	113	22	induce	induce	VERB
aiua-6590	113	23	the	the	DET
aiua-6590	113	24	discontinuation	discontinuation	NOUN
aiua-6590	113	25	of	of	ADP
aiua-6590	113	26	the	the	DET
aiua-6590	113	27	treatment	treatment	NOUN
aiua-6590	113	28	,	,	PUNCT
aiua-6590	113	29	documenting	document	VERB
aiua-6590	113	30	the	the	DET
aiua-6590	113	31	safety	safety	NOUN
aiua-6590	113	32	of	of	ADP
aiua-6590	113	33	this	this	DET
aiua-6590	113	34	nutraceutical	nutraceutical	NOUN
aiua-6590	113	35	.	.	PUNCT
aiua-6590	114	1	moreover	moreover	ADV
aiua-6590	114	2	,	,	PUNCT
aiua-6590	114	3	must	must	AUX
aiua-6590	114	4	be	be	AUX
aiua-6590	114	5	underlined	underline	VERB
aiua-6590	114	6	that	that	SCONJ
aiua-6590	114	7	enrolled	enrol	VERB
aiua-6590	114	8	patients	patient	NOUN
aiua-6590	114	9	did	do	AUX
aiua-6590	114	10	not	not	PART
aiua-6590	114	11	develop	develop	VERB
aiua-6590	114	12	sexual	sexual	ADJ
aiua-6590	114	13	dysfunction	dysfunction	NOUN
aiua-6590	114	14	,	,	PUNCT
aiua-6590	114	15	and	and	CCONJ
aiua-6590	114	16	the	the	DET
aiua-6590	114	17	optimal	optimal	ADJ
aiua-6590	114	18	sexual	sexual	ADJ
aiua-6590	114	19	activity	activity	NOUN
aiua-6590	114	20	should	should	AUX
aiua-6590	114	21	be	be	AUX
aiua-6590	114	22	considered	consider	VERB
aiua-6590	114	23	as	as	ADP
aiua-6590	114	24	one	one	NUM
aiua-6590	114	25	principal	principal	ADJ
aiua-6590	114	26	aim	aim	NOUN
aiua-6590	114	27	in	in	ADP
aiua-6590	114	28	the	the	DET
aiua-6590	114	29	management	management	NOUN
aiua-6590	114	30	of	of	ADP
aiua-6590	114	31	patients	patient	NOUN
aiua-6590	114	32	with	with	ADP
aiua-6590	114	33	luts	luts	PROPN
aiua-6590	114	34	associated	associate	VERB
aiua-6590	114	35	to	to	ADP
aiua-6590	114	36	bph	bph	NOUN
aiua-6590	114	37	(	(	PUNCT
aiua-6590	114	38	30	30	NUM
aiua-6590	114	39	)	)	PUNCT
aiua-6590	114	40	.	.	PUNCT
aiua-6590	115	1	previously	previously	ADV
aiua-6590	115	2	,	,	PUNCT
aiua-6590	115	3	we	we	PRON
aiua-6590	115	4	documented	document	VERB
aiua-6590	115	5	that	that	SCONJ
aiua-6590	115	6	a	a	DET
aiua-6590	115	7	better	well	ADJ
aiua-6590	115	8	sexual	sexual	ADJ
aiua-6590	115	9	quality	quality	NOUN
aiua-6590	115	10	of	of	ADP
aiua-6590	115	11	life	life	NOUN
aiua-6590	115	12	is	be	AUX
aiua-6590	115	13	correlated	correlate	VERB
aiua-6590	115	14	with	with	ADP
aiua-6590	115	15	a	a	DET
aiua-6590	115	16	higher	high	ADJ
aiua-6590	115	17	overall	overall	ADJ
aiua-6590	115	18	quality	quality	NOUN
aiua-6590	115	19	of	of	ADP
aiua-6590	115	20	life	life	NOUN
aiua-6590	115	21	regardless	regardless	ADV
aiua-6590	115	22	of	of	ADP
aiua-6590	115	23	the	the	DET
aiua-6590	115	24	urinary	urinary	ADJ
aiua-6590	115	25	function	function	NOUN
aiua-6590	115	26	in	in	ADP
aiua-6590	115	27	patients	patient	NOUN
aiua-6590	115	28	affected	affect	VERB
aiua-6590	115	29	by	by	ADP
aiua-6590	115	30	luts	luts	PROPN
aiua-6590	115	31	due	due	ADP
aiua-6590	115	32	to	to	ADP
aiua-6590	115	33	bph10	bph10	PROPN
aiua-6590	115	34	.	.	PUNCT
aiua-6590	116	1	finally	finally	ADV
aiua-6590	116	2	,	,	PUNCT
aiua-6590	116	3	in	in	ADP
aiua-6590	116	4	our	our	PRON
aiua-6590	116	5	study	study	NOUN
aiua-6590	116	6	we	we	PRON
aiua-6590	116	7	documented	document	VERB
aiua-6590	116	8	a	a	DET
aiua-6590	116	9	complete	complete	ADJ
aiua-6590	116	10	adherence	adherence	NOUN
aiua-6590	116	11	(	(	PUNCT
aiua-6590	116	12	100	100	NUM
aiua-6590	116	13	%	%	NOUN
aiua-6590	116	14	)	)	PUNCT
aiua-6590	116	15	to	to	ADP
aiua-6590	116	16	the	the	DET
aiua-6590	116	17	treatment	treatment	NOUN
aiua-6590	116	18	and	and	CCONJ
aiua-6590	116	19	a	a	DET
aiua-6590	116	20	complete	complete	ADJ
aiua-6590	116	21	compliance	compliance	NOUN
aiua-6590	116	22	(	(	PUNCT
aiua-6590	116	23	100	100	NUM
aiua-6590	116	24	%	%	NOUN
aiua-6590	116	25	)	)	PUNCT
aiua-6590	116	26	to	to	ADP
aiua-6590	116	27	the	the	DET
aiua-6590	116	28	experimental	experimental	ADJ
aiua-6590	116	29	protocol	protocol	NOUN
aiua-6590	116	30	and	and	CCONJ
aiua-6590	116	31	it	it	PRON
aiua-6590	116	32	may	may	AUX
aiua-6590	116	33	be	be	AUX
aiua-6590	116	34	related	relate	VERB
aiua-6590	116	35	to	to	ADP
aiua-6590	116	36	the	the	DET
aiua-6590	116	37	improvement	improvement	NOUN
aiua-6590	116	38	of	of	ADP
aiua-6590	116	39	qol	qol	NOUN
aiua-6590	116	40	.	.	PUNCT
aiua-6590	117	1	the	the	DET
aiua-6590	117	2	present	present	ADJ
aiua-6590	117	3	study	study	NOUN
aiua-6590	117	4	has	have	VERB
aiua-6590	117	5	two	two	NUM
aiua-6590	117	6	limitations	limitation	NOUN
aiua-6590	117	7	:	:	PUNCT
aiua-6590	117	8	first	first	ADV
aiua-6590	117	9	,	,	PUNCT
aiua-6590	117	10	the	the	DET
aiua-6590	117	11	lacks	lack	NOUN
aiua-6590	117	12	of	of	ADP
aiua-6590	117	13	placebo	placebo	NOUN
aiua-6590	117	14	arm	arm	NOUN
aiua-6590	117	15	,	,	PUNCT
aiua-6590	117	16	because	because	SCONJ
aiua-6590	117	17	in	in	ADP
aiua-6590	117	18	italy	italy	PROPN
aiua-6590	117	19	ethically	ethically	ADV
aiua-6590	117	20	patients	patient	NOUN
aiua-6590	117	21	must	must	AUX
aiua-6590	117	22	receive	receive	VERB
aiua-6590	117	23	a	a	DET
aiua-6590	117	24	treatment	treatment	NOUN
aiua-6590	117	25	during	during	ADP
aiua-6590	117	26	a	a	DET
aiua-6590	117	27	spontaneous	spontaneous	ADJ
aiua-6590	117	28	study	study	NOUN
aiua-6590	117	29	,	,	PUNCT
aiua-6590	117	30	as	as	ADP
aiua-6590	117	31	ours	our	NOUN
aiua-6590	117	32	;	;	PUNCT
aiua-6590	117	33	second	second	X
aiua-6590	117	34	,	,	PUNCT
aiua-6590	117	35	we	we	PRON
aiua-6590	117	36	evaluated	evaluate	VERB
aiua-6590	117	37	the	the	DET
aiua-6590	117	38	safety	safety	NOUN
aiua-6590	117	39	and	and	CCONJ
aiua-6590	117	40	efficacy	efficacy	NOUN
aiua-6590	117	41	of	of	ADP
aiua-6590	117	42	this	this	DET
aiua-6590	117	43	new	new	ADJ
aiua-6590	117	44	compound	compound	NOUN
aiua-6590	117	45	for	for	ADP
aiua-6590	117	46	a	a	DET
aiua-6590	117	47	short	short	ADJ
aiua-6590	117	48	time	time	NOUN
aiua-6590	117	49	that	that	PRON
aiua-6590	117	50	did	do	AUX
aiua-6590	117	51	not	not	PART
aiua-6590	117	52	allow	allow	VERB
aiua-6590	117	53	evaluating	evaluate	VERB
aiua-6590	117	54	its	its	PRON
aiua-6590	117	55	effects	effect	NOUN
aiua-6590	117	56	for	for	ADP
aiua-6590	117	57	a	a	DET
aiua-6590	117	58	long	long	ADJ
aiua-6590	117	59	time	time	NOUN
aiua-6590	117	60	.	.	PUNCT
aiua-6590	118	1	conclusions	conclusion	NOUN
aiua-6590	118	2	in	in	ADP
aiua-6590	118	3	this	this	DET
aiua-6590	118	4	study	study	NOUN
aiua-6590	118	5	,	,	PUNCT
aiua-6590	118	6	we	we	PRON
aiua-6590	118	7	demonstrated	demonstrate	VERB
aiua-6590	118	8	that	that	DET
aiua-6590	118	9	combination	combination	NOUN
aiua-6590	118	10	of	of	ADP
aiua-6590	118	11	daidzein	daidzein	ADJ
aiua-6590	118	12	plus	plus	CCONJ
aiua-6590	118	13	isolase	isolase	NOUN
aiua-6590	118	14	and	and	CCONJ
aiua-6590	118	15	zinc	zinc	NOUN
aiua-6590	118	16	(	(	PUNCT
aiua-6590	118	17	migar	migar	NOUN
aiua-6590	118	18	®	®	NOUN
aiua-6590	118	19	mg	mg	PROPN
aiua-6590	118	20	retard	retard	PROPN
aiua-6590	118	21	)	)	PUNCT
aiua-6590	118	22	reduces	reduce	VERB
aiua-6590	118	23	the	the	DET
aiua-6590	118	24	symptoms	symptom	NOUN
aiua-6590	118	25	and	and	CCONJ
aiua-6590	118	26	improves	improve	VERB
aiua-6590	118	27	the	the	DET
aiua-6590	118	28	quality	quality	NOUN
aiua-6590	118	29	of	of	ADP
aiua-6590	118	30	life	life	NOUN
aiua-6590	118	31	in	in	ADP
aiua-6590	118	32	patients	patient	NOUN
aiua-6590	118	33	affected	affect	VERB
aiua-6590	118	34	by	by	ADP
aiua-6590	118	35	luts	luts	PROPN
aiua-6590	118	36	due	due	ADP
aiua-6590	118	37	to	to	ADP
aiua-6590	118	38	bph	bph	NOUN
aiua-6590	118	39	,	,	PUNCT
aiua-6590	118	40	without	without	ADP
aiua-6590	118	41	the	the	DET
aiua-6590	118	42	development	development	NOUN
aiua-6590	118	43	of	of	ADP
aiua-6590	118	44	adrs	adr	NOUN
aiua-6590	118	45	.	.	PUNCT
aiua-6590	119	1	acknowledgements	acknowledgement	NOUN
aiua-6590	119	2	we	we	PRON
aiua-6590	119	3	are	be	AUX
aiua-6590	119	4	grateful	grateful	ADJ
aiua-6590	119	5	to	to	ADP
aiua-6590	119	6	professor	professor	PROPN
aiua-6590	119	7	john	john	PROPN
aiua-6590	119	8	denton	denton	PROPN
aiua-6590	119	9	(	(	PUNCT
aiua-6590	119	10	department	department	NOUN
aiua-6590	119	11	of	of	ADP
aiua-6590	119	12	modern	modern	ADJ
aiua-6590	119	13	philology	philology	NOUN
aiua-6590	119	14	,	,	PUNCT
aiua-6590	119	15	university	university	NOUN
aiua-6590	119	16	of	of	ADP
aiua-6590	119	17	florence	florence	NOUN
aiua-6590	119	18	)	)	PUNCT
aiua-6590	119	19	for	for	ADP
aiua-6590	119	20	manuscript	manuscript	NOUN
aiua-6590	119	21	language	language	NOUN
aiua-6590	119	22	revision	revision	NOUN
aiua-6590	119	23	.	.	PUNCT
aiua-6590	120	1	contributions	contribution	NOUN
aiua-6590	120	2	tc	tc	NOUN
aiua-6590	120	3	,	,	PUNCT
aiua-6590	120	4	dt	dt	X
aiua-6590	120	5	,	,	PUNCT
aiua-6590	120	6	it	it	PRON
aiua-6590	120	7	data	data	VERB
aiua-6590	120	8	collecting	collect	VERB
aiua-6590	120	9	and	and	CCONJ
aiua-6590	120	10	analyzing	analyzing	NOUN
aiua-6590	120	11	;	;	PUNCT
aiua-6590	120	12	tc	tc	X
aiua-6590	120	13	,	,	PUNCT
aiua-6590	120	14	dt	dt	X
aiua-6590	120	15	,	,	PUNCT
aiua-6590	121	1	pv	pv	INTJ
aiua-6590	121	2	manuscript	manuscript	NOUN
aiua-6590	121	3	writing	writing	NOUN
aiua-6590	121	4	;	;	PUNCT
aiua-6590	121	5	gm	gm	PROPN
aiua-6590	121	6	,	,	PUNCT
aiua-6590	121	7	rb	rb	PROPN
aiua-6590	121	8	,	,	PUNCT
aiua-6590	121	9	ap	ap	PROPN
aiua-6590	121	10	,	,	PUNCT
aiua-6590	121	11	lg	lg	NOUN
aiua-6590	121	12	,	,	PUNCT
aiua-6590	121	13	vm	vm	PROPN
aiua-6590	121	14	supervision	supervision	PROPN
aiua-6590	121	15	.	.	PUNCT
aiua-6590	122	1	references	reference	NOUN
aiua-6590	122	2	1	1	NUM
aiua-6590	122	3	.	.	PUNCT
aiua-6590	122	4	egan	egan	PROPN
aiua-6590	122	5	kb	kb	PROPN
aiua-6590	122	6	.	.	PUNCT
aiua-6590	123	1	the	the	DET
aiua-6590	123	2	epidemiology	epidemiology	NOUN
aiua-6590	123	3	of	of	ADP
aiua-6590	123	4	benign	benign	ADJ
aiua-6590	123	5	prostatic	prostatic	ADJ
aiua-6590	123	6	hyperplasia	hyperplasia	NOUN
aiua-6590	123	7	associated	associate	VERB
aiua-6590	123	8	with	with	ADP
aiua-6590	123	9	lower	low	ADJ
aiua-6590	123	10	urinary	urinary	ADJ
aiua-6590	123	11	tract	tract	NOUN
aiua-6590	123	12	symptoms	symptom	NOUN
aiua-6590	123	13	:	:	PUNCT
aiua-6590	123	14	prevalence	prevalence	NOUN
aiua-6590	123	15	and	and	CCONJ
aiua-6590	123	16	incident	incident	NOUN
aiua-6590	123	17	rates	rate	NOUN
aiua-6590	123	18	.	.	PUNCT
aiua-6590	124	1	urol	urol	PROPN
aiua-6590	124	2	clin	clin	PROPN
aiua-6590	124	3	north	north	PROPN
aiua-6590	124	4	am	am	PROPN
aiua-6590	124	5	.	.	PUNCT
aiua-6590	125	1	2016	2016	NUM
aiua-6590	125	2	;	;	PUNCT
aiua-6590	125	3	43:289	43:289	NUM
aiua-6590	125	4	-	-	SYM
aiua-6590	125	5	97	97	NUM
aiua-6590	125	6	.	.	NOUN
aiua-6590	126	1	2	2	NUM
aiua-6590	126	2	.	.	X
aiua-6590	126	3	fitzpatrick	fitzpatrick	PROPN
aiua-6590	126	4	jm	jm	PROPN
aiua-6590	126	5	.	.	PROPN
aiua-6590	127	1	the	the	DET
aiua-6590	127	2	natural	natural	ADJ
aiua-6590	127	3	history	history	NOUN
aiua-6590	127	4	of	of	ADP
aiua-6590	127	5	benign	benign	ADJ
aiua-6590	127	6	prostatic	prostatic	ADJ
aiua-6590	127	7	hyperplasia	hyperplasia	NOUN
aiua-6590	127	8	.	.	PUNCT
aiua-6590	128	1	bju	bju	NOUN
aiua-6590	128	2	int	int	PROPN
aiua-6590	128	3	.	.	PUNCT
aiua-6590	129	1	2006	2006	NUM
aiua-6590	129	2	;	;	PUNCT
aiua-6590	129	3	97	97	NUM
aiua-6590	129	4	suppl	suppl	ADJ
aiua-6590	129	5	2:3	2:3	NUM
aiua-6590	129	6	-	-	SYM
aiua-6590	129	7	6	6	NUM
aiua-6590	129	8	;	;	PUNCT
aiua-6590	129	9	discussion	discussion	NOUN
aiua-6590	129	10	21	21	NUM
aiua-6590	129	11	-	-	SYM
aiua-6590	129	12	2	2	NUM
aiua-6590	129	13	.	.	NOUN
aiua-6590	129	14	3	3	NUM
aiua-6590	129	15	.	.	NOUN
aiua-6590	129	16	oelke	oelke	PROPN
aiua-6590	129	17	m	m	PROPN
aiua-6590	129	18	,	,	PUNCT
aiua-6590	129	19	bachmann	bachmann	PROPN
aiua-6590	129	20	a	a	PRON
aiua-6590	129	21	,	,	PUNCT
aiua-6590	129	22	descazeaud	descazeaud	VERB
aiua-6590	129	23	a	a	PRON
aiua-6590	129	24	,	,	PUNCT
aiua-6590	129	25	et	et	PROPN
aiua-6590	129	26	al	al	PROPN
aiua-6590	129	27	.	.	PUNCT
aiua-6590	130	1	eau	eau	PROPN
aiua-6590	130	2	guidelines	guideline	NOUN
aiua-6590	130	3	on	on	ADP
aiua-6590	130	4	the	the	DET
aiua-6590	130	5	treatment	treatment	NOUN
aiua-6590	130	6	and	and	CCONJ
aiua-6590	130	7	follow	follow	NOUN
aiua-6590	130	8	-	-	PUNCT
aiua-6590	130	9	up	up	NOUN
aiua-6590	130	10	of	of	ADP
aiua-6590	130	11	non	non	ADJ
aiua-6590	130	12	-	-	ADJ
aiua-6590	130	13	neurogenic	neurogenic	ADJ
aiua-6590	130	14	male	male	NOUN
aiua-6590	130	15	lower	low	ADJ
aiua-6590	130	16	urinary	urinary	ADJ
aiua-6590	130	17	tiscione_stesura	tiscione_stesura	PROPN
aiua-6590	130	18	seveso	seveso	VERB
aiua-6590	130	19	04/04/17	04/04/17	PROPN
aiua-6590	130	20	09:05	09:05	NUM
aiua-6590	130	21	pagina	pagina	NOUN
aiua-6590	130	22	15	15	NUM
aiua-6590	130	23	archivio	archivio	NOUN
aiua-6590	130	24	italiano	italiano	X
aiua-6590	130	25	di	di	X
aiua-6590	130	26	urologia	urologia	PROPN
aiua-6590	130	27	e	e	PROPN
aiua-6590	130	28	andrologia	andrologia	NOUN
aiua-6590	130	29	2017	2017	NUM
aiua-6590	130	30	;	;	PUNCT
aiua-6590	130	31	89	89	NUM
aiua-6590	130	32	,	,	PUNCT
aiua-6590	130	33	1	1	NUM
aiua-6590	130	34	d.	d.	PROPN
aiua-6590	130	35	tiscione	tiscione	PROPN
aiua-6590	130	36	,	,	PUNCT
aiua-6590	130	37	l.	l.	PROPN
aiua-6590	130	38	gallelli	gallelli	PROPN
aiua-6590	130	39	,	,	PUNCT
aiua-6590	130	40	i.	i.	PROPN
aiua-6590	130	41	tamanini	tamanini	PROPN
aiua-6590	130	42	,	,	PUNCT
aiua-6590	130	43	l.g	l.g	PROPN
aiua-6590	130	44	.	.	PROPN
aiua-6590	130	45	luciani	luciani	PROPN
aiua-6590	130	46	,	,	PUNCT
aiua-6590	130	47	p.	p.	NOUN
aiua-6590	130	48	verze	verze	PROPN
aiua-6590	130	49	,	,	PUNCT
aiua-6590	130	50	a.	a.	NOUN
aiua-6590	130	51	palmieri	palmieri	PROPN
aiua-6590	130	52	,	,	PUNCT
aiua-6590	130	53	v.	v.	ADP
aiua-6590	130	54	mirone	mirone	PROPN
aiua-6590	130	55	,	,	PUNCT
aiua-6590	130	56	r.	r.	PROPN
aiua-6590	130	57	bartoletti	bartoletti	PROPN
aiua-6590	130	58	,	,	PUNCT
aiua-6590	130	59	g.	g.	PROPN
aiua-6590	130	60	malossini1	malossini1	PROPN
aiua-6590	130	61	,	,	PUNCT
aiua-6590	130	62	t.	t.	PROPN
aiua-6590	130	63	cai	cai	PROPN
aiua-6590	130	64	16	16	NUM
aiua-6590	130	65	tract	tract	NOUN
aiua-6590	130	66	symptoms	symptom	NOUN
aiua-6590	130	67	including	include	VERB
aiua-6590	130	68	benign	benign	ADJ
aiua-6590	130	69	prostatic	prostatic	ADJ
aiua-6590	130	70	obstruction	obstruction	NOUN
aiua-6590	130	71	.	.	PUNCT
aiua-6590	131	1	eur	eur	PROPN
aiua-6590	131	2	urol	urol	PROPN
aiua-6590	131	3	.	.	PUNCT
aiua-6590	132	1	2013	2013	NUM
aiua-6590	132	2	;	;	PUNCT
aiua-6590	132	3	64:118	64:118	NUM
aiua-6590	132	4	-	-	SYM
aiua-6590	132	5	40	40	NUM
aiua-6590	132	6	.	.	PUNCT
aiua-6590	133	1	4	4	X
aiua-6590	133	2	.	.	X
aiua-6590	133	3	kaplan	kaplan	PROPN
aiua-6590	133	4	sa	sa	PROPN
aiua-6590	133	5	.	.	PUNCT
aiua-6590	133	6	side	side	NOUN
aiua-6590	133	7	effects	effect	NOUN
aiua-6590	133	8	of	of	ADP
aiua-6590	133	9	α	α	NOUN
aiua-6590	133	10	-	-	NOUN
aiua-6590	133	11	blocker	blocker	NOUN
aiua-6590	133	12	use	use	NOUN
aiua-6590	133	13	:	:	PUNCT
aiua-6590	133	14	retrograde	retrograde	ADJ
aiua-6590	133	15	ejaculation	ejaculation	NOUN
aiua-6590	133	16	.	.	PUNCT
aiua-6590	134	1	rev	rev	PROPN
aiua-6590	134	2	urol	urol	PROPN
aiua-6590	134	3	.	.	PUNCT
aiua-6590	134	4	2009	2009	NUM
aiua-6590	134	5	;	;	PUNCT
aiua-6590	134	6	11(suppl	11(suppl	NUM
aiua-6590	134	7	1):s14	1):s14	NUM
aiua-6590	134	8	-	-	SYM
aiua-6590	134	9	s18	s18	NOUN
aiua-6590	134	10	.	.	PUNCT
aiua-6590	135	1	5	5	NUM
aiua-6590	135	2	.	.	X
aiua-6590	135	3	nickel	nickel	PROPN
aiua-6590	135	4	jc	jc	PROPN
aiua-6590	135	5	,	,	PUNCT
aiua-6590	135	6	sander	sander	PROPN
aiua-6590	135	7	s	s	PROPN
aiua-6590	135	8	,	,	PUNCT
aiua-6590	135	9	moon	moon	NOUN
aiua-6590	135	10	td	td	NOUN
aiua-6590	135	11	.	.	PUNCT
aiua-6590	136	1	a	a	DET
aiua-6590	136	2	meta	meta	ADJ
aiua-6590	136	3	-	-	PUNCT
aiua-6590	136	4	analysis	analysis	NOUN
aiua-6590	136	5	of	of	ADP
aiua-6590	136	6	the	the	DET
aiua-6590	136	7	vascularrelated	vascularrelate	VERB
aiua-6590	136	8	safety	safety	NOUN
aiua-6590	136	9	profile	profile	NOUN
aiua-6590	136	10	and	and	CCONJ
aiua-6590	136	11	efficacy	efficacy	NOUN
aiua-6590	136	12	of	of	ADP
aiua-6590	136	13	alpha	alpha	NOUN
aiua-6590	136	14	-	-	PUNCT
aiua-6590	136	15	adrenergic	adrenergic	ADJ
aiua-6590	136	16	blockers	blocker	NOUN
aiua-6590	136	17	for	for	ADP
aiua-6590	136	18	symptoms	symptom	NOUN
aiua-6590	136	19	related	relate	VERB
aiua-6590	136	20	to	to	ADP
aiua-6590	136	21	benign	benign	ADJ
aiua-6590	136	22	prostatic	prostatic	ADJ
aiua-6590	136	23	hyperplasia	hyperplasia	NOUN
aiua-6590	136	24	.	.	PUNCT
aiua-6590	137	1	int	int	PROPN
aiua-6590	138	1	j	j	PROPN
aiua-6590	138	2	clin	clin	PROPN
aiua-6590	138	3	pract	pract	PROPN
aiua-6590	138	4	.	.	PUNCT
aiua-6590	138	5	2008	2008	NUM
aiua-6590	138	6	;	;	PUNCT
aiua-6590	138	7	62:1547	62:1547	X
aiua-6590	138	8	-	-	SYM
aiua-6590	138	9	59	59	NUM
aiua-6590	138	10	.	.	PUNCT
aiua-6590	139	1	6	6	NUM
aiua-6590	139	2	.	.	PUNCT
aiua-6590	140	1	liu	liu	PROPN
aiua-6590	140	2	l	l	PROPN
aiua-6590	140	3	,	,	PUNCT
aiua-6590	140	4	zhao	zhao	PROPN
aiua-6590	140	5	s	s	PROPN
aiua-6590	140	6	,	,	PUNCT
aiua-6590	140	7	li	li	PROPN
aiua-6590	140	8	f	f	PROPN
aiua-6590	140	9	,	,	PUNCT
aiua-6590	140	10	et	et	PROPN
aiua-6590	140	11	al	al	PROPN
aiua-6590	140	12	.	.	PROPN
aiua-6590	140	13	effect	effect	NOUN
aiua-6590	140	14	of	of	ADP
aiua-6590	140	15	5α	5α	ADJ
aiua-6590	140	16	-	-	PUNCT
aiua-6590	140	17	reductase	reductase	NOUN
aiua-6590	140	18	inhibitors	inhibitor	NOUN
aiua-6590	140	19	on	on	ADP
aiua-6590	140	20	sexual	sexual	ADJ
aiua-6590	140	21	function	function	NOUN
aiua-6590	140	22	:	:	PUNCT
aiua-6590	140	23	a	a	DET
aiua-6590	140	24	meta	meta	ADJ
aiua-6590	140	25	-	-	PUNCT
aiua-6590	140	26	analysis	analysis	NOUN
aiua-6590	140	27	and	and	CCONJ
aiua-6590	140	28	systematic	systematic	ADJ
aiua-6590	140	29	review	review	NOUN
aiua-6590	140	30	of	of	ADP
aiua-6590	140	31	randomized	randomized	ADJ
aiua-6590	140	32	controlled	control	VERB
aiua-6590	140	33	trials	trial	NOUN
aiua-6590	140	34	.	.	PUNCT
aiua-6590	141	1	j	j	PROPN
aiua-6590	141	2	sex	sex	PROPN
aiua-6590	141	3	med	me	VERB
aiua-6590	141	4	.	.	PUNCT
aiua-6590	141	5	2016	2016	NUM
aiua-6590	141	6	;	;	PUNCT
aiua-6590	141	7	13:1297	13:1297	NUM
aiua-6590	141	8	-	-	SYM
aiua-6590	141	9	310	310	NUM
aiua-6590	141	10	.	.	NOUN
aiua-6590	142	1	7	7	NUM
aiua-6590	142	2	.	.	NOUN
aiua-6590	142	3	cindolo	cindolo	PROPN
aiua-6590	142	4	l	l	PROPN
aiua-6590	142	5	,	,	PUNCT
aiua-6590	142	6	pirozzi	pirozzi	PROPN
aiua-6590	142	7	l	l	NOUN
aiua-6590	142	8	,	,	PUNCT
aiua-6590	142	9	sountoulides	sountoulide	VERB
aiua-6590	142	10	p	p	PROPN
aiua-6590	142	11	,	,	PUNCT
aiua-6590	142	12	et	et	PROPN
aiua-6590	142	13	al	al	PROPN
aiua-6590	142	14	.	.	PUNCT
aiua-6590	142	15	patient	patient	PROPN
aiua-6590	142	16	's	's	PART
aiua-6590	142	17	adherence	adherence	NOUN
aiua-6590	142	18	on	on	ADP
aiua-6590	142	19	pharmacological	pharmacological	NOUN
aiua-6590	142	20	therapy	therapy	NOUN
aiua-6590	142	21	for	for	ADP
aiua-6590	142	22	benign	benign	ADJ
aiua-6590	142	23	prostatic	prostatic	ADJ
aiua-6590	142	24	hyperplasia	hyperplasia	NOUN
aiua-6590	142	25	(	(	PUNCT
aiua-6590	142	26	bph)associated	bph)associate	VERB
aiua-6590	142	27	lower	low	ADJ
aiua-6590	142	28	urinary	urinary	ADJ
aiua-6590	142	29	tract	tract	NOUN
aiua-6590	142	30	symptoms	symptom	NOUN
aiua-6590	142	31	(	(	PUNCT
aiua-6590	142	32	luts	luts	PROPN
aiua-6590	142	33	)	)	PUNCT
aiua-6590	142	34	is	be	AUX
aiua-6590	142	35	different	different	ADJ
aiua-6590	142	36	:	:	PUNCT
aiua-6590	142	37	is	be	AUX
aiua-6590	142	38	combination	combination	NOUN
aiua-6590	142	39	therapy	therapy	NOUN
aiua-6590	142	40	better	well	ADV
aiua-6590	142	41	than	than	ADP
aiua-6590	142	42	monotherapy	monotherapy	NOUN
aiua-6590	142	43	?	?	PUNCT
aiua-6590	143	1	bmc	bmc	PROPN
aiua-6590	143	2	urol	urol	PROPN
aiua-6590	143	3	.	.	PUNCT
aiua-6590	144	1	2015	2015	NUM
aiua-6590	144	2	;	;	PUNCT
aiua-6590	144	3	15:96	15:96	NUM
aiua-6590	144	4	.	.	NOUN
aiua-6590	145	1	8	8	NUM
aiua-6590	145	2	.	.	PUNCT
aiua-6590	145	3	cai	cai	PROPN
aiua-6590	145	4	t	t	PROPN
aiua-6590	145	5	,	,	PUNCT
aiua-6590	145	6	tiscione	tiscione	NOUN
aiua-6590	145	7	d	d	NOUN
aiua-6590	145	8	,	,	PUNCT
aiua-6590	145	9	gallelli	gallelli	PROPN
aiua-6590	145	10	l	l	PROPN
aiua-6590	145	11	,	,	PUNCT
aiua-6590	145	12	et	et	PROPN
aiua-6590	145	13	al	al	PROPN
aiua-6590	145	14	.	.	PROPN
aiua-6590	145	15	serenoarepens	serenoarepen	NOUN
aiua-6590	145	16	associated	associate	VERB
aiua-6590	145	17	with	with	ADP
aiua-6590	145	18	selenium	selenium	NOUN
aiua-6590	145	19	and	and	CCONJ
aiua-6590	145	20	lycopene	lycopene	NOUN
aiua-6590	145	21	extract	extract	NOUN
aiua-6590	145	22	and	and	CCONJ
aiua-6590	145	23	bromelain	bromelain	NOUN
aiua-6590	145	24	and	and	CCONJ
aiua-6590	145	25	methylsulfonylmethane	methylsulfonylmethane	ADJ
aiua-6590	145	26	extract	extract	NOUN
aiua-6590	145	27	are	be	AUX
aiua-6590	145	28	able	able	ADJ
aiua-6590	145	29	to	to	PART
aiua-6590	145	30	improve	improve	VERB
aiua-6590	145	31	the	the	DET
aiua-6590	145	32	efficacy	efficacy	NOUN
aiua-6590	145	33	of	of	ADP
aiua-6590	145	34	levofloxacin	levofloxacin	NOUN
aiua-6590	145	35	in	in	ADP
aiua-6590	145	36	chronic	chronic	ADJ
aiua-6590	145	37	bacterial	bacterial	ADJ
aiua-6590	145	38	prostatitis	prostatitis	NOUN
aiua-6590	145	39	patients	patient	NOUN
aiua-6590	145	40	.	.	PUNCT
aiua-6590	146	1	arch	arch	ADJ
aiua-6590	146	2	ital	ital	PROPN
aiua-6590	146	3	urol	urol	PROPN
aiua-6590	146	4	androl	androl	PROPN
aiua-6590	146	5	.	.	PROPN
aiua-6590	146	6	2016	2016	NUM
aiua-6590	146	7	;	;	PUNCT
aiua-6590	146	8	88:177	88:177	NUM
aiua-6590	146	9	-	-	SYM
aiua-6590	146	10	182	182	NUM
aiua-6590	146	11	.	.	PUNCT
aiua-6590	147	1	9	9	NUM
aiua-6590	147	2	.	.	X
aiua-6590	147	3	cai	cai	PROPN
aiua-6590	147	4	t	t	PROPN
aiua-6590	147	5	,	,	PUNCT
aiua-6590	147	6	gallelli	gallelli	PROPN
aiua-6590	147	7	l	l	PROPN
aiua-6590	147	8	,	,	PUNCT
aiua-6590	147	9	meacci	meacci	PROPN
aiua-6590	147	10	f	f	PROPN
aiua-6590	147	11	,	,	PUNCT
aiua-6590	147	12	et	et	PROPN
aiua-6590	147	13	al	al	PROPN
aiua-6590	147	14	.	.	PUNCT
aiua-6590	148	1	the	the	DET
aiua-6590	148	2	efficacy	efficacy	NOUN
aiua-6590	148	3	of	of	ADP
aiua-6590	148	4	umbelliferone	umbelliferone	NOUN
aiua-6590	148	5	,	,	PUNCT
aiua-6590	148	6	arbutin	arbutin	NOUN
aiua-6590	148	7	,	,	PUNCT
aiua-6590	148	8	and	and	CCONJ
aiua-6590	148	9	n	n	CCONJ
aiua-6590	148	10	-	-	VERB
aiua-6590	148	11	acetylcysteine	acetylcysteine	NOUN
aiua-6590	148	12	to	to	PART
aiua-6590	148	13	prevent	prevent	VERB
aiua-6590	148	14	microbial	microbial	ADJ
aiua-6590	148	15	colonization	colonization	NOUN
aiua-6590	148	16	and	and	CCONJ
aiua-6590	148	17	biofilm	biofilm	NOUN
aiua-6590	148	18	development	development	NOUN
aiua-6590	148	19	on	on	ADP
aiua-6590	148	20	urinary	urinary	ADJ
aiua-6590	148	21	catheter	catheter	NOUN
aiua-6590	148	22	surface	surface	NOUN
aiua-6590	148	23	:	:	PUNCT
aiua-6590	148	24	results	result	VERB
aiua-6590	148	25	from	from	ADP
aiua-6590	148	26	a	a	DET
aiua-6590	148	27	preliminary	preliminary	ADJ
aiua-6590	148	28	study	study	NOUN
aiua-6590	148	29	.	.	PUNCT
aiua-6590	149	1	j	j	PROPN
aiua-6590	149	2	pathog	pathog	PROPN
aiua-6590	149	3	.	.	PUNCT
aiua-6590	150	1	2016	2016	NUM
aiua-6590	150	2	;	;	PUNCT
aiua-6590	150	3	2016:1590952	2016:1590952	NUM
aiua-6590	150	4	.	.	NOUN
aiua-6590	151	1	10	10	NUM
aiua-6590	151	2	.	.	PUNCT
aiua-6590	152	1	cai	cai	PROPN
aiua-6590	152	2	t	t	PROPN
aiua-6590	152	3	,	,	PUNCT
aiua-6590	152	4	morgia	morgia	NOUN
aiua-6590	152	5	g	g	NOUN
aiua-6590	152	6	,	,	PUNCT
aiua-6590	152	7	carrieri	carrieri	ADJ
aiua-6590	152	8	g	g	PROPN
aiua-6590	152	9	,	,	PUNCT
aiua-6590	152	10	et	et	PROPN
aiua-6590	152	11	al	al	PROPN
aiua-6590	152	12	.	.	PUNCT
aiua-6590	153	1	an	an	DET
aiua-6590	153	2	improvement	improvement	NOUN
aiua-6590	153	3	in	in	ADP
aiua-6590	153	4	sexual	sexual	ADJ
aiua-6590	153	5	function	function	NOUN
aiua-6590	153	6	is	be	AUX
aiua-6590	153	7	related	relate	VERB
aiua-6590	153	8	to	to	ADP
aiua-6590	153	9	better	well	ADJ
aiua-6590	153	10	quality	quality	NOUN
aiua-6590	153	11	of	of	ADP
aiua-6590	153	12	life	life	NOUN
aiua-6590	153	13	,	,	PUNCT
aiua-6590	153	14	regardless	regardless	ADV
aiua-6590	153	15	of	of	ADP
aiua-6590	153	16	urinary	urinary	ADJ
aiua-6590	153	17	function	function	NOUN
aiua-6590	153	18	improvement	improvement	NOUN
aiua-6590	153	19	:	:	PUNCT
aiua-6590	153	20	results	result	VERB
aiua-6590	153	21	from	from	ADP
aiua-6590	153	22	the	the	DET
aiua-6590	153	23	idiprost	idiprost	NOUN
aiua-6590	153	24	®	®	NOUN
aiua-6590	153	25	gold	gold	NOUN
aiua-6590	153	26	study	study	NOUN
aiua-6590	153	27	.	.	PUNCT
aiua-6590	154	1	arch	arch	PROPN
aiua-6590	154	2	ital	ital	PROPN
aiua-6590	154	3	urol	urol	PROPN
aiua-6590	154	4	androl	androl	PROPN
aiua-6590	154	5	.	.	PROPN
aiua-6590	154	6	2013	2013	NUM
aiua-6590	154	7	;	;	PUNCT
aiua-6590	154	8	85:184	85:184	NUM
aiua-6590	154	9	-	-	SYM
aiua-6590	154	10	9	9	NUM
aiua-6590	154	11	.	.	NOUN
aiua-6590	154	12	11	11	NUM
aiua-6590	154	13	.	.	PUNCT
aiua-6590	155	1	tanaka	tanaka	PROPN
aiua-6590	155	2	m	m	PROPN
aiua-6590	155	3	,	,	PUNCT
aiua-6590	155	4	fujimoto	fujimoto	PROPN
aiua-6590	155	5	k	k	PROPN
aiua-6590	155	6	,	,	PUNCT
aiua-6590	155	7	chihara	chihara	PROPN
aiua-6590	155	8	y	y	PROPN
aiua-6590	155	9	,	,	PUNCT
aiua-6590	155	10	et	et	PROPN
aiua-6590	155	11	al	al	PROPN
aiua-6590	155	12	.	.	PUNCT
aiua-6590	156	1	isoflavone	isoflavone	NOUN
aiua-6590	156	2	supplements	supplement	NOUN
aiua-6590	156	3	stimulated	stimulate	VERB
aiua-6590	156	4	the	the	DET
aiua-6590	156	5	production	production	NOUN
aiua-6590	156	6	of	of	ADP
aiua-6590	156	7	serum	serum	NOUN
aiua-6590	156	8	equol	equol	NOUN
aiua-6590	156	9	and	and	CCONJ
aiua-6590	156	10	decreased	decrease	VERB
aiua-6590	156	11	the	the	DET
aiua-6590	156	12	serum	serum	NOUN
aiua-6590	156	13	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-6590	156	14	levels	level	NOUN
aiua-6590	156	15	in	in	ADP
aiua-6590	156	16	healthy	healthy	ADJ
aiua-6590	156	17	male	male	NOUN
aiua-6590	156	18	volunteers	volunteer	NOUN
aiua-6590	156	19	.	.	PUNCT
aiua-6590	157	1	prostate	prostate	NOUN
aiua-6590	157	2	cancer	cancer	NOUN
aiua-6590	157	3	prostatic	prostatic	PROPN
aiua-6590	157	4	dis	dis	PROPN
aiua-6590	157	5	.	.	PUNCT
aiua-6590	158	1	2009	2009	NUM
aiua-6590	158	2	;	;	PUNCT
aiua-6590	158	3	12:247	12:247	NUM
aiua-6590	158	4	-	-	SYM
aiua-6590	158	5	52	52	NUM
aiua-6590	158	6	.	.	PUNCT
aiua-6590	159	1	12	12	NUM
aiua-6590	159	2	.	.	PUNCT
aiua-6590	160	1	fortina	fortina	PROPN
aiua-6590	160	2	mg	mg	PROPN
aiua-6590	160	3	,	,	PUNCT
aiua-6590	160	4	ricci	ricci	PROPN
aiua-6590	160	5	g	g	PROPN
aiua-6590	160	6	,	,	PUNCT
aiua-6590	160	7	foschino	foschino	NOUN
aiua-6590	160	8	r	r	NOUN
aiua-6590	160	9	,	,	PUNCT
aiua-6590	160	10	et	et	PROPN
aiua-6590	160	11	al	al	PROPN
aiua-6590	160	12	.	.	PROPN
aiua-6590	160	13	phenotypic	phenotypic	ADJ
aiua-6590	160	14	typing	typing	NOUN
aiua-6590	160	15	,	,	PUNCT
aiua-6590	160	16	technological	technological	ADJ
aiua-6590	160	17	properties	property	NOUN
aiua-6590	160	18	and	and	CCONJ
aiua-6590	160	19	safety	safety	NOUN
aiua-6590	160	20	aspects	aspect	NOUN
aiua-6590	160	21	of	of	ADP
aiua-6590	160	22	lactococcus	lactococcus	NOUN
aiua-6590	160	23	garvieae	garvieae	ADV
aiua-6590	160	24	strains	strain	VERB
aiua-6590	160	25	from	from	ADP
aiua-6590	160	26	dairy	dairy	NOUN
aiua-6590	160	27	environments	environment	NOUN
aiua-6590	160	28	.	.	PUNCT
aiua-6590	161	1	j	j	PROPN
aiua-6590	161	2	appl	appl	PROPN
aiua-6590	161	3	microbiol	microbiol	PROPN
aiua-6590	161	4	.	.	PUNCT
aiua-6590	162	1	2007	2007	NUM
aiua-6590	162	2	;	;	PUNCT
aiua-6590	162	3	103:445	103:445	NUM
aiua-6590	162	4	-	-	SYM
aiua-6590	162	5	53	53	NUM
aiua-6590	162	6	.	.	NOUN
aiua-6590	162	7	13	13	NUM
aiua-6590	162	8	.	.	PUNCT
aiua-6590	163	1	kenneth	kenneth	PROPN
aiua-6590	163	2	d	d	PROPN
aiua-6590	163	3	,	,	PUNCT
aiua-6590	163	4	setchell	setchell	ADJ
aiua-6590	163	5	r	r	NOUN
aiua-6590	163	6	,	,	PUNCT
aiua-6590	163	7	clerici	clerici	PROPN
aiua-6590	163	8	c.	c.	PROPN
aiua-6590	163	9	equol	equol	PROPN
aiua-6590	163	10	:	:	PUNCT
aiua-6590	163	11	history	history	NOUN
aiua-6590	163	12	,	,	PUNCT
aiua-6590	163	13	chemistry	chemistry	NOUN
aiua-6590	163	14	,	,	PUNCT
aiua-6590	163	15	and	and	CCONJ
aiua-6590	163	16	formation	formation	NOUN
aiua-6590	163	17	.	.	PUNCT
aiua-6590	164	1	j	j	PROPN
aiua-6590	164	2	nutr	nutr	PROPN
aiua-6590	164	3	.	.	PROPN
aiua-6590	164	4	2010	2010	NUM
aiua-6590	164	5	;	;	PUNCT
aiua-6590	164	6	140:1355s-1362s	140:1355s-1362s	NOUN
aiua-6590	164	7	.	.	PUNCT
aiua-6590	165	1	14	14	NUM
aiua-6590	165	2	.	.	PUNCT
aiua-6590	166	1	badia	badia	PROPN
aiua-6590	166	2	x	x	PROPN
aiua-6590	166	3	,	,	PUNCT
aiua-6590	166	4	garcia	garcia	PROPN
aiua-6590	166	5	-	-	PUNCT
aiua-6590	166	6	losa	losa	PROPN
aiua-6590	166	7	m	m	PROPN
aiua-6590	166	8	,	,	PUNCT
aiua-6590	166	9	dal	dal	NOUN
aiua-6590	166	10	-	-	PUNCT
aiua-6590	166	11	re	re	PROPN
aiua-6590	166	12	r.	r.	PROPN
aiua-6590	166	13	ten	ten	NUM
aiua-6590	166	14	-	-	PUNCT
aiua-6590	166	15	language	language	NOUN
aiua-6590	166	16	translation	translation	NOUN
aiua-6590	166	17	andharmonization	andharmonization	NOUN
aiua-6590	166	18	of	of	ADP
aiua-6590	166	19	the	the	DET
aiua-6590	166	20	international	international	ADJ
aiua-6590	166	21	prostate	prostate	NOUN
aiua-6590	166	22	symptom	symptom	NOUN
aiua-6590	166	23	score	score	NOUN
aiua-6590	166	24	:	:	PUNCT
aiua-6590	166	25	developinga	developinga	VERB
aiua-6590	166	26	methodology	methodology	NOUN
aiua-6590	166	27	for	for	ADP
aiua-6590	166	28	multinational	multinational	ADJ
aiua-6590	166	29	clinical	clinical	ADJ
aiua-6590	166	30	trials	trial	NOUN
aiua-6590	166	31	.	.	PUNCT
aiua-6590	167	1	eur	eur	PROPN
aiua-6590	167	2	urol	urol	PROPN
aiua-6590	167	3	.	.	PUNCT
aiua-6590	168	1	1997	1997	NUM
aiua-6590	168	2	;	;	PUNCT
aiua-6590	168	3	31:129	31:129	NUM
aiua-6590	168	4	-	-	SYM
aiua-6590	168	5	40	40	NUM
aiua-6590	168	6	.	.	PUNCT
aiua-6590	169	1	15	15	NUM
aiua-6590	169	2	.	.	PUNCT
aiua-6590	169	3	rosen	rosen	PROPN
aiua-6590	169	4	rc	rc	PROPN
aiua-6590	169	5	,	,	PUNCT
aiua-6590	169	6	riley	riley	PROPN
aiua-6590	169	7	a	a	PRON
aiua-6590	169	8	,	,	PUNCT
aiua-6590	169	9	wagner	wagner	PROPN
aiua-6590	169	10	g	g	PROPN
aiua-6590	169	11	,	,	PUNCT
aiua-6590	169	12	et	et	PROPN
aiua-6590	169	13	al	al	PROPN
aiua-6590	169	14	.	.	PUNCT
aiua-6590	170	1	the	the	DET
aiua-6590	170	2	international	international	ADJ
aiua-6590	170	3	index	index	NOUN
aiua-6590	170	4	of	of	ADP
aiua-6590	170	5	erectilefunction	erectilefunction	PROPN
aiua-6590	170	6	(	(	PUNCT
aiua-6590	170	7	iief	iief	PROPN
aiua-6590	170	8	):	):	PUNCT
aiua-6590	170	9	a	a	DET
aiua-6590	170	10	multidimensional	multidimensional	ADJ
aiua-6590	170	11	scale	scale	NOUN
aiua-6590	170	12	for	for	ADP
aiua-6590	170	13	assessment	assessment	NOUN
aiua-6590	170	14	of	of	ADP
aiua-6590	170	15	erectiledysfunction	erectiledysfunction	NOUN
aiua-6590	170	16	.	.	PUNCT
aiua-6590	171	1	urology	urology	NOUN
aiua-6590	171	2	.	.	PUNCT
aiua-6590	172	1	1997	1997	NUM
aiua-6590	172	2	;	;	PUNCT
aiua-6590	172	3	49:822	49:822	NUM
aiua-6590	172	4	-	-	SYM
aiua-6590	172	5	30	30	NUM
aiua-6590	172	6	.	.	PUNCT
aiua-6590	173	1	16	16	NUM
aiua-6590	173	2	.	.	PUNCT
aiua-6590	174	1	kaplan	kaplan	PROPN
aiua-6590	174	2	rm	rm	PROPN
aiua-6590	174	3	,	,	PUNCT
aiua-6590	174	4	bush	bush	PROPN
aiua-6590	174	5	jw	jw	PROPN
aiua-6590	174	6	,	,	PUNCT
aiua-6590	174	7	berry	berry	PROPN
aiua-6590	174	8	cc	cc	PROPN
aiua-6590	174	9	.	.	PROPN
aiua-6590	174	10	health	health	NOUN
aiua-6590	174	11	status	status	NOUN
aiua-6590	174	12	:	:	PUNCT
aiua-6590	174	13	types	type	NOUN
aiua-6590	174	14	of	of	ADP
aiua-6590	174	15	validity	validity	NOUN
aiua-6590	174	16	and	and	CCONJ
aiua-6590	174	17	the	the	DET
aiua-6590	174	18	index	index	NOUN
aiua-6590	174	19	of	of	ADP
aiua-6590	174	20	wellbeing	wellbee	VERB
aiua-6590	174	21	.	.	PUNCT
aiua-6590	175	1	health	health	NOUN
aiua-6590	175	2	serv	serv	PROPN
aiua-6590	175	3	res	re	VERB
aiua-6590	175	4	1976	1976	NUM
aiua-6590	175	5	;	;	PUNCT
aiua-6590	175	6	11:478	11:478	NUM
aiua-6590	175	7	-	-	SYM
aiua-6590	175	8	507	507	NUM
aiua-6590	175	9	.	.	NUM
aiua-6590	175	10	17	17	NUM
aiua-6590	175	11	.	.	PUNCT
aiua-6590	176	1	apolone	apolone	PROPN
aiua-6590	176	2	g	g	PROPN
aiua-6590	176	3	,	,	PUNCT
aiua-6590	176	4	mosconi	mosconi	PROPN
aiua-6590	176	5	p.	p.	PROPN
aiua-6590	177	1	the	the	DET
aiua-6590	177	2	italian	italian	ADJ
aiua-6590	177	3	sf-36	sf-36	NOUN
aiua-6590	177	4	health	health	NOUN
aiua-6590	177	5	survey	survey	NOUN
aiua-6590	177	6	:	:	PUNCT
aiua-6590	177	7	translation	translation	NOUN
aiua-6590	177	8	,	,	PUNCT
aiua-6590	177	9	validation	validation	NOUN
aiua-6590	177	10	and	and	CCONJ
aiua-6590	177	11	norming	norming	NOUN
aiua-6590	177	12	.	.	PUNCT
aiua-6590	178	1	j	j	PROPN
aiua-6590	178	2	clin	clin	PROPN
aiua-6590	178	3	epidemiol	epidemiol	PROPN
aiua-6590	178	4	.	.	PUNCT
aiua-6590	179	1	1998	1998	NUM
aiua-6590	179	2	;	;	PUNCT
aiua-6590	179	3	51:1025	51:1025	NUM
aiua-6590	179	4	-	-	SYM
aiua-6590	179	5	36	36	NUM
aiua-6590	179	6	.	.	PUNCT
aiua-6590	180	1	18	18	NUM
aiua-6590	180	2	.	.	PUNCT
aiua-6590	180	3	gallelli	gallelli	PROPN
aiua-6590	180	4	l	l	PROPN
aiua-6590	180	5	,	,	PUNCT
aiua-6590	180	6	colosimo	colosimo	PROPN
aiua-6590	180	7	m	m	PROPN
aiua-6590	180	8	,	,	PUNCT
aiua-6590	180	9	tolotta	tolotta	PROPN
aiua-6590	180	10	ga	ga	PROPN
aiua-6590	180	11	,	,	PUNCT
aiua-6590	180	12	et	et	PROPN
aiua-6590	180	13	al	al	PROPN
aiua-6590	180	14	.	.	PROPN
aiua-6590	180	15	prospective	prospective	PROPN
aiua-6590	180	16	randomized	randomize	VERB
aiua-6590	180	17	double	double	ADJ
aiua-6590	180	18	-	-	PUNCT
aiua-6590	180	19	blind	blind	ADJ
aiua-6590	180	20	trial	trial	NOUN
aiua-6590	180	21	of	of	ADP
aiua-6590	180	22	racecadotril	racecadotril	NOUN
aiua-6590	180	23	compared	compare	VERB
aiua-6590	180	24	with	with	ADP
aiua-6590	180	25	loperamide	loperamide	NOUN
aiua-6590	180	26	in	in	ADP
aiua-6590	180	27	elderly	elderly	ADJ
aiua-6590	180	28	people	people	NOUN
aiua-6590	180	29	with	with	ADP
aiua-6590	180	30	gastroenteritis	gastroenteritis	NOUN
aiua-6590	180	31	living	live	VERB
aiua-6590	180	32	in	in	ADP
aiua-6590	180	33	nursing	nursing	NOUN
aiua-6590	180	34	homes	home	NOUN
aiua-6590	180	35	.	.	PUNCT
aiua-6590	181	1	eur	eur	PROPN
aiua-6590	181	2	j	j	PROPN
aiua-6590	181	3	clin	clin	PROPN
aiua-6590	181	4	pharmacol	pharmacol	PROPN
aiua-6590	181	5	.	.	PUNCT
aiua-6590	182	1	2010	2010	NUM
aiua-6590	182	2	;	;	PUNCT
aiua-6590	182	3	66:137	66:137	NUM
aiua-6590	182	4	-	-	SYM
aiua-6590	182	5	44	44	NUM
aiua-6590	182	6	.	.	PUNCT
aiua-6590	183	1	19	19	NUM
aiua-6590	183	2	.	.	PUNCT
aiua-6590	184	1	naranjo	naranjo	PROPN
aiua-6590	184	2	ca	ca	PROPN
aiua-6590	184	3	,	,	PUNCT
aiua-6590	184	4	busto	busto	NOUN
aiua-6590	184	5	u	u	NOUN
aiua-6590	184	6	,	,	PUNCT
aiua-6590	184	7	sellers	seller	VERB
aiua-6590	184	8	em	em	PRON
aiua-6590	184	9	,	,	PUNCT
aiua-6590	184	10	et	et	PROPN
aiua-6590	184	11	al	al	PROPN
aiua-6590	184	12	.	.	PUNCT
aiua-6590	185	1	a	a	DET
aiua-6590	185	2	method	method	NOUN
aiua-6590	185	3	for	for	ADP
aiua-6590	185	4	estimating	estimate	VERB
aiua-6590	185	5	the	the	DET
aiua-6590	185	6	probability	probability	NOUN
aiua-6590	185	7	of	of	ADP
aiua-6590	185	8	adverse	adverse	ADJ
aiua-6590	185	9	drug	drug	NOUN
aiua-6590	185	10	reactions	reaction	NOUN
aiua-6590	185	11	.	.	PUNCT
aiua-6590	186	1	clin	clin	PROPN
aiua-6590	186	2	pharmacol	pharmacol	PROPN
aiua-6590	186	3	ther	ther	ADV
aiua-6590	186	4	.	.	PUNCT
aiua-6590	187	1	1981	1981	NUM
aiua-6590	187	2	;	;	PUNCT
aiua-6590	187	3	30:239	30:239	NUM
aiua-6590	187	4	-	-	SYM
aiua-6590	187	5	245	245	NUM
aiua-6590	187	6	.	.	NOUN
aiua-6590	188	1	20	20	NUM
aiua-6590	188	2	.	.	PUNCT
aiua-6590	188	3	kuiper	kuiper	PROPN
aiua-6590	188	4	gg	gg	PROPN
aiua-6590	188	5	,	,	PUNCT
aiua-6590	188	6	carlsson	carlsson	PROPN
aiua-6590	188	7	b	b	PROPN
aiua-6590	188	8	,	,	PUNCT
aiua-6590	188	9	grandien	grandien	NOUN
aiua-6590	188	10	k	k	PROPN
aiua-6590	188	11	,	,	PUNCT
aiua-6590	188	12	et	et	PROPN
aiua-6590	188	13	al	al	PROPN
aiua-6590	188	14	.	.	PROPN
aiua-6590	188	15	comparison	comparison	NOUN
aiua-6590	188	16	of	of	ADP
aiua-6590	188	17	the	the	DET
aiua-6590	188	18	ligand	ligand	ADJ
aiua-6590	188	19	binding	bind	VERB
aiua-6590	188	20	specificity	specificity	NOUN
aiua-6590	188	21	and	and	CCONJ
aiua-6590	188	22	transcript	transcript	VERB
aiua-6590	188	23	tissue	tissue	NOUN
aiua-6590	188	24	distribution	distribution	NOUN
aiua-6590	188	25	of	of	ADP
aiua-6590	188	26	estrogen	estrogen	NOUN
aiua-6590	188	27	receptors	receptor	NOUN
aiua-6590	188	28	alpha	alpha	NOUN
aiua-6590	188	29	and	and	CCONJ
aiua-6590	188	30	beta	beta	NOUN
aiua-6590	188	31	.	.	PUNCT
aiua-6590	189	1	endocrinology	endocrinology	NOUN
aiua-6590	189	2	.	.	PUNCT
aiua-6590	190	1	1997	1997	NUM
aiua-6590	190	2	;	;	PUNCT
aiua-6590	190	3	138:863	138:863	NOUN
aiua-6590	190	4	-	-	SYM
aiua-6590	190	5	870	870	NUM
aiua-6590	190	6	.	.	PUNCT
aiua-6590	191	1	21	21	NUM
aiua-6590	191	2	.	.	PUNCT
aiua-6590	192	1	margeat	margeat	PROPN
aiua-6590	192	2	e	e	NOUN
aiua-6590	192	3	,	,	PUNCT
aiua-6590	192	4	bourdoncle	bourdoncle	PROPN
aiua-6590	192	5	a	a	X
aiua-6590	192	6	,	,	PUNCT
aiua-6590	192	7	margueron	margueron	NOUN
aiua-6590	192	8	r	r	NOUN
aiua-6590	192	9	,	,	PUNCT
aiua-6590	192	10	et	et	PROPN
aiua-6590	192	11	al	al	PROPN
aiua-6590	192	12	.	.	PUNCT
aiua-6590	192	13	ligands	ligand	NOUN
aiua-6590	192	14	differentially	differentially	ADV
aiua-6590	192	15	modulate	modulate	VERB
aiua-6590	192	16	the	the	DET
aiua-6590	192	17	protein	protein	NOUN
aiua-6590	192	18	interactions	interaction	NOUN
aiua-6590	192	19	of	of	ADP
aiua-6590	192	20	the	the	DET
aiua-6590	192	21	human	human	ADJ
aiua-6590	192	22	estrogen	estrogen	NOUN
aiua-6590	192	23	receptors	receptor	NOUN
aiua-6590	192	24	alpha	alpha	NOUN
aiua-6590	192	25	and	and	CCONJ
aiua-6590	192	26	beta	beta	NOUN
aiua-6590	192	27	.	.	PUNCT
aiua-6590	193	1	j	j	PROPN
aiua-6590	193	2	mol	mol	PROPN
aiua-6590	193	3	biol	biol	PROPN
aiua-6590	193	4	.	.	PUNCT
aiua-6590	194	1	2003	2003	NUM
aiua-6590	194	2	;	;	PUNCT
aiua-6590	195	1	326:77	326:77	PROPN
aiua-6590	195	2	-	-	SYM
aiua-6590	195	3	92	92	NUM
aiua-6590	195	4	.	.	PUNCT
aiua-6590	196	1	22	22	NUM
aiua-6590	196	2	.	.	PUNCT
aiua-6590	197	1	zhang	zhang	PROPN
aiua-6590	197	2	w	w	PROPN
aiua-6590	197	3	,	,	PUNCT
aiua-6590	197	4	makela	makela	PROPN
aiua-6590	197	5	s	s	PROPN
aiua-6590	197	6	,	,	PUNCT
aiua-6590	197	7	andersson	andersson	PROPN
aiua-6590	197	8	lc	lc	PROPN
aiua-6590	197	9	,	,	PUNCT
aiua-6590	197	10	et	et	PROPN
aiua-6590	197	11	al	al	PROPN
aiua-6590	197	12	.	.	PUNCT
aiua-6590	198	1	a	a	DET
aiua-6590	198	2	role	role	NOUN
aiua-6590	198	3	for	for	ADP
aiua-6590	198	4	estrogen	estrogen	NOUN
aiua-6590	198	5	receptor	receptor	NOUN
aiua-6590	198	6	beta	beta	NOUN
aiua-6590	198	7	in	in	ADP
aiua-6590	198	8	the	the	DET
aiua-6590	198	9	regulation	regulation	NOUN
aiua-6590	198	10	of	of	ADP
aiua-6590	198	11	growth	growth	NOUN
aiua-6590	198	12	of	of	ADP
aiua-6590	198	13	the	the	DET
aiua-6590	198	14	ventral	ventral	ADJ
aiua-6590	198	15	prostate	prostate	NOUN
aiua-6590	198	16	.	.	PUNCT
aiua-6590	199	1	proc	proc	PROPN
aiua-6590	199	2	natl	natl	PROPN
aiua-6590	199	3	acad	acad	PROPN
aiua-6590	199	4	sci	sci	PROPN
aiua-6590	199	5	.	.	PROPN
aiua-6590	199	6	usa	usa	PROPN
aiua-6590	199	7	2001	2001	NUM
aiua-6590	199	8	;	;	PUNCT
aiua-6590	199	9	98:6330	98:6330	PROPN
aiua-6590	199	10	-	-	PUNCT
aiua-6590	199	11	6335	6335	NUM
aiua-6590	199	12	.	.	PUNCT
aiua-6590	200	1	23	23	NUM
aiua-6590	200	2	.	.	PUNCT
aiua-6590	201	1	imamov	imamov	PROPN
aiua-6590	201	2	o	o	PROPN
aiua-6590	201	3	,	,	PUNCT
aiua-6590	201	4	morani	morani	PROPN
aiua-6590	201	5	a	a	PRON
aiua-6590	201	6	,	,	PUNCT
aiua-6590	201	7	shim	shim	NOUN
aiua-6590	201	8	gj	gj	PROPN
aiua-6590	201	9	,	,	PUNCT
aiua-6590	201	10	et	et	PROPN
aiua-6590	201	11	al	al	PROPN
aiua-6590	201	12	.	.	PUNCT
aiua-6590	201	13	estrogen	estrogen	PROPN
aiua-6590	201	14	receptor	receptor	NOUN
aiua-6590	201	15	-	-	PUNCT
aiua-6590	201	16	beta	beta	NOUN
aiua-6590	201	17	regulates	regulate	VERB
aiua-6590	201	18	epithelial	epithelial	ADJ
aiua-6590	201	19	cell	cell	NOUN
aiua-6590	201	20	differentiation	differentiation	NOUN
aiua-6590	201	21	in	in	ADP
aiua-6590	201	22	the	the	DET
aiua-6590	201	23	mouse	mouse	NOUN
aiua-6590	201	24	ventral	ventral	ADJ
aiua-6590	201	25	prostate	prostate	NOUN
aiua-6590	201	26	.	.	PUNCT
aiua-6590	202	1	proc	proc	PROPN
aiua-6590	202	2	natl	natl	PROPN
aiua-6590	202	3	acad	acad	PROPN
aiua-6590	202	4	sci	sci	PROPN
aiua-6590	202	5	.	.	PROPN
aiua-6590	202	6	usa	usa	PROPN
aiua-6590	202	7	2004	2004	NUM
aiua-6590	202	8	;	;	PUNCT
aiua-6590	202	9	101:9375	101:9375	NUM
aiua-6590	202	10	-	-	SYM
aiua-6590	202	11	9380	9380	NUM
aiua-6590	202	12	.	.	PUNCT
aiua-6590	203	1	24	24	NUM
aiua-6590	203	2	.	.	PUNCT
aiua-6590	204	1	mcpherson	mcpherson	PROPN
aiua-6590	204	2	sj	sj	PROPN
aiua-6590	204	3	,	,	PUNCT
aiua-6590	204	4	hussain	hussain	PROPN
aiua-6590	204	5	s	s	PART
aiua-6590	204	6	,	,	PUNCT
aiua-6590	204	7	balanathan	balanathan	VERB
aiua-6590	204	8	p	p	NOUN
aiua-6590	204	9	,	,	PUNCT
aiua-6590	204	10	et	et	PROPN
aiua-6590	204	11	al	al	PROPN
aiua-6590	204	12	.	.	PUNCT
aiua-6590	204	13	estrogen	estrogen	PROPN
aiua-6590	204	14	receptor	receptor	NOUN
aiua-6590	204	15	-	-	PUNCT
aiua-6590	204	16	beta	beta	NOUN
aiua-6590	204	17	activated	activate	VERB
aiua-6590	204	18	apoptosis	apoptosis	NOUN
aiua-6590	204	19	in	in	ADP
aiua-6590	204	20	benign	benign	ADJ
aiua-6590	204	21	hyperplasia	hyperplasia	NOUN
aiua-6590	204	22	and	and	CCONJ
aiua-6590	204	23	cancer	cancer	NOUN
aiua-6590	204	24	of	of	ADP
aiua-6590	204	25	the	the	DET
aiua-6590	204	26	prostate	prostate	NOUN
aiua-6590	204	27	is	be	AUX
aiua-6590	204	28	androgen	androgen	NOUN
aiua-6590	204	29	independent	independent	ADJ
aiua-6590	204	30	and	and	CCONJ
aiua-6590	204	31	tnfalpha	tnfalpha	NOUN
aiua-6590	204	32	mediated	mediate	VERB
aiua-6590	204	33	.	.	PUNCT
aiua-6590	205	1	proc	proc	PROPN
aiua-6590	205	2	natl	natl	PROPN
aiua-6590	205	3	acad	acad	PROPN
aiua-6590	205	4	sci	sci	PROPN
aiua-6590	205	5	.	.	PROPN
aiua-6590	205	6	usa	usa	PROPN
aiua-6590	205	7	2010	2010	NUM
aiua-6590	205	8	;	;	PUNCT
aiua-6590	205	9	107:3123	107:3123	NUM
aiua-6590	205	10	-	-	SYM
aiua-6590	205	11	3128	3128	NUM
aiua-6590	205	12	.	.	PUNCT
aiua-6590	206	1	25	25	NUM
aiua-6590	206	2	.	.	PUNCT
aiua-6590	207	1	zhang	zhang	PROPN
aiua-6590	207	2	q	q	PROPN
aiua-6590	207	3	,	,	PUNCT
aiua-6590	207	4	feng	feng	PROPN
aiua-6590	207	5	h	h	PROPN
aiua-6590	207	6	,	,	PUNCT
aiua-6590	207	7	qluwakemi	qluwakemi	PROPN
aiua-6590	207	8	b	b	PROPN
aiua-6590	207	9	,	,	PUNCT
aiua-6590	207	10	et	et	PROPN
aiua-6590	207	11	al	al	PROPN
aiua-6590	207	12	.	.	PUNCT
aiua-6590	207	13	phytoestrogens	phytoestrogen	NOUN
aiua-6590	207	14	and	and	CCONJ
aiua-6590	207	15	risk	risk	NOUN
aiua-6590	207	16	of	of	ADP
aiua-6590	207	17	prostate	prostate	NOUN
aiua-6590	207	18	cancer	cancer	NOUN
aiua-6590	207	19	:	:	PUNCT
aiua-6590	207	20	an	an	DET
aiua-6590	207	21	updated	update	VERB
aiua-6590	207	22	meta	meta	ADJ
aiua-6590	207	23	-	-	PUNCT
aiua-6590	207	24	analysis	analysis	NOUN
aiua-6590	207	25	of	of	ADP
aiua-6590	207	26	epidemiologic	epidemiologic	ADJ
aiua-6590	207	27	studies	study	NOUN
aiua-6590	207	28	.	.	PUNCT
aiua-6590	208	1	int	int	PROPN
aiua-6590	208	2	j	j	PROPN
aiua-6590	208	3	food	food	PROPN
aiua-6590	208	4	sci	sci	PROPN
aiua-6590	208	5	nutr	nutr	PROPN
aiua-6590	208	6	.	.	PROPN
aiua-6590	208	7	2016	2016	NUM
aiua-6590	208	8	;	;	PUNCT
aiua-6590	208	9	9:1	9:1	NUM
aiua-6590	208	10	-	-	SYM
aiua-6590	208	11	15	15	NUM
aiua-6590	208	12	.	.	NOUN
aiua-6590	209	1	26	26	NUM
aiua-6590	209	2	.	.	PUNCT
aiua-6590	210	1	lu	lu	PROPN
aiua-6590	211	1	z	z	PROPN
aiua-6590	211	2	,	,	PUNCT
aiua-6590	211	3	zhou	zhou	PROPN
aiua-6590	211	4	r	r	PROPN
aiua-6590	211	5	,	,	PUNCT
aiua-6590	211	6	kong	kong	PROPN
aiua-6590	211	7	y	y	PROPN
aiua-6590	211	8	,	,	PUNCT
aiua-6590	211	9	et	et	PROPN
aiua-6590	211	10	al	al	PROPN
aiua-6590	211	11	.	.	PUNCT
aiua-6590	212	1	s	s	X
aiua-6590	212	2	-	-	PUNCT
aiua-6590	212	3	equol	equol	NOUN
aiua-6590	212	4	,	,	PUNCT
aiua-6590	212	5	a	a	DET
aiua-6590	212	6	secondary	secondary	ADJ
aiua-6590	212	7	metabolite	metabolite	NOUN
aiua-6590	212	8	of	of	ADP
aiua-6590	212	9	natural	natural	ADJ
aiua-6590	212	10	anticancer	anticancer	NOUN
aiua-6590	212	11	isoflavone	isoflavone	NOUN
aiua-6590	212	12	daidzein	daidzein	NOUN
aiua-6590	212	13	,	,	PUNCT
aiua-6590	212	14	inhibits	inhibit	VERB
aiua-6590	212	15	prostate	prostate	NOUN
aiua-6590	212	16	cancer	cancer	NOUN
aiua-6590	212	17	growth	growth	NOUN
aiua-6590	212	18	in	in	ADP
aiua-6590	212	19	vitro	vitro	X
aiua-6590	212	20	and	and	CCONJ
aiua-6590	212	21	in	in	ADP
aiua-6590	212	22	vivo	vivo	NOUN
aiua-6590	212	23	,	,	PUNCT
aiua-6590	212	24	though	though	SCONJ
aiua-6590	212	25	activating	activate	VERB
aiua-6590	212	26	the	the	DET
aiua-6590	212	27	akt	akt	PROPN
aiua-6590	212	28	/	/	SYM
aiua-6590	212	29	foxo3a	foxo3a	PROPN
aiua-6590	212	30	pathway	pathway	NOUN
aiua-6590	212	31	.	.	PUNCT
aiua-6590	213	1	curr	curr	PROPN
aiua-6590	213	2	cancer	cancer	NOUN
aiua-6590	213	3	drug	drug	NOUN
aiua-6590	213	4	targets	target	NOUN
aiua-6590	213	5	.	.	PUNCT
aiua-6590	214	1	2016	2016	NUM
aiua-6590	214	2	;	;	PUNCT
aiua-6590	214	3	16:455	16:455	NUM
aiua-6590	214	4	-	-	SYM
aiua-6590	214	5	65	65	NUM
aiua-6590	214	6	.	.	PUNCT
aiua-6590	215	1	27	27	NUM
aiua-6590	215	2	.	.	PUNCT
aiua-6590	216	1	bae	bae	PROPN
aiua-6590	216	2	m	m	PROPN
aiua-6590	216	3	,	,	PUNCT
aiua-6590	216	4	woo	woo	VERB
aiua-6590	216	5	m	m	PROPN
aiua-6590	216	6	,	,	PUNCT
aiua-6590	216	7	kusuma	kusuma	PROPN
aiua-6590	216	8	iw	iw	PROPN
aiua-6590	216	9	,	,	PUNCT
aiua-6590	216	10	et	et	PROPN
aiua-6590	216	11	al	al	PROPN
aiua-6590	216	12	.	.	PUNCT
aiua-6590	217	1	inhibitory	inhibitory	ADJ
aiua-6590	217	2	effects	effect	NOUN
aiua-6590	217	3	of	of	ADP
aiua-6590	217	4	isoflavonoids	isoflavonoid	NOUN
aiua-6590	217	5	on	on	ADP
aiua-6590	217	6	rat	rat	NOUN
aiua-6590	217	7	prostate	prostate	NOUN
aiua-6590	217	8	testosterone	testosterone	NOUN
aiua-6590	217	9	5α	5α	ADJ
aiua-6590	217	10	-	-	PUNCT
aiua-6590	217	11	reductase.j	reductase.j	NOUN
aiua-6590	217	12	acupunct	acupunct	ADJ
aiua-6590	217	13	meridian	meridian	PROPN
aiua-6590	217	14	stud	stud	NOUN
aiua-6590	217	15	.	.	PUNCT
aiua-6590	218	1	2012	2012	NUM
aiua-6590	218	2	;	;	PUNCT
aiua-6590	218	3	5:319	5:319	NUM
aiua-6590	218	4	-	-	SYM
aiua-6590	218	5	22	22	NUM
aiua-6590	218	6	.	.	PUNCT
aiua-6590	219	1	28	28	NUM
aiua-6590	219	2	.	.	PUNCT
aiua-6590	220	1	wong	wong	PROPN
aiua-6590	220	2	sy	sy	PROPN
aiua-6590	220	3	,	,	PUNCT
aiua-6590	220	4	lau	lau	PROPN
aiua-6590	220	5	ww	ww	PROPN
aiua-6590	220	6	,	,	PUNCT
aiua-6590	220	7	leung	leung	PROPN
aiua-6590	220	8	pc	pc	PROPN
aiua-6590	220	9	,	,	PUNCT
aiua-6590	220	10	et	et	PROPN
aiua-6590	220	11	al	al	PROPN
aiua-6590	220	12	.	.	PUNCT
aiua-6590	221	1	the	the	DET
aiua-6590	221	2	association	association	NOUN
aiua-6590	221	3	between	between	ADP
aiua-6590	221	4	isoflavone	isoflavone	NOUN
aiua-6590	221	5	and	and	CCONJ
aiua-6590	221	6	lower	low	ADJ
aiua-6590	221	7	urinary	urinary	ADJ
aiua-6590	221	8	tract	tract	NOUN
aiua-6590	221	9	symptoms	symptom	NOUN
aiua-6590	221	10	in	in	ADP
aiua-6590	221	11	elderly	elderly	ADJ
aiua-6590	221	12	men	man	NOUN
aiua-6590	221	13	.	.	PUNCT
aiua-6590	222	1	br	br	PROPN
aiua-6590	222	2	j	j	PROPN
aiua-6590	222	3	nutr	nutr	PROPN
aiua-6590	222	4	.	.	PROPN
aiua-6590	222	5	2007	2007	NUM
aiua-6590	222	6	;	;	PUNCT
aiua-6590	222	7	98:1237	98:1237	X
aiua-6590	222	8	-	-	SYM
aiua-6590	222	9	42	42	NUM
aiua-6590	222	10	.	.	PUNCT
aiua-6590	223	1	29	29	NUM
aiua-6590	223	2	.	.	PUNCT
aiua-6590	224	1	jarosz	jarosz	PROPN
aiua-6590	224	2	m	m	PROPN
aiua-6590	224	3	,	,	PUNCT
aiua-6590	224	4	olbert	olbert	PROPN
aiua-6590	224	5	m	m	PROPN
aiua-6590	224	6	,	,	PUNCT
aiua-6590	224	7	wyszogrodzka	wyszogrodzka	ADJ
aiua-6590	224	8	g	g	NOUN
aiua-6590	224	9	,	,	PUNCT
aiua-6590	224	10	et	et	PROPN
aiua-6590	224	11	al	al	PROPN
aiua-6590	224	12	.	.	PROPN
aiua-6590	224	13	antioxidant	antioxidant	PROPN
aiua-6590	224	14	and	and	CCONJ
aiua-6590	224	15	anti	anti	ADJ
aiua-6590	224	16	-	-	ADJ
aiua-6590	224	17	inflammatory	inflammatory	ADJ
aiua-6590	224	18	effects	effect	NOUN
aiua-6590	224	19	of	of	ADP
aiua-6590	224	20	zinc	zinc	NOUN
aiua-6590	224	21	.	.	PUNCT
aiua-6590	225	1	zinc	zinc	NOUN
aiua-6590	225	2	-	-	PUNCT
aiua-6590	225	3	dependent	dependent	ADJ
aiua-6590	225	4	nf	nf	NOUN
aiua-6590	225	5	-	-	PUNCT
aiua-6590	225	6	αb	αb	NOUN
aiua-6590	225	7	signaling	signal	VERB
aiua-6590	225	8	.	.	PUNCT
aiua-6590	226	1	inflammopharmacology	inflammopharmacology	NOUN
aiua-6590	226	2	2017	2017	NUM
aiua-6590	226	3	;	;	PUNCT
aiua-6590	226	4	25:11	25:11	NUM
aiua-6590	226	5	-	-	SYM
aiua-6590	226	6	24	24	NUM
aiua-6590	226	7	30	30	NUM
aiua-6590	226	8	.	.	PUNCT
aiua-6590	227	1	messina	messina	PROPN
aiua-6590	227	2	r	r	PROPN
aiua-6590	227	3	,	,	PUNCT
aiua-6590	227	4	mirone	mirone	NOUN
aiua-6590	227	5	v.	v.	ADP
aiua-6590	227	6	benign	benign	ADJ
aiua-6590	227	7	prostatic	prostatic	ADJ
aiua-6590	227	8	hyperplasia	hyperplasia	NOUN
aiua-6590	227	9	an	an	DET
aiua-6590	227	10	economic	economic	ADJ
aiua-6590	227	11	assessment	assessment	NOUN
aiua-6590	227	12	of	of	ADP
aiua-6590	227	13	fixed	fix	VERB
aiua-6590	227	14	combination	combination	NOUN
aiua-6590	227	15	therapy	therapy	NOUN
aiua-6590	227	16	based	base	VERB
aiua-6590	227	17	on	on	ADP
aiua-6590	227	18	a	a	DET
aiua-6590	227	19	literature	literature	NOUN
aiua-6590	227	20	review	review	NOUN
aiua-6590	227	21	.	.	PUNCT
aiua-6590	228	1	arch	arch	PROPN
aiua-6590	228	2	ital	ital	PROPN
aiua-6590	228	3	urol	urol	PROPN
aiua-6590	228	4	androl	androl	PROPN
aiua-6590	228	5	.	.	PROPN
aiua-6590	228	6	2015	2015	NUM
aiua-6590	228	7	;	;	PUNCT
aiua-6590	228	8	87:185	87:185	NUM
aiua-6590	228	9	-	-	SYM
aiua-6590	228	10	9	9	NUM
aiua-6590	228	11	.	.	PUNCT
aiua-6590	229	1	correspondence	correspondence	NOUN
aiua-6590	229	2	daniele	daniele	PROPN
aiua-6590	229	3	tiscione	tiscione	PROPN
aiua-6590	229	4	,	,	PUNCT
aiua-6590	229	5	md	md	PROPN
aiua-6590	229	6	irene	irene	PROPN
aiua-6590	229	7	tamanini	tamanini	PROPN
aiua-6590	229	8	,	,	PUNCT
aiua-6590	229	9	md	md	PROPN
aiua-6590	229	10	lorenzo	lorenzo	PROPN
aiua-6590	229	11	giuseppe	giuseppe	PROPN
aiua-6590	229	12	luciani	luciani	PROPN
aiua-6590	229	13	,	,	PUNCT
aiua-6590	229	14	md	md	PROPN
aiua-6590	229	15	gianni	gianni	PROPN
aiua-6590	229	16	malossini	malossini	PROPN
aiua-6590	229	17	,	,	PUNCT
aiua-6590	229	18	md	md	PROPN
aiua-6590	229	19	tommaso	tommaso	PROPN
aiua-6590	229	20	cai	cai	PROPN
aiua-6590	229	21	,	,	PUNCT
aiua-6590	229	22	md	md	PROPN
aiua-6590	229	23	ktommy@libero.it	ktommy@libero.it	PROPN
aiua-6590	229	24	department	department	PROPN
aiua-6590	229	25	of	of	ADP
aiua-6590	229	26	urology	urology	NOUN
aiua-6590	229	27	,	,	PUNCT
aiua-6590	229	28	santa	santa	PROPN
aiua-6590	229	29	chiara	chiara	PROPN
aiua-6590	229	30	regional	regional	PROPN
aiua-6590	229	31	hospital	hospital	PROPN
aiua-6590	229	32	largo	largo	PROPN
aiua-6590	229	33	medaglie	medaglie	NOUN
aiua-6590	229	34	d'oro	d'oro	PROPN
aiua-6590	229	35	9	9	NUM
aiua-6590	229	36	trento	trento	PROPN
aiua-6590	229	37	,	,	PUNCT
aiua-6590	229	38	italy	italy	PROPN
aiua-6590	229	39	luca	luca	PROPN
aiua-6590	229	40	gallelli	gallelli	PROPN
aiua-6590	229	41	,	,	PUNCT
aiua-6590	229	42	md	md	PROPN
aiua-6590	229	43	department	department	PROPN
aiua-6590	229	44	of	of	ADP
aiua-6590	229	45	health	health	PROPN
aiua-6590	229	46	science	science	NOUN
aiua-6590	229	47	,	,	PUNCT
aiua-6590	229	48	school	school	NOUN
aiua-6590	229	49	of	of	ADP
aiua-6590	229	50	medicine	medicine	NOUN
aiua-6590	229	51	,	,	PUNCT
aiua-6590	229	52	university	university	NOUN
aiua-6590	229	53	of	of	ADP
aiua-6590	229	54	catanzaro	catanzaro	PROPN
aiua-6590	229	55	,	,	PUNCT
aiua-6590	229	56	catanzaro	catanzaro	PROPN
aiua-6590	229	57	,	,	PUNCT
aiua-6590	229	58	italy	italy	PROPN
aiua-6590	229	59	paolo	paolo	PROPN
aiua-6590	229	60	verze	verze	PROPN
aiua-6590	229	61	,	,	PUNCT
aiua-6590	229	62	md	md	PROPN
aiua-6590	229	63	alessandro	alessandro	PROPN
aiua-6590	229	64	palmieri	palmieri	PROPN
aiua-6590	229	65	,	,	PUNCT
aiua-6590	229	66	md	md	PROPN
aiua-6590	229	67	vincenzo	vincenzo	PROPN
aiua-6590	229	68	mirone	mirone	PROPN
aiua-6590	229	69	,	,	PUNCT
aiua-6590	229	70	md	md	PROPN
aiua-6590	229	71	department	department	PROPN
aiua-6590	229	72	of	of	ADP
aiua-6590	229	73	urology	urology	NOUN
aiua-6590	229	74	,	,	PUNCT
aiua-6590	229	75	university	university	PROPN
aiua-6590	229	76	of	of	ADP
aiua-6590	229	77	naples	naples	PROPN
aiua-6590	229	78	,	,	PUNCT
aiua-6590	229	79	federico	federico	PROPN
aiua-6590	229	80	ii	ii	PROPN
aiua-6590	229	81	,	,	PUNCT
aiua-6590	229	82	naples	naples	PROPN
aiua-6590	229	83	,	,	PUNCT
aiua-6590	229	84	italy	italy	PROPN
aiua-6590	229	85	riccardo	riccardo	PROPN
aiua-6590	229	86	bartoletti	bartoletti	PROPN
aiua-6590	229	87	,	,	PUNCT
aiua-6590	229	88	md	md	PROPN
aiua-6590	229	89	department	department	PROPN
aiua-6590	229	90	of	of	ADP
aiua-6590	229	91	urology	urology	NOUN
aiua-6590	229	92	,	,	PUNCT
aiua-6590	229	93	university	university	NOUN
aiua-6590	229	94	of	of	ADP
aiua-6590	229	95	pisa	pisa	PROPN
aiua-6590	229	96	,	,	PUNCT
aiua-6590	229	97	pisa	pisa	PROPN
aiua-6590	229	98	,	,	PUNCT
aiua-6590	229	99	italy	italy	PROPN
aiua-6590	229	100	tiscione_stesura	tiscione_stesura	PROPN
aiua-6590	229	101	seveso	seveso	VERB
aiua-6590	229	102	04/04/17	04/04/17	PROPN
aiua-6590	229	103	09:05	09:05	NUM
aiua-6590	229	104	pagina	pagina	NOUN
aiua-6590	229	105	16	16	NUM